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Obesity and its associated comorbidities represent one of the greatest public health challenges
of the 21st century. Whilst the increase in prevalence has been driven by changes in lifestyle
and environment, it is clear that there is a genetic component underlying the variation in
body weight between individuals. However, the speed of translating obesity genetics into
insightful biological knowledge has not kept pace with the rate of identification of potential
genes of interest. One reason for this is that studies have so far been addressed in complex
model organisms such as mice.
Drosophila melanogaster is a key model for research in developmental biology, cell
biology and neurobiology, and has also recently been demonstrated to be an excellent model
for dissecting metabolic homeostasis pathways. In this thesis, a suite of assays was developed
in Drosophila to examine changes in the state of energy homeostasis and changes in energy
intake in response to specific genetic perturbations. This screen was validated by its ability
to detect metabolic perturbation in wild-type flies, and to differentiate between positive and
negative control genes. Different Drosophila models were investigated for their suitability
for the screen, and neuron-specific RNAi was found to provide the most useful information.
CRISPR was also investigated as a method of generating mutations in target genes de novo.
The validated screen was then used to explore genes highlighted by GWAS studies of
human body mass index (BMI), and by transcriptomics studies of fasted mouse hypothalamic
neurons. Each of these screens identified some genes which are already known to play an
important role in the control of energy homeostasis in mammals, demonstrating that the
screen is able to produce relevant results. They also highlighted several genes for which
there is currently no published functional data, demonstrating the utility of Drosophila in a
high-throughput screen to assay the potential involvement of genes in the neuronal control of
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1.1 Obesity and public health
Being overweight is defined as having an excessive accumulation of fat that negatively
impacts health. In practice, body fat is often assessed using Body Mass Index (BMI - a
person’s weight divided by the square of their height): >25kg/m2 is classed as overweight
and >30kg/m2 as obese. Average body weight has been increasing rapidly all over the world
and obesity is now classed as a global epidemic by the World Health Organization. Since
1975, the proportion of obese people has more than tripled and today 39% of adults are
overweight and an additional 13% are obese, which is significantly more than the <10% who
are underweight (GBD, 2017; NCD Risk Factor Collaboration, 2016; WHO, 2018).
The high levels of body fat in obesity increases the risk of many diseases including type 2
diabetes, cardiovascular disease, hypertension, cancer, and mental health (Must et al., 1999).
Therefore, high body weight is a major contributor to the global burden of disease. High BMI
is attributed to 4 million deaths each year globally, and 14% of premature deaths in Europe
(GBD, 2017; Di Angelantonio et al., 2018). Obesity also has an economic cost. For example
in 2007 the cost to the NHS of treating overweight and obese patients was £5.1 billion
and an additional £11.6 billion was spent on costs related to consequent unemployment
(Scarborough et al., 2011).
Over recent years, governments and health professionals have made many attempts to
reduce obesity but these have proved unsuccessful and the prevalence is still rising. It is
predicted that >20% of the world’s population will be obese by 2025 (NCD Risk Factor
Collaboration, 2016). Gaining a full understanding of the causes of obesity is therefore
critical in order to find effective and sustainable solutions.
2 Introduction
1.2 Environmental factors influencing obesity
An individual’s body weight is a reflection of the balance between their energy intake (food
and drink ingested) versus their energy output (for example movement, heat generation,
immune system function). A stable weight is maintained when these two figures are equal
but any discrepancies cause weight gain or weight loss. Large prolonged excesses of energy
intake lead to obesity and metabolic disease.
Because it has only become a problem relatively recently, the obesity epidemic is mainly
attributed to our modern lifestyle. Calorie intake has risen due to the increased abundance of
easy-to-access and processed high-calorie food whereas energy expenditure has decreased
as both work and leisure have become more sedentary (French et al., 2001). Together these
factors create an obesogenic environment which tips the energy balance towards weight gain.
Although lifestyle changes are undoubtedly responsible for the recent surge in obesity,
there is also evidence that other factors influence obesity risk such as in utero exposure
to maternal nutrition, sleep patterns, the microbiome, and obesity in social acquaintances
(Rooney and Ozanne, 2011; Hruby and Hu, 2015). In addition, genetics has been shown to
be an important factor for determining obesity risk.
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1.3 Genetic factors influencing obesity
The genes and alleles present in the population have not changed significantly in the same
time frame as the obesity epidemic has developed. Instead, the environment has become
obesogenic and how an individual responds to this environment is influenced by their genetics.
The earliest evidence for a role of genetics in obesity risk came from studying families. For
example, fat mass is more similar between monozygotic twins than it is between dizygotic
twins (Stunkard et al., 1986a; Feinleib et al., 1977), even when they are raised apart (Stunkard
et al., 1990). Further, the BMI of adopted individuals correlates with their biological parents
and not with their adoptive parents (Stunkard et al., 1986b). These and similar studies have
together concluded that up to 70% of the variation in BMI and fat mass between individuals
is due to genetic factors (Maes et al., 1997).
Monogenic obesity
A monogenic disorder is a disease caused by a deleterious mutation in a single gene. For such
disorders, genetics has a strong impact with only a small influence from the environment.
Monogenic obesity is rare, severe and early-onset (Huvenne et al., 2016) and mutations in
several different genes are known to cause this. One example is leptin: congenital leptin
deficiency is inherited in an autosomal recessive manner and results in intense hyperphagia,
leading to severe obesity from early childhood (Montague et al., 1997; Mutch and Clement,
2006; Echwald et al., 1997; Oksanen et al., 1997). Studies of leptin-deficient patients and
rodent models have shown that leptin is a hormone released by adipose tissue as a signal of
the level of triacylglycerol (TAG) stores (Considine et al., 1996; Halaas et al., 1995). The
hyperphagia (and other symptoms such as infertility) seen in leptin deficient individuals are
due to the inability of their adipose tissue to communicate to the body that there is fat stored.
Fewer than 100 patients worldwide are known to have homozygous deleterious mutations
in their leptin gene (Huvenne et al., 2016) and in total, monogenic obesity syndromes account
for <5% of obesity cases (Xia and Grant, 2013). Nevertheless, much of our knowledge
about the physiological systems involved in energy homeostasis has come from identifying
humans with monogenic obesity syndromes and studying genetically engineered rodent
models. Most of the known monogenic obesity mutations are in genes that are part of the
leptin-melanocortin axis which has a key role in the regulation of food intake (see section
1.4) for example leptin (Zhang et al., 1994; Montague et al., 1997), the leptin receptor LEPR
(Tartaglia et al., 1995; Chua et al., 1996), POMC (Challis et al., 2004; Krude et al., 1998),
and PCSK1 (Jackson et al., 1997).
4 Introduction
Oligogenic obesity
2-3% of obese adults and children have a genetic mutation which produces an obesity
phenotype of variable severity which is partly dependent on the environment, but which has
no additional specific phenotypes (Huvenne et al., 2016). This is referred to as oligogenic
obesity. An example is the MC4R gene for which mutations have an autosomal dominant
mode of transmission, incomplete age-related penetrance, and variability in the severity of
hyperphagia and obesity (MacKenzie, 2006).
Syndromic obesity
There are also more than 100 syndromic disorders which are associated with severe obesity.
Unlike monogenic and oligogenic obesity disorders, the syndromic obesity syndromes have
additional distinct clinical phenotypes, often mental retardation, dysmorphic features, and/or
developmental abnormalities (Huvenne et al., 2016). Whilst other syndromes that affect
cognition such as Down syndrome show an increased incidence of obesity, syndromic obesity
has specific effects on food intake (Chung, 2012).
The most common syndromic obesity disorder is Prader-Willi Syndrome which affects
1 in 15,000-25,000 live births (Chung, 2012) and is caused by a deletion of the region on
paternal chromosome 15 which encompasses the SNORD116 locus (Bieth et al., 2015). In
recent years genetic sequencing of patients with syndromic obesity disorders has identified
mutations in genes such as SH2B1 (Doche et al., 2012), TUB (Borman et al., 2014), CPE
(Alsters et al., 2015), NTRK2 (Yeo et al., 2004), SIM1 (Michaud et al., 2001), ACP1,
TMEM18, MYT1L (Doco-Fenzy et al., 2014), KSR2 (Pearce et al., 2013), and RAI1 (Alsters
et al., 2015).
Polygenic obesity
Monogenic, oligogenic and syndromic obesity disorders are rare. Instead the obesity in most
patients has a polygenic aetiology and is referred to as common obesity. This type of obesity
is influenced by the combined effect of common subtle variants in multiple different genes.
Individually these genetic variants only have a small effect, but they interact with each other
and with the environment. Given that the control of body weight has likely been subject to
a number of evolutionary selection pressures, it is not surprising that common obesity is a
complex polygenic trait. It is only with the advent of modern genetic techniques that the
genes involved in polygenic obesity are starting to be revealed.
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Early studies of common obesity looked for variants in genes that had already been
identified in monogenic obesity. For example, common variants in the leptin gene are
associated with BMI (Jiang et al., 2004; Li et al., 1999; Mizuta et al., 2008). However,
because monogenic obesity is rare, the number of genes that can be identified in this way is
limited. Further, any genes for which severe mutations cause lethality will never be found.
Therefore, hypothesis-driven approaches have only explained a small fraction of the genetic
risk for obesity.
The leading non-hypothesis-driven approach is currently a Genome Wide Association
Study (GWAS). GWASs genotype millions of single nucleotide polymorphisms (SNPs) in
thousands of people. The SNPs are spread across the entire genome in an unbiased and dense
manner. The frequency of a variant is compared between disease and control subjects and
any significant differences signal the presence of as allele that confers risk or protection.
Since 2007, multiple GWASs have been performed for several different obesity-related
characteristics such as BMI, body fat percentage and waist-to-hip ratio. These studies have
identified new genetic loci associated with obesity that have then been replicated across
many large independent studies with hundreds of thousands of subjects. The effect sizes of
these GWAS SNPs are much smaller than those seen in monogenic obesity - for example
the largest effect is seen with the FTO locus where homozygotes for the rs9939609 risk
allele weigh 3kg more and have a 1.67-fold increased risk of obesity than homozygotes for
the protective allele (Frayling et al., 2007). However, these genetic variants are much more
common than the mutations associated with monogenic obesity which arguably makes their
impact greater - for example 18% of people with European ancestry carry 2 risk FTO alleles
and 46% carry 1 (Frayling et al., 2007).
GWASs have associated BMI with SNPs near many of the genes involved in monogenic,
oligogenic and syndromic obesity, for example LEPR, POMC, MC4R, PCSK1, SH2B1,
TMEM18, BDNF, and TUB, as well as >100 novel genetic loci (Speliotes et al., 2010; Locke
et al., 2015; Akiyama et al., 2017).
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1.4 Neuronal control of feeding behaviour
Although the obesity epidemic is caused / influenced by a large number of factors, weight
gain can only occur when energy input from feeding exceeds energy output. Therefore
the study of feeding behaviour (energy intake) is an important part of understanding the
regulation of energy homeostasis and its dysregulation in obesity.
Feeding is a fundamental activity of all animals as they require energy for growth, survival
and reproduction. Therefore species have evolved feeding habits based on their internal
metabolic needs and external sensory signals which together affect meal size, frequency, and
content.
The central nervous system (CNS) is key for processing relevant information to generate
appropriate feeding responses. In particular, the hypothalamus is a critical mediator of energy
homeostasis in mammals. Early studies showed that introducing lesions into specific regions
of the rat hypothalamus caused hyperphagia and weight gain (Hetherington and Ranson,
1942). Studies of monogenic, oligogenic and syndromic obesity have provided insight into
the underlying molecular mechanisms that control food intake in the CNS.
The best characterised pathway is the leptin/melancortin axis in the hypothalamus which
is summarised in figure 1.1. After release from the adipose tissue, leptin travels in the blood
to its target tissues. The arcuate nucleus (ARC) of the hypothalamus is located near the
semipermeable blood brain barrier, allowing it to sense and respond to peripheral signals of
energy state such as leptin. In the ARC, key populations of neurons express the leptin receptor
(Fei et al., 1997). One of these sets of neurons also express POMC and are thus referred to
as POMC neurons. Binding of leptin to its receptor on these cells causes depolarisation of
the neurons (Cowley et al., 2001). It also activates the JAK-STAT signalling pathway which
includes SH2B1 and TUB (Ren et al., 2005; Carroll et al., 2004) and results in increased
expression of POMC (Ernst et al., 2009; Yazdi et al., 2015). The POMC precursor peptide
is cleaved into several proteins including α-MSH and β -MSH by the enzymes PCSK1 and
CPE (Bertagna, 1994; Castro and Morrison, 1997). α-MSH and β -MSH are secreted by
active POMC neurons and can then bind to MC4R on the surface of downstream neurons.
Various genes are known to be involved in signalling pathways in the downstream neurons
including BDNF and its receptor TrkB (Xu et al., 2003; Kernie et al., 2000; Yeo et al., 2004;
Gray et al., 2007).
































Fig. 1.1 The leptin-melanocortin signalling pathway influences food intake. Highlighted in
red are genes found in monogenic/oligogenic/syndromic obesity.
AgRP = agouti-related peptide, ARC = arcuate nucleus, BDNF = brain-derived neurotrophic
factor, CPE = carboxypeptidase E, LEPR = leptin receptor, MC4R = melanocortin 4 re-
ceptor, α/β -MSH = α/β -melanocyte-stimulating hormone, NPY = neuropeptide Y, PCSK1
= proprotein Convertase Subtilisin/Kexin Type 1, POMC = pro-opiomelanocortin, PVN =
paraventricular nucleus, SH2B1 = SH2B adapter protein 1, SIM1 = single-minded homolog
1, STAT3 = signal transducer and activator of transcription 3, TrkB = tropomyosin receptor
kinase B, TUB = tubby Bipartite Transcription Factor.
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The POMC neurons in the ARC project to other areas of the hypothalamus including
the ventromedial nucleus (VMN), dorsomedial nucleus (DMN), paraventricular nucleus
(PVN) and lateral hypothalamus (LH) (see figure 1.2) (Cone, 2005). Studies in which these
hypothalamic areas are individually ablated, genetically perturbed, or injected with specific
neuropeptides have shown that they are all involved in feeding behaviour regulation (Simpson
et al., 2009). POMC neurons also project to other areas of the brain, for example the amygdala
which is involved in reward. By signalling to all of these areas, the leptin-melanocortin
pathway inhibits food intake (anorexigenic) and so it is unsurprising that mutations in many
of the involved genes have been found in obesity syndromes.
Not all of the genes identified from obese patients are directly part of the leptin-
melanocortin pathway, but many still act in a related manner. For example SIM1 encodes a


















Fig. 1.2 The main hypothalamic nuclei involved in the regulation of appetite in the human
brain. Diagram based on Simpson et al. (2009).
ARC = arcuate nucleus, DMN = dorsomedial nucleus, GLP1 = glucagon-like peptide-1,
LH = lateral hypothalamus, PVN = paraventricular nucleus, PYY = peptide YY, VMN =
ventromedial nucleus.
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Another population of neurons in the ARC also sense and respond to leptin: the
NPY/AgRP neurons (figure 1.1). Leptin binding to LEPR on these neurons inhibits the
production of both NPY and AgRP proteins (Varela and Horvath, 2012). Release of NPY
and GABA from these neurons to receptors in the PVN, DMN, VMN and LH has an orexi-
genic (appetite-stimulating) effect, and release of AgRP antagonises MC4R to prevent its
anorexigenic effect (Ollmann et al., 1997). Consequently, constitutive expression of AgRP in
mice results in hyperphagia and obesity (Graham et al., 1997).
As well as leptin, the POMC and NPY/AgRP neurons in the ARC respond in a similar
manner to other circulating signals of peripheral energy surplus including insulin and the
post-prandial gut peptides PYY and GLP1 (Brüning et al., 2000; Teubner and Bartness, 2013;
NamKoong et al., 2017). The ARC neurons respond in the opposite manner to ghrelin, a
hormone released by the stomach during fasting (Riediger et al., 2003).
Finally, GWAS studies of common obesity have also shown the importance of the brain
for regulating energy homeostasis: the genes in loci which correlate with BMI (a measure of
total fat mass) are enriched for expression in the CNS (Locke et al., 2015). By comparison,
genes associated with waist-to-hip ratio (a measure of the distribution of body fat) are instead
enriched in adipose tissue (Shungin et al., 2015).
Therefore, studying the CNS is key to understanding mechanisms of energy homeostasis
and its dysregulation in obesity.
10 Introduction
1.5 Why study obesity genetics?
Discovery of genes which influence common obesity make it possible to identify those who
are at risk, so that lifestyle modifications (changed diet and increased exercise) can be made
before weight gain and its comorbidities even occur. However, for those already suffering
from obesity there is currently no treatment that is both safe and highly effective. Lifestyle
modifications are the safest means of weight loss, but patient compliance is generally poor
which reduces efficacy. Bariatric surgery can result in weight loss of 20%, but like all surgery
it is expensive and risky. Currently five pharmaceutical agents are approved for use in the US
for weight loss and one in the UK, but these drugs have major side-effects and only bring
about modest weight loss that is not maintained longer than one year (Gadde et al., 2018).
The discovery of leptin led to the development of an effective treatment for leptin-deficient
patients: subcutaneous injection of leptin reduces hyperphagia and food intake and leads to
weight loss (Farooqi et al., 1999). Another drug currently in clinical trials for patients with
deficiencies of LEPR or POMC is setmelanotide: an agonist of MC4R shown to decrease
food intake and cause weight loss in humans (Clément et al., 2018; Ayers et al., 2018).
These two treatments show how a genetic discovery can directly lead to development of a
novel pharmaceutical reagent for the treatment of obesity. However, leptin injection is not
effective for the treatment of common obesity (Heymsfield et al., 1999) because most of
these individuals have elevated levels of leptin and are instead leptin resistant (Frederich
et al., 1995).
Therefore understanding the biology of pathways and systems that are involved in energy
homeostasis is necessary in order to develop treatments for common obesity. Studying the
function of individual genes using single gene mutants is a good way to dissect the genetic
basis of a disease pathway (Moore, 2010). Since genetics strongly impacts body weight,
genetic approaches offer an effective tool for identifying and understanding the complex
molecular mechanisms of energy homeostasis. The polygenic basis of common obesity
makes it a rich source of potential novel insights which may, in the future, aid development
of pharmaceutical agents which are both effective and specific.
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1.6 The difficulties of studying obesity genetics
Following completion of the human genome project, the advent of large-scale sequencing
methods has driven the study of human disease genetics forward at a remarkable pace.
Genomic techniques have identified hundreds of human genes associated with BMI, fat mass,
and other obesity-related characteristics. Examples of such techniques include GWASs and
RNAseq.
The problem is that because the control of energy homeostasis involves large numbers
of genes, interactions between these genes and interactions with the environment, these
genetic techniques generate large data sets. Unfortunately the scientific community lacks
the resources to study all of the genes identified in detail and so few have been followed up
functionally.
As techniques become more advanced, results are being generated at an ever increasing
rate. The question then arises as to which of the identified genes are likely to be the most
fruitful to study. What is needed is a method of prioritising the genes from these large data
sets to determine which should be the subject of further research.
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1.7 Animal models for the study of obesity genetics
To study obesity genetics relevant to humans, the most accurate model would, of course, be
humans. However the obvious ethical barriers to creating mutants de novo mean that research
relies instead on the serendipitous identification of rare genetic mutants. Even then, the
person’s environment is not controlled which decreases the power to link genetic variation to
phenotype. Further, it is difficult to obtain tissue samples from the brain (the most relevant
tissue).
To date, most obesity genetics studies have used mice and rats. These rodents share 99%
of their genome with humans as well as many biochemical pathways, physiological features
and pathological symptoms (Vandamme, 2014; Rosenthal and Brown, 2007). However,
rodents have several characteristics which make them unsuitable for looking at large genetic
data sets. Firstly, experiments are time-consuming with low statistical power because
breeding rodents is slow (generation time of 10 weeks with <10 pups per litter (Phifer-Rixey
and Nachman, 2015)). Experiments are also expensive due to the high cost of purchasing
(>£15 for 1 wild-type from the Jackson Laboratory) and maintaining (>£5.60 per week per
mouse in the Cambridge University PDN mouse facility) the animals. The estimated cost of
producing and phenotyping a mouse model for a single gene is £30,000 (Moore, 2010).
Cell culture has also provided many useful insights into obesity genetics, and unlike
with rodents, such experiments are fast and cheap. However, their unicellularity means that
cells can have only limited use for studying a systems disorder such as obesity or related
behaviours like feeding.
Drosophila melanogaster have been used as a model organism for over 100 years. They
have many features that make them potentially well suited for use in high-throughput genetic
studies of energy homeostasis. These attributes will now be explored.
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It is economical to work with Drosophila: stocks are freely shared amongst researchers or
purchased cheaply (£1-£2) from international stock centres and it is 10,000 times cheaper to
maintain fly stocks than mice (Neckameyer and Argue, 2013). Experiments using Drosophila
are also time-efficient: the generation time is only 10 days and 1 female fly can lay up to 100
embryos each day (Jennings, 2011). These two factors make experiments with Drosophila
high-throughput and thus suitable for studying large numbers of genes.
For studying genetics it is important to be able to generate specific genotypes. In this
regard, flies offer the following advantages: (i) there are only four chromosome pairs to
consider, (ii) there is no meiotic recombination in males, (iii) it is easy to distinguish males
vs females and virgins vs mated flies, and (iv) transgenes can be tracked with many different
markers that affect external characteristics visible using just a bench microscope.
Further, a huge variety of genetic techniques have been developed for use in Drosophila.
A plethora of mutant and transgenic Drosophila lines have been created which are readily
available and enable over-expression, mis-expression, knock-down, or knock-out (KO) of
virtually any gene in a specific tissue or condition. Four genetic techniques are used in this
thesis, and will be explained in more detail in chapters 3 and 5: transposon insertion, the
GAL4-UAS system, RNA-interference (RNAi), and CRISPR.
Another important factor for genetic studies is that only 25% of Drosophila genes are
adult-lethal when mutant, and many of these are still viable as larvae. Even mutants for most
housekeeping genes are able to complete embryogenesis (Wangler et al., 2017). This means
that is is possible to study most genes in a homozygous mutant fashion. For those genes
which are not viable, many tissues in Drosophila are amenable to mosaic analysis which
allows lethal genes to be perturbed and studied in just a single tissue which is often less
detrimental than mutation throughout the entire fly. Alternatively, balancer chromosomes
are readily available and allow the mutations to be maintained in heterozygote populations.
Balancer chromosomes are engineered constructs with DNA inversions to suppress meiotic
recombination (Hentges and Justice, 2004), and since they are homozygous lethal/sterile and
carry dominant phenotypic markers that can be scored visually, there is no need to constantly
PCR genotype as is the case with mice.
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1.9 Genetic conservation between Drosophila and humans
Drosophila have been used extensively in the past as a model for human disease and this is
possible because of high levels of genetic conservation. Studies have shown that 53% of
human genes are present in Drosophila, but genes linked to human disease show even higher
conservation with 77% having an orthologue in flies (Fortini et al., 2000; Reiter et al., 2001;
Wangler et al., 2017). The nucleotide/protein sequence identity of homologues is usually
around 40% but can be more than 90% within functional domains (Pandey and Nichols,
2011).
As well as sequence conservation there is also conservation of tissue expression patterns.
For example, of human genes associated with neurological disorders, more fly homologues
were found to be expressed in the fly CNS than in the fly digestive system (Wangler et al.,
2017).
Even for genes with no apparent sequence homologue, there are studies in which express-
ing the human gene in flies has yielded useful information (St Johnston, 2002). For example,
expression of human synphilin-1 in fly neurons increases food intake, body weight, and fat
deposition which is the same phenotype observed in mice (Li et al., 2012; Liu et al., 2012;
Smith et al., 2014). Further, mutations in upd1 increase food intake and TAG stores in flies
but these phenotypes can be rescued by expression of the human leptin gene (Beshel et al.,
2017).
Importantly for this thesis, energy homeostasis in Drosophila is also influenced by
genetics. Several genes have been found which model monogenic obesity in Drosophila and
some examples such as upd1 will be discussed in section 1.11. Further, applying starvation
as an evolutionary selective pressure over 15 generations (only those that survived starvation
were mated) eventually resulted in flies with hugely increased stores of TAG and sugar, and
reduced activity levels compared to controls (Schwasinger-Schmidt et al., 2012). It is also
possible to perform GWASs on flies to identify SNPs that are associated with variations in
metabolic traits, for example Jehrke et al. (2018).
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1.10 Metabolic conservation in Drosophila
Many physiological and biochemical pathways involved in energy storage and utilisation are
well conserved across the animal kingdom, including between humans and Drosophila. This
is an important point if flies are to be used to study energy homeostasis, and four examples
will be shown briefly here.
1.10.1 Conserved metabolic tissues and physiology
As defined by their structure, function, and gene expression patterns, all of the principal
mammalian metabolic tissues and organs have homologues in Drosophila, as shown in
the table below and figure 1.3. Like in mammals, the regulation of energy homeostasis in
Drosophila requires the interplay between all of these metabolically active tissues in changing
environmental conditions.
Mammalian organ Drosophila organ Function
adipose tissue fat body stores TAG, secretes adipokine-like factors
liver fat body stores and regulates glycogen
liver oenocytes stores and regulates lipids, senses metabolic status
GI tract GI tract digestion and absorption of nutrients
kidneys malpighian tubules, nephrocytes excretion, osmoregulation, detoxification
pancreas Insulin-like peptide producing cells (IPCs) glucose homeostasis
Adipokinetic Hormone (AKH) producing cells (APCs)









Fig. 1.3 Metabolic organs in Drosophila. Figure based on Musselman and Kühnlein (2018).
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1.10.2 Conserved metabolic pathway: lipid storage
In times of energy excess, both mammals and Drosophila store TAG in the form of lipid
droplets (LDs) in adipose tissue and the fat body, respectively. This TAG is released into
circulation during periods of scarcity.
Formation of TAG
The stored TAG is formed by the Kennedy pathway in four enzymatic steps (Yen et al., 2008).
The first and second steps are largely unexplored in Drosophila (Kühnlein, 2012). The third
step is catalysed by the highly conserved lipin gene family: Lipin-1 deficient mice exhibit
lipodystrophy and insulin resistance (Peterfy et al., 2001; Reue, 2009) and Drosophila larvae
lacking lipin have smaller LDs and a smaller fat body (Ugrankar et al., 2011). The final step
is catalysed by diglyceride-acyltransferase enzymes: DGAT1-deficient mice have 50% less
adiposity and are resistant to diet-induced obesity (Smith et al., 2000) and adult Drosophila
with knockout of mdy are also lean (Beller et al., 2010).
Basal lipolysis
Under basal conditions, mammalian perilipin and Drosophila Lsd2 proteins are bound to the
surface of LDs where they prevent access by lipases (Wolins et al., 2006). Consequently,
humans, mice and flies which lack functional perilipin/Lsd2 have smaller TAG stores due to
increased basal lypolysis (Gandotra et al., 2011; Tansey et al., 2001; Teixeira et al., 2003).
Conversely, overexpression of Lsd2 in the fat body of flies increases fat accumulation (Arrese
et al., 2008; Fauny et al., 2005; Gronke et al., 2003). Basal lipolysis is mediated by ATGL in
mammals and bmm in Drosophila, and mutants in these genes show excessive accumulation
of lipids (Gronke et al., 2005; Haemmerle et al., 2006; Schweiger et al., 2009).
TAG release
In times of negative energy balance, glucagon / adipokinetic hormone (AKH) bind to their
receptors on adipose / fat body cells, which activates PKA. In turn, PKA phosphorylates
perilipin-1 / Dmplin1 proteins which makes them able to recruit hormone-sensitive lipase
(HSL) to the LD, triggering lipolysis (Arrese et al., 1999, 2008; Bi et al., 2012; Miyoshi
et al., 2006; Sztalryd et al., 2003; Kühnlein, 2012). Mouse cells with loss of perilipin-1
phosphorylation can not enhance lipolysis (Miyoshi et al., 2006), and starvation-induced
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lipolysis is blunted in AKHR mutant flies whereas ectopic expression of AKH in the fat body
decreases stored lipids (Gronke et al., 2007; Lee and Park, 2004; Kühnlein, 2012).
1.10.3 Conserved metabolic signalling: glucose homeostasis
Insulin release
In both mammals and flies, carbohydrate homeostasis is controlled by hormones secreted
into the blood and haemolymph circulation respectively. In response to high glucose levels,
mammalian pancreatic β cells secrete insulin and Drosophila insulin-producing cells (IPCs)
secrete insulin-like peptide (dILP)-2, -3 and -5 (Brogiolo et al., 2001; Fridell et al., 2009;
Kreneisz et al., 2010). Consequently, ablation of pancreatic β cells / IPCs or mutation of
insulin / dilp1-5 results in elevated levels of sugars in the blood / haemolymph (Atkinson
and Maclaren, 1994; Nishi and Nanjo, 2011; Rulifson et al., 2002; Zhang et al., 2009). The
development of IPCs is controlled by the transcription factor eyeless whose mammalian
homologue, Pax6, is required for β -cell specification (Clements et al., 2008).
In β cells, glucose sensing by GLUT1 and/or GLUT2 triggers release of ATP from
mitochondria (Graham and Pick, 2017). GLUT1 is also involved in flies as knockdown of
glut1 in IPCs decreases levels of circulating dILP2 (Park et al., 2014).
In mammals, the released ATP regulates KATP channels in the cell membrane, causing
depolarisation which in turn activates Ca2+ channels, leading to exocytosis of insulin from β
cells (Nassel and Broeck, 2016). In Drosophila, KATP channels are also involved, as shown
using glibenclamide (a KATP channel inhibitor) and glucose causes an influx of Ca2+ in IPCs
(Fridell et al., 2009; Kreneisz et al., 2010).
18 Introduction
Insulin action
Insulin / dILPs travel in the blood / haemolymph to their target tissues and bind to the




























Fig. 1.4 The insulin signalling pathway is conserved between mammals and Drosophila.
dILP = Drosophila insulin-like peptide, GLUT4 = glucose transporter 4, InR = insulin/ILP re-
ceptor, IRS = insulin receptor substrate 1, PDK = phosphoinositide-dependent kinase-1, PIP2
= phosphatidylinositol 4,5-bisphosphate, PIP3 = phosphatidylinositol 3,4,5-trisphosphate,
PI3K = phosphoinositide 3-kinase, AKT/PKB = protein kinase B, PTEN = phosphatase and
tensin homolog.
This signalling pathway activates a sugar transporter, promoting uptake of glucose into
peripheral tissues (Huang and Czech, 2007). Mice with decreased levels of the GLUT4
transporter protein in muscle or adipose tissue show insulin resistance and propensity toward
diabetes (Abel et al., 2001; Zisman et al., 2000; Li et al., 2000; Stenbit et al., 1997; Rossetti
et al., 1997). Fat cells from transgenic Drosophila expressing tagged human GLUT4 respond
to insulin by increasing GLUT4 trafficking and translocation to the plasma membrane,
showing that Drosophila have the necessary signals to direct mammalian-like trafficking in
response to insulin signalling (Crivat et al., 2013).
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Glucagon action
On the other hand, when sugar levels are low, mammalian pancreatic α cells secrete glucagon
and Drosophila AKH-producing cells (APCs) secrete the structurally similar AKH (Van
der Horst, 2003). Glucagon/AKH bind to their receptors on the liver/fat body, leading to
activation of glycogen phosphorylase and consequent release of glucose into circulation
(Arrese and Soulages, 2010; Jiang and Zhang, 2003). Knockout of the glucagon receptor
in mice or Akh in flies results in lower glucose levels, whereas ectopic expression of Akh in
the fly fat body results in release of stored carbohydrate (Gelling et al., 2003; Van der Horst,
2003; Lee and Park, 2004)
1.10.4 Conserved metabolic pathology: the effect of high-calorie diets
As discussed earlier, the modern obesity epidemic is partially driven by high calorie diets.
Drosophila develop the same metabolic phenotypes as mammals when given diets high in
fat and/or sugar. This includes weight gain, increased fat storage, hyperglycaemia, insulin-
resistance, cardiopathy, and decreased life span, suggesting that there is conservation of the
underlying pathological molecular mechanisms (Birse et al., 2010; Heinrichsen and Haddad,
2012; Morris et al., 2012a; Musselman et al., 2011; Na et al., 2013).
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1.11 Neuronal control of feeding behaviour in Drosophila
As discussed in section 1.4, the human brain is key for controlling energy homeostasis
and feeding behaviour. The Drosophila brain contains approximately 200,000 neurons
(Moloney et al., 2010) which is significantly smaller than a human brain which contains
approximately 86 billion neurons (Azevedo et al., 2009). However, many parallels exist
between the CNS of Drosophila and that of humans. Like in humans, the fly brain is
composed of specific substructures specialised for function such as sensory processing
(optic and antennal lobes), memory (mushroom bodies), and motor output (central complex)
(Moloney et al., 2010). Individual Drosophila neurons are also similar to human neurons in
terms of their physical structure and biochemical signatures (Moloney et al., 2010). Many
homologous features are governed by homologous genes in both species including neuron
identity and pruning, axon insulation and pathfinding, and neurotransmitters (Held, 2017).
These functional and structural similarities of the CNS have been successfully exploited
in studies of neurodegenerative disease but have only recently been applied to the study
of obesity. Like in humans, the Drosophila brain has a key role in regulation of feeding
behaviour and many of the genes involved in mammals have homologues in flies. A few
examples will now be described.
NPF and food seeking
In humans, NPY plays a key role in the control of energy homeostasis (see section 1.4). NPY
is expressed in hypothalamic neurons and its five GPCR receptors (Y1, Y2, Y4, Y5 and Y6)
are distributed across the central and peripheral nervous systems (Tatemoto et al., 1982). In
Drosophila, neuropeptide F (NPF) and short (s)NPF, and their receptors NPFR and sNPFR,
show sequence and structural similarity to NPY and the Y receptor family, and are expressed
in the central and peripheral nervous systems (Brown et al., 1999; Garczynski et al., 2002;
Lee et al., 2004; Mertens et al., 2002).
These NPY/(s)NPF neurons are activated by energy deficit - NPY neurons by ghrelin
and NPFR neurons by starvation (Kohno et al., 2003; Wu et al., 2005a,b). Conversely, both
NPY and NPF neurons are negatively regulated by signals of energy surplus such as leptin /
upd1 and insulin / dILPs (Sahu, 1998; Schwartz et al., 1992; Wu et al., 2005a,b; Beshel et al.,
2017).
Increases in NPY/(s)NPF expression has an orexigenic effect. Intracerebroventricular
(ICV) injection of NPY or Y1 agonists into mice causes hyperphagia and weight gain (Henry
1.11 Neuronal control of feeding behaviour in Drosophila 21
et al., 2005; Mullins et al., 2001; Sainsbury et al., 1997). NPF and sNPF mainly act on
foraging behaviour, mediated by attraction towards food odours. Over-expression of sNPF
in the Drosophila nervous system promotes food intake and causes flies to behave in a
manner that mimics starvation (Lee et al., 2004; Root et al., 2011). Expression of NPF in
wandering larvae causes them to return to continuous feeding, and NPFR activation increases
the attractiveness of both food- and aversive-odours and promotes feeding on noxious and
unattractive food, partially mediated by ILP-receptor signalling (Wu et al., 2003, 2005b,a;
Beshel and Zhong, 2013; Kohno et al., 2003).
Conversely, ablation of NPY neurons in adult mice leads to anorexia (Wu and Palmiter,
2011) and genetic deletion of Y1 in ob/ob mice reduces their food intake (Pralong et al.,
2002). Genetic perturbation of NPF and sNPF neurons also leads to changes in food intake,
wandering behaviour, and food-search behaviour in response to starvation (Beshel and Zhong,
2013; Lee et al., 2004; Root et al., 2011; Wu et al., 2003).
upd1 and feeding motivation
As discussed in section 1.3, leptin hormone is released by adipose tissue in relation to fat
storage levels in humans. It has an anorexigenic effect, in part brought about by inhibiting
NPY neurons (Stephens et al., 1995). The Drosophila gene upd1 shows sequence and
structural homology to leptin, and binds to the domeless receptor found on NPF neurons,
leading to suppressed NPF activity (Beshel, 2016; Boulay et al., 2003; Harrison et al., 1998;
Wright et al., 2011).
Leptin-deficient rodents and humans are heavier with larger fat stores due to increased
food intake but still show increased food-seeking behaviour (Farooqi and O’Rahilly, 2014).
All of these phenotypes are also seen in flies with knock-down of upd1 (Beshel, 2016).
Interestingly, this Drosophila phenotype could be rescued by expression of the human leptin
gene, highlighting the conservation between humans and Drosophila (Beshel, 2016).
hugin and meal initiation
Another component of the neural circuitry of feeding is mammalian neuromedin U (NmU)
and the Drosophila homologue hugin. NmU and hugin have similar structures, and are both
cleaved into 8mer peptides with similar sequences that bind to homologous GPCRs (Austin
et al., 1995; Brighton et al., 2004; Meng et al., 2002; Rosenkilde et al., 2003). Rat NmU is
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specifically expressed in the VMN and hugin in the subesophageal ganglion, regions involved
in regulating feeding (Howard et al., 2000; Melcher and Pankratz, 2005).
Expression of both NmU and hugin is down-regulated by fasting (Itskov and Ribeiro,
2013). Accordingly, NmU knockout mice are obese with increased feeding (Bechtold et al.,
2009; Hanada et al., 2004), and blocking synaptic activity of hugin-expressing neurons
using tetanus toxin decreases the time taken to initiate feeding in Drosophila (Melcher and
Pankratz, 2005; Melcher et al., 2006, 2007). Conversely, ICV administration of NmU, or
overexpression of NmU or hugin, suppresses feeding (Bechtold et al., 2009; Howard et al.,
2000; Kowalski et al., 2005; Melcher and Pankratz, 2005; Melcher et al., 2006, 2007; Schoofs
et al., 2014).
Leucokinin and feeding cessation
The tachykinins are a family of small peptides which, along with their receptors, are expressed
in the mammalian hypothalamus and have a role in feeding behaviour (Cvetkovic et al., 2003;
Achapu et al., 1992; Sahu et al., 1988; Itskov and Ribeiro, 2013). For example, injection of
NPK in rats delays feeding initiation (Sahu et al., 1988).
The Drosophila protein leucokinin (Lk) shows sequence homology to the tachykinins,
and is expressed in the CNS (Radford et al., 2002). According to published data, flies with
mutations of Lk or its receptor (Lkr) show increased food intake each meal, but compensate
by increasing the interval between their meals (Al-Anzi, 2010; Zandawala et al., 2018). The
effects of Lk on meal termination are independent of hugin and NPF neurons (Al-Anzi,
2010).
Serotinergic neurons and satiety
Serotonin is a neurotransmitter synthesised within the CNS exclusively in the raphe nuclei in
the brainstem of mammals and in the R50H05 region of the central brain in Drosophila (Albin
et al., 2015; Donovan and Tecott, 2013). In both cases, these small groups of neurons project
extensively throughout the CNS. One of the targets of the serotonin neurons in Drosophila is
Lk neurons (Liu et al., 2015).
In rodents, CNS serotonin signalling suppresses feeding. Hyperphagia can be induced by
lesioning the raphe nuclei or ICV injection of pharmaceutical agents that block serotonin
signalling (Breisch et al., 1976; Geyer et al., 1976; Klitenick and Wirtshafter, 1988; Saller
and Stricker, 1976). Conversely, hypophagia results after central injection of serotonin or
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its precursor 5HTP, or by blocking serotonin re-uptake (Blundell et al., 1975; Blundell and
Latham, 1979; Simansky, 1996)
In Drosophila, disruption of serotonin signalling also strongly affects feeding, but in the
opposite direction. Acute activation of the R50H05 serotonergic neurons causes sated flies to
feed the same way as starved flies (Albin et al., 2015) whereas using a serotonin receptor
antagonist to blocking signalling inhibits feeding in larvae (Gasque et al., 2013).
DSK and satiety
DSK is the Drosophila homologue of mammalian CCK (Söderberg et al., 2012). CCK is
found in both the brain and the gastrointestinal tract and injection into mammals inhibits food
intake by producing satiety (Moran, 2000). In the Drosophila brain, DSK is produced by
IPCs and knockdown of DSK in IPCs, or inactivation of IPCs, decreases satiety signalling in
flies and hence increases food intake, even when the food is less palatable or bitter (Söderberg
et al., 2012).
The TFAP-2 and twz genes regulate expression of DSK (Williams et al., 2014). The
human homologues of these two genes do not yet have a proven role in energy homeostasis
but they have been associated with BMI by GWAS (Speliotes et al., 2010).
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Foraging Meal initiation Satiety / 
meal termination
NPF(s)NPF hugin DSK Lk
upd1 dILPs serotonin
fasting
Fig. 1.5 Neural pathways that regulate feeding behaviour in the Drosophila adult brain.
Figure based on Pool and Scott (2014).
dILP = Drosophila insulin-like peptide, DSK = drosulfakinin, Lk = leucokinin, NPF =
neuropeptide F, upd1 = unpaired 1.






Fig. 1.6 Expression of some neuropeptides involved in feeding behaviour in the Drosophila
adult brain. Figure shows a coronal section of the Drosophila adult brain, adapted from
Nässel (2018).
dILP2 = Drosophila insulin-like peptide 2, DSK = drosulfakinin, NPF = neuropeptide F,
upd1 = unpaired 1.
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1.12 High-throughput genetic screens for energy homeostasis
phenotypes
1.12.1 Screens in mice
The International Mouse Phenotyping Consortium (IMPC) is currently undertaking a project
to produce and phenotype knock-out mouse lines for 20,000 genes (Moore, 2010; Dickinson
et al., 2016). The project started in 2011, and has now created mutant mouse lines for 5505
genes. These lines are only partially phenotyped, for example only 594 lines have had
food intake measured (data release 8.0, July 2018). Further, because the IMPC are creating
whole-organism gene knock-out mutations, there is no phenotype information specific to the
brain, and 35% of the lines created so far are lethal before weaning so can not be examined.
Although this data will, one day, be available for all of the genes, the speed of results
generation in mice is exponentially slower than that for Drosophila. Therefore, at least for
the time being, there is need for a high-throughput screen for the role of genes in the brain’s
control of feeding behaviour and energy homeostasis.
1.12.2 Screens in Drosophila
There are many published examples of using Drosophila to study one or a few genes involved
in energy homeostasis, and some of these were mentioned previously. But as was highlighted
in section 1.8, studies using Drosophila have the potential to be high-throughput. This,
coupled with the well-developed genetic techniques available in flies and the high level of
genetic and metabolic conservation means that Drosophila have also recently been used for
large-scale genetic screens of metabolic phenotypes.
As just one example, Pospisilik et al. (2010) performed a genome-wide screen for TAG
levels in adult flies using RNAi knockdown. Overall, the top hit was the hedgehog signalling
pathway in the fat body. They went on to show that mice with activation of the same pathway
in adipose tissue show a near total loss of white fat due to blocked differentiation of white
adipocytes. Such studies are "fishing" experiments in which there is no starting hypothesis
and results from Drosophila physiology are then used to look for results in mice/humans.
Although this is often successful (see also screens for metabolic phenotypes by Reis et al.
(2010) and Baumbach et al. (2014)), there is no guarantee that results will be applicable to
human disease. A different approach was used in this thesis: human genetics are already
known but require an animal model for functional investigation.
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A PubMed search revealed two published large-scale (>50 genes) Drosophila-based
screens which started with genes from human metabolic disease. Pendse et al. (2013) and
Baranski et al. (2018) studied genetic loci that have been associated by GWAS with type 2
diabetes and BMI respectively in humans. These studies will be explored in more detail in
chapter 4, but briefly, Pendse et al. looked for a sucrose-dependent toxicity phenotype, and
Baranski et al. for a TAG phenotype. Based on their results, both were able to suggest which
genes should be the focus of further studies in humans/mice and in many cases these were not
the genes which would have been selected based solely on the original human statistics-based
data, highlighting the utility of Drosophila for unbiased screening of genes. However, these
studies assessed just one phenotype and did not look at feeding behaviour.
In terms of feeding behaviour, a PubMed search found only two published large-scale
screens in Drosophila. The first screen used a collection of lines (not genome-wide) to
look for larval feeding defects and identified the genes ppl and klu (Melcher and Pankratz,
2005; Zinke et al., 1999). The second screen used Drosophila larvae to screen 3630 drugs
for inhibition of food intake, leading to identification of an anorectic serotonin receptor
antagonist called metitepine (Gasque et al., 2013). As above, these screens may or may not
provide information applicable to human disease.
Thus, to my knowledge, there are no published large-scale screens of human genes using




The public health concerns over obesity combined with the lack of a full understanding of
the mechanisms of energy homeostasis are the primary motivation of this work. This thesis
aimed to develop an in vivo, high-throughput, Drosophila-based screen to assess large lists
of human genes for a role in the neuronal control of energy homeostasis and in particular
feeding behaviour, and then to use the screen to identify top candidates for further studies in
mice and humans. The aims of each chapter are to:
• Chapter 3: Develop and validate a Drosophila-based screen for looking at the in vivo
impact of genes on energy homeostasis and feeding behaviour using readily available
Drosophila lines
• Chapter 4: use this high-throughput screen to analyse genes suggested by GWAS to
affect BMI. This list of candidate genes has already been probed but only to a limited
extent, making it ideal for use as both proof-of-principle as well as a potential source
of novel results.
• Chapter 5: Explore the possibility of creating specific de novo genetic mutations in
Drosophila for use in the screen
• Chapter 6: Use the final screen developed in chapters 3 through 5 to explore genes
from the hypothalamus which have been shown to be regulated by fasting, and thus




The different diet media to which flies were exposed are listed in the table below. All
flies were raised on ND. Adult flies for phenotyping were kept on either ND, HSD, HFD,
starvation media, or dye food, as appropriate.
Diet Name Ingredients
Normal diet ND agar, dextrose, maize, yeast, nipagin, water
High fat diet HFD ND + 20% coconut oil
High sucrose diet HSD ND + 35% sucrose
Starvation media SM agar and water only
Dye food - ND + 1% Fast Green FCF dye (Sigma)
All experimental flies were kept at 25oC and 60-70% humidity with a 14 hour light / 10
hour dark cycle, except for flies on HFD which were kept at 20oC, variable humidity, in the
dark.
2.2 Lines used
All lines used in this thesis are listed in table 2.1. Lines were purchased from VDRC,
Bloomington, Kyoto, Harvard, or provided by the University of Cambridge fly facility.
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Label Drosophila gene CGNR Stock centre ID Human gene
Vienna Drosophila Resource Center (VDRC, www.vdrc.at)
V1 CG10920 CG10920 109327KK MTCH2
V3 fuss CG11093 103367KK LBXCOR1
V4 St2 CG16733 47019GD SULT1A2
V5 PKN CG11221 100163KK SBK1
V6/VV59 CG4945 CG4945 24683GD SBK1
V7 CG8916 CG8916 101633KK GABRG1
V8 CG6550 CG6550 4947GD CDKAL1
V9 dSp1 CG1343 12607GD KLF9
V10 cabot CG4427 15555GD KLF9
V11 rab21 CG17515 109991KK RBJ
V12 mIF3 CG13163 39785GD MTIF3
V13 boss CG8285 4365GD GPRC5B
V14 Ets96B CG6892 30552GD ETV5
V15 dSec16 CG32654 29635GD SEC16B
V16 NT1 CG42576 108894KK BDNF
VV1 psn CG18803 101379KK PSEN1
VV2 engrailed CG9015 105678KK EN1
VV3 upd1 CG5993 3282GD LEPTIN
VV5 fz CG17697 43075GD FZD3
VV6 Ptp61F CG9181 37436GD PTPN2
VV7 trn CG11280 5242GD LRRN6C
VV8 HGTX CG13475 12608GD NKX6.1
VV9 fur1 CG10772 22853GD PCSK1
VV10 caps CG11282 27097GD LRRN6C
VV11 cert CG7207 27914GD COL4A3BP
VV12 shtd CG9198 29072GD ANAPC1
VV13 Fancl CG12812 32025GD FANCL
VV14 Ac3 CG1506 33217GD ADCY3
VV15 heph CG31000 33735GD PTBP2
VV16 rab2 CG3269 34767GD PCSK1
VV17 Lrp1 CG33087 39215GD LRP1B
VV18 dsor1 CG15793 40026GD KCTD15
VV19 TfAP-2 CG7807 41130GD TFAP2B
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Label Drosophila gene CGNR Stock centre ID Human gene
VV20/VV57 sbb CG5580 41845GD ZNF608
VV21 Tmem18 CG30051 43067GD TMEM18
VV22 Fili CG34368 44532GD LRRN6C
VV23 RpL27A CG15442 46439GD RPL27A
VV24 mEFTu1 CG6050 48981GD TUFM
VV25 isoQC CG5976 101533KK QPCTL
VV26 CG3732 CG3732 105968KK ZRANB2
VV27 Oscillin CG6957 106685KK GNPDA2
VV28 Nmda1 CG3798 108378KK FAIM2
VV29 Hmgcr CG10367 108617KK HMGCR
VV30 Atx2 CG5166 108843KK ATXN2L
VV31 RtGEF CG10043 17966GD SH3YL1
VV32 hth CG17117 100630KK MEIS1
VV33 DSK CG18090 14201GD CCK
VV34 unc13 CG2999 33606GD UNC13A
VV35 unc13-4a CG32381 109304KK UNC13A
VV36 DSK CG18090 106592KK CCK
VV37 CG2118 CG2118 25406GD MCCC1
VV40 sns CG33141 109442KK CADM2
VV41 Dh44-R1 CG8422 110708KK GIPR
VV42 Dh44-R2 CG12370 43313GD GIPR
VV43 Mtch CG6851 44305GD MTCH2
VV44 Lac CG12369 35524GD NEGR1
VV45 DIP-iota CG11320 18054GD NEGR1
VV46 Ama CG2198 22944GD NEGR1
VV47 Nrx-1 CG7050 4306GD NRXN3
VV48 Aps CG6391 110607KK NUDT3
VV49 Fur2 CG18734 1021GD PCSK1
VV50 QC CG32412 38277GD QPCTL
VV51 Zip71B CG10006 44538GD SLC39A8
VV52 Syn2 CG4905 110602KK SNTG2
VV53 TfAP-2 CG7807 41130GD TFAP2B
VV54 twz CG10440 110265KK KCTD15
VV55 Grd CG7446 5329GD GABRG1
VV56 CG14762 CG14762 31014GD LRRN6C
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Label Drosophila gene CGNR Stock centre ID Human gene
VV58 PKD CG7125 106255KK PRKD1
VV60 mIF3 CG13163 107373KK MTIF3
VV70 prosap CG30483 44830GD SHANK3
VV71 auxilin CG1107 16182GD GAK
VV72 chico CG5686 7776GD IRS1
VV74 hugin CG6371 26766GD Neuromedin U
VV75 mRpS21 CG32854 101430KK MRPS21
VV78 Ect3 CG3132 16779GD GLB1
VV79 KDM4A CG15835 107868KK KDM4C
VV80 poe CG14472 17648GD UBR4
VT1 betaTub56D CG9277 109736KK Tubb4b
VT2 Arpc5 CG9881 28141GD Arpc5l
VT3 spidey CG1444 40949GD Hsd17b12
VT4 Rep CG8432 28866GD Chml
VT5 CG1764 CG1764 20507GD Ddah1
VT6 CG9231 CG9231 9101GD Fam162a
VT7 Rgk1 CG44011 25574GD Gem
VT8 SIFaR CG10823 1783GD Hcrtr2
VT9 GCS2β CG6453 37991GD Prkcsh
VT10 CG9267 CG9267 2879GD Ptplad1
VT11 Spred CG10155 18025GD Spred2 / Spred3
VT12 Tapδ CG9035 8759GD Ssr4
VT14 put CG7904 848GD Acvr2a
VT15 PMCA CG42314 30203GD Atp2b2
VT16 yrt CG9764 28674GD Epb4.1l4b
VT17 CG2656 CG2656 25423GD Gpn3
VT18 na CG1517 3307GD Nalcn
VT19 Nmt CG7436 28019GD Nmt1
VT20 O-fut1 CG12366 44045GD Pofut1
VT21 AMPKα CG3051 1827GD Prkaa1
VT22 Purα CG1507 12765GD Pura
VT23 GlyP CG7254 27928GD Pygl
VT24 Syt7 CG2381 24988GD Syt7
VT25 ktub CG9398 29110GD Tub
VT26 Vps50 CG4996 34913GD Ccdc132
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Label Drosophila gene CGNR Stock centre ID Human gene
VT27 kug CG7749 3749GD Fat3
VT28 Irk2 CG4370 4341GD Kcnj3
VT29 KCNQ CG33135 8754GD Kcnq3
VT30 CG18301 CG18301 31023GD Lipa
VT31 Ctl2 CG11880 22867GD Slc44a5
VT32 CG32052 CG32052 21437GD Smpdl3b
VT33 btsz CG44012 35205GD Sytl4
VT34 Vps39 CG7146 40425GD Vps39
VT35 CG17896 CG17896 5581GD Aldh6a1
VT36 Eip63E CG10579 47860GD Cdk14
VT37 CG31064 CG31064 33754GD Rufy2
VT38 Caβ CG42403 102188KK Cacnb4
VT39 DhpD CG18143 106096KK Gda
VT40 Nedd4 CG42279 108475KK Nedd4l
VT41 S6kII CG17596 101451KK Rps6ka6
VT42 Gat CG1732 106638KK Slc6a1
VT43 Lrch CG6860 107047KK Lrch2
VT44 Eip75B CG8127 108399KK Nr1d2
VT45 JIL-1 CG6297 107001KK Rps6ka5
VT46 Dyb CG8529 104485KK Dtna
VT47 Hs6st CG4451 110424KK Hs6st2
VT48 Rbfox1 CG32062 110518KK Rbfox1
VT49 CG7369 CG7369 100824KK Rasgef1a / Rasgef1c
VT50 CG4853 CG4853 19877GD Rasgef1a / Rasgef1c
VT51 5-HT1A CG16720 106094KK Htr1a
VT52 5-HT1B CG15113 109929KK Htr1a
VT53 Rbp9 CG3151 101412KK Elavl2
VT54 fne CG4396 101508KK Elavl2
KK n/a n/a 60100 n/a
GD n/a n/a 60000 n/a
VV4 KKtiptop n/a 60101 n/a
KYOTO Stock Center (DGRC, www.kyotofly.kit.jp)
K1 Aps CG6391 103540 NUDT3
K2 Ama CG2198 103970 NEGR1
K3 fur2 CG18734 104593 PCSK1
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Label Drosophila gene CGNR Stock centre ID Human gene
K4 Fancl CG12812 140133 FANCL
K5 Tmem18 CG30051 141615 TMEM18
K6 Zip71B CG10006 207317 SLC39A8
KK1 unc13 CG2999 101911 UNC13A
KK2 psn CG18803 123495 PSEN1
Exelixis Collection at the Harvard Medical School (www.drosophila.med.harvard.edu)
H1 isoQC CG5976 c04389 QPCTL
H2 CG3732 CG3732 c06521 ZRANB2
H3 CG11342 CG11342 f06786 BCDIN3D
H4 cert CG7207 f04650 COL4A3BP
H5 Oscillin CG6957 e01629 GNPDA2
HH1 DSK CG18090 f02648 CCK
HH2 hip14 CG6017 d07562 Hip14
Bloomington Drosophila stock centre (www.bdsc.indiana.edu)
B1 heph CG31000 635 PTBP2
B2 trn CG11280 4550 LRRN6C
B3 dsor1 CG7693 5545 MAP2K5
B4 Rpl27A CG15442 5697 RPL27A
B7 shtd CG9198 9243 APC1
B8 Hmgcr CG10367 11522 HMGCR
B9 caps CG11282 11579 LRRN6C
B10 mEFTu1 CG6050 12215 TUFM
B11 sbb CG5580 12772 ZNF608
B12 Lac CG12369 14577 NEGR1
B13 Lrp1 CG33087 16864 LRP1B
B14 HGTX CG13475 19133 NKX6.1
B15 rab2 CG3269 19993 PCSK1
B16 Atx2 CG5166 21645 ATXN2L
B17 Nrx-1 CG7050 21977 NRXN3
B18 TfAP-2 CG7807 22901 TFAP2B
B19 DIP-iota CG11320 23405 NEGR1
B20 Dh44-R1 CG8422 23517 GIPR
B21 twz CG10440 25846 KCTD15
B22 Mtch CG6851 27981 MTCH2
B23 QC CG32412 29127 QPCTL
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Label Drosophila gene CGNR Stock centre ID Human gene
B24 Grd CG7446 30596 GABRG1
B25 sns CG33141 35916 CADM2
B26 TfAP-2 CG7807 36132 TFAP2B
B27 Syn2 CG4905 37052 SNTG2
B28 fili CG34368 38026 LRRN6C
B29 CG14762 CG14762 44774 LRRN6C
B30 PKD CG7125 52147 PRKD1
B31 Dh44-R2 CG12370 53102 GIPR
B32 NMDA1 CG3798 53122 FAIM2
B33 fur1 CG10772 53406 PCSK1
B34 RtGEF CG10043 53466 SH3YL1
B35 Ac3 CG1506 53472 ADCY3
BB1 engrailed CG9015 265 EN1
BB2 frizzled CG17697 1676 FZD3
BB3 engrailed CG9015 1817 EN1
BB4 upd1 CG5993 4767 Leptin
BB5 psn CG18803 5463 PSEN1
BB6 psn CG18803 8299 PSEN1
BB7 chico CG5686 10738 IRS1
BB8 chico CG5686 14337 IRS1
BB9 Btbd9 CG1826 14666 BTBD9
BB10 bmm CG5295 15959 ATGL
BB11 leucokinin CG13480 16324 Tachykinin
BB12 prosap CG30483 17047 SHANK3
BB13 DSK CG18090 17146 CCK
BB14 Hip14 CG6017 17614 Hip14
BB15 nACHRα5 CG8178 18381 CHRNA7
BB16 mfrn CG4963 19811 SLC25A37
BB17 hugin CG6371 23491 Neuromedin U
BB18 prosap CG30483 24446 SHANK3
BB19 auxilin CG1107 25674 GAK
BB20 lap CG2520 26463 PICALM
BB21 auxilin CG1107 30174 GAK
BB22 hugin CG6371 34419 Neuromedin U
BB23 upd2 CG5988 55727 Leptin
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Label Drosophila gene CGNR Stock centre ID Human gene
BB24 bmm CG5295 58659 ATGL
BB25 nACHRα5 CG8178 59218 CHRNA7
BB26 mfrn CG4963 59729 SLC25A37
BB27 bmm CG5295 62615 ATGL
BB28 tau CG45110 63271 MAPT
BB29 tau CG45110 64782 MAPT
BB30 tht CG17117 65540 MEIS1





DB if / CyO ; TM6b / MKRS
CFD1 y1 P(act5c-cas9, w+) M(3xP3-RFP.attP)ZH-2A w*(I)
FM7 FM7 / wa
w1118 w1118
yw y1w1
JP084 UASG-Cas9 / TM6b
nanos-Cas9 y[1] sc[1] v[1]; (y[+t7.7] v[+t1.8]=nanos-Cas9)attp40
PhiC31+attP y w M(eGFP, vas-int, dmRFP)ZH-2A; P(CaryP)attP40
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2.3 Experimental flies
2.3.1 Homologue identification
Drosophila homologues of the human / mouse genes of interest were identified using the
ENSEMBL orthologue tool (Zerbino et al., 2018), and FlyBase BLAST searches of protein
sequences derived from NCBI (Gramates et al., 2017).
2.3.2 Generation of experimental RNAi flies
UASG-siRNA lines were crossed to GAL4 lines (elav-GAL4 or act-GAL4). Controls were
created by crossing each GAL4 line individually to KK, KKtiptop and GD. Experimental
flies were compared to the relevant control background. To standardise the effects of
parental environment on offspring fitness, all UASG-siRNA stocks were kept in bottles at
an approximately constant density. To standardise the effects of parental age on offspring
fitness, crosses were set up using flies which were 1-5 days old.
On day 1, 5 UASG-siRNA female virgins were placed in a vial of ND at 25oC with 2 elav-
GAL4 or 5 act-GAL4 males. On day 4 these parents were removed. On day 14 offspring were
transferred to a new vial and allowed to mate, as mating alters gene expression and metabolic
parameters (Ellis and Carney, 2010; Papanastasiou et al., 2013). On day 15 the females
were removed, and on day 16 male flies were placed on SM for 3 hours to synchronise their
metabolism, before being returned to the appropriate diet for the experiment.
2.3.3 Generation of experimental LoF flies
Stocks were kept in bottles at approximately constant density. Bottles were cleared and newly
eclosed males collected every 24 hours. Immediately after collection, flies were placed on
SM for 3 hours to synchronise their metabolism, before being moved to the appropriate diet
for the experiment. w1118 and y1w1 were used as background control lines.
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2.4 Assays to phenotype Drosophila
2.4.1 Timeline
During the 3 hour synchronisation starvation, flies were counted into groups for assaying. All
assays were done at a certain time relative to the synchronisation (day 0), because Drosophila
activity and feeding behaviours are affected by age and circadian rhythms (Xu et al., 2008;
Iliadi and Boulianne, 2010).
Assay No of flies / repeat Assay day Assay time
qPCR 10 4 10am
Wet mass, TAG, glucose 15 5 10am
Dry mass 15 5 + 8 3.30pm
Starvation resistance 15 4 + 7 10am
Dye feeding over-feeding 15 4 + 5 9am
Dye feeding absoprtion 15 8 + 9 9am
CAFE 8 4 + 5 2pm
Climbing 15 4 3.30pm
Feeding motivation 1 5 10am
2.4.2 Repeats and statistics
For LoF flies, each assay was repeated 7 times using flies from independent collections. For
RNAi flies, each assay was repeated 5 times on independent crosses. Data was analysed by
unpaired homoscedastic Student t-test, except where stated otherwise. Based on the use of
the protocols in the literature, the assays may have standard deviation up to 25%. In this case,
sample sizes of 5 repeats per experimental group will be able to detect changes of 50% at a
significance level of p<0.05 (two- tailed) and 80% power (Kadam and Bhalerao, 2010).
2.4.3 Wet mass
Groups of 15 Drosophila were frozen on dry ice and weighed using a microbalance, then
stored at -80oC for TAG/glucose analysis.
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2.4.4 Dry mass
Flies in groups of 15 were frozen on dry ice then placed in a 95oC heat-block for 6 minutes
(1 minute with the lid closed, 5 minutes with it open). Flies were kept in eppendorf tubes at
room temperature for 3 days to dessicate and then weighed using a microbalance.
2.4.5 TAG and glucose levels
Frozen Drosophila were placed in FastPrep tubes containing Lysis Beads and Matrix D (MP
Biomedicals) and 350µl of cold PBST (PBS + 0.05% Tween-20) then homogenised using
a FastPrep-24 homogeniser (MP Biomedicals) for 60s at 6m/s. Solutions were centrifuged
(16100rcf, 4oC, 3 minutes) to pellet debris and 300µl of supernatant pipetted into a fresh
Eppendorf on ice. Homogenates were heat-inactivated (5 minutes, 70oC) then 50µl trans-
ferred into a fresh tube and stored at -80oC for TAG analysis. The remaining supernatant was
re-centrifuged (16100rcf, 4oC, 3 minutes) to pellet debris and 100µl transferred into a fresh
tube and stored at -80oC for glucose analysis. TAG analysis and glucose analysis was done
by the Cambridge Core Biochemical Assay Laboratory (www.cuh.nhs.uk/core-biochemical-
assay-laboratory) using enzymatic assays. TAG and glucose amounts were normalised to
number of Drosophila.
2.4.6 Dye food over-feeding
Drosophila were transferred onto: SM for 24 hours, ND for 20 minutes and then dye food
for 16 minutes. The number of flies with visible dye in their abdomen (mid-gut and/or crop)
was counted as a percentage of the total number.
2.4.7 Dye food absorption
After the first dye food assay, flies were returned to ND for 48 hours then dye food for
24 hours. Anaesthetised flies were frozen on dry ice and stored at -80oC. Samples were
transferred into FastPrep tubes containing Lysis Beads and Matrix D and 300µl of PBST
(PBS + 1% triton X) then homogenised using a FastPrep-24 homogeniser (30s, 6m/s).
Samples were centrifuged (1500g, RT, 3 minutes) and 50µ l of supernatant pipetted into each
of 2 wells of a CoStar 96-well flat bottom UV-transparent plate (Corning). The absorbance at
625nm was measured using a microplate reader (TECAN Infinite M1000 PRO). Each sample
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was repeated twice and an average taken. The amount of dye was normalised to the number
of flies.
2.4.8 CAFE assay
Flies were placed onto SM. Specialised caps (made by the Cambridge University Psychology
Department Electronics Workshop) were inserted into the vials. Per vial, two 5µl capillary
tubes were filled with liquid food (9ml water + 0.5g sucrose + 0.5g yeast extract) via capillary
action. The top of the meniscus was marked, and the filled capillaries were inserted into the
lid, and then left at 25oC for 24 hours. The movement of the meniscus was measured and
evaporation (as measured by a vial containing no flies) subtracted to give the volume of food
eaten. This value was normalised to the number of flies.
2.4.9 Climbing assay
Flies were placed in empty vials with a line 4.5cm from the bottom (mid-way). Vials were
placed in front of a white background, tapped 3 times to displace flies to the bottom surface,
and recorded for 10s using a Sony DCR-SR32 camera. Videos were analysed and the number
of flies past each line was counted at 75 frames (3s) after displacement. Flies on the line
were counted as above.
2.4.10 Starvation resistance
Drosophila were placed in vials containing SM. The number of dead flies was counted at
4pm every day until all flies were dead. Flies were transferred into new vials of SM every
other day, noting how many dead flies transferred into the new tube, and whether any live
flies escaped. Vials were kept inverted to prevent flies becoming trapped in the media.
2.4.11 Feeding motivation
At one end of each lane of a 14-well plate, 10µl of a 10-6 dilution of benzaldehyde solution
(Sigma) was placed on top of a small ball of cotton wool to act as a repellent. A small blob
of fresh yeast paste food was then placed in between the repellent and the flies. Individual
flies were anaesthetised using ice and placed into each lane. Hardware and software to track
the movement of flies was developed by Zantiks (www.zantiks.com). Each lane was split
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into 3 equal size zones, and the time that each fly spent within each zone was measured over
a 1 hour period. The tracking script is given in figure 2.1.
Fig. 2.1 Coding developed in collaboration with Zantiks to measure feeding motivation in
adult Drosophila.
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2.4.12 Larval assays
Cages were set up containing 60 virgin female and 30 male flies on apple juice agar plates
with fresh yeast paste and left for 3 days at 25oC. On the day of collection, a new plate
with fresh yeast paste was given every 30 minutes for 1 hour to clear old embryos from the
oviducts of the female flies. Embryos were collected on a fresh plate for 3 hours and then
left for 3 days to develop into 3rd instar larvae. For the assay, larvae were either fasted in
distilled water for 2 hours or fed in liquid yeast for 2 hours. Yeast paste (6ml of distilled
water + 6g of active dry yeast) was placed in the centre of, and 20 larvae were placed on the
inside rim of, an apple juice agar plate. The number of larvae in/out of the food was counted
after 20 minutes.
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2.5 Gene editing using CRISPR
2.5.1 gRNA design
gRNAs to target the white gene were taken from the literature (Ge et al., 2016). For other
genes of interest, possible gRNA sites were identified using the online CRISPOR tool
(Haeussler et al., 2016) and the final gRNAs chosen based on the following criteria: 20bp
long, Fusi-Doench score >50, no predicted off-targets with 3 or fewer mismatches, position
near the beginning/end of the gene, presence in all isoforms, avoidance of overlapping genes.
The sequences used were:




For each target gene (fuss, rab21, white), 1 plasmid was created each containing 2 gRNA
sequences
2.5.2 Creation of the gRNA-tRNA insert









Amplification of the insert was done using pCFD5 as a template. 25µl of Q5 Hot Start
High-Fidelity 2x Master Mix (NEB), 2.5µl of 10µM primer F, 2.5µl of 10µM primer R,
1ng of pCFD5 and to 50µl of nuclease-free water were mixed by pipetting. The reaction
was incubated as follows: 98oC fo 30s, then 32 cycles of 98oC for 10s, 61oC (increasing by
0.5oC each cycle up to 72oC) and 72oC for 20s, then 72oC for 120s. PCR products were
separated by agarose gel electrophoresis and bands of the correct size (234bp) were excised
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and purified using a Qiaquick gel extraction kit (Qiagen) according to the manufacturer’s
instructions.
2.5.3 Plasmid digestion
Plasmid pCFD5 was a gift from Simon Bullock (Addgene plasmid 73914). pCFD5-containing
cultures were grown in 2ml of LB broth + 100µg/ml Ampicillin overnight in a 37oC shaking
incubator. pCFD5 was extracted using QIAprep Miniprep kit (Qiagen) according to the
manufacturer’s instructions, and then digested using Bpil (Thermo Scientific). Digested
plasmid was separated from undigested plasmid by electrophoresis (80V, 1.5 hours, 1%
agarose gel), cut out of the gel under UV light, and then extracted using a Qiaquick gel
extraction kit (Qiagen) according to the manufacturer’s instructions.
2.5.4 Insertion of gRNA-tRNA into pCFD5
Digested pCFD5 plasmid was combined with the PCR inserts by a Gibson Assembly reaction
using Gibson Assembly Master Mix 2x (NEB) according to the manufacturer’s instructions.
Plasmids were transformed by heat shock into 5-alpha Competent E. coli cells (NEB). The
cells were streaked onto LBampicillin plates and grown overnight at 37oC. Individual colonies
were cultured in 2ml of LB broth + 100µg/ml Ampicillin overnight in a 37oC shaking
incubator. The resulting cultures were purified using a GeneJET Plasmid Miniprep Kit
(Thermo Scientific) according to manufacturer’s instructions.
Production of the expected plasmid was confirmed by 2 sequencing reaction using either
primer pCFD5 F (cgactgggtaaatggtcctg) or primer pCFD5 R (ggcgaacagagatgagatttgac),
and Big Dye Terminator v3.1 Cycle (Thermo Fischer) according to the manufacturer’s
instructions. Reaction mixtures were cleaned using AgenCourt CleanSEQ magnetic beads
according to the manufacturer’s instructions, and then sequenced using a ABI 3730 DNA
Sequencer (48 Cap). Sequences were analysed using ApE software.
Successful plasmids were re-transformed and cultured, and then purified using a HiSpeed
Plasmid Midi kit (Qiagen) according to the manufacturer’s instructions.
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2.5.5 Embryo injection
gRNA-tRNA plasmids were micro-injected into dechorionated syncytial embryos by the
Cambridge University Drosophila microinjection service, according to the following table:
Plasmids injected Concentration Drosophila line injected
fuss + white 100ng/µl nanos-Cas9
rab21 + white 100ng/µl nanos-Cas9
fuss 400ng/µl PhiC31+attP
rab21 400ng/µl PhiC31+attP
Embryos were grown to adulthood, crossed to balancers, and the offspring genotyped by
eye colour, PCR, and sequencing.
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2.6 Genotyping of Drosophila by PCR
2.6.1 DNA extraction
Individual flies were placed into a PCR tube and mashed using a pipette tip with 50µl of
sterile Squish Buffer (9.8ml of nuclease-free water, 100µ l of 1M Tris pH 8.0, 20µ l 0.5M of
EDTA, 50µl 5M of NaCl, and 0.1µl of 10mg/ml Proteinase K (Sigma)). The solution was
incubated at 37oC for 1 hour to release the DNA and then heated to 95oC for 3 minutes to
inactivate the Proteinase K. 50µl of solution was transferred to a new tube and diluted with
50µl of nuclease-free water.
2.6.2 PCR reaction
Per sample, 25µl of 2x Terra PCR Direct Buffer (Takara), 2µl of 10µM primer F, 2µl
of 10µM primer R, 5µl of DNA extract (see above), 1µl of Terra PCR direct polymerase
mix (Takara), and 16µl of nuclease-free water were mixed gently by pipetting. The primer
sequences were:
Gene Primer F sequence Primer R sequence
fuss cgactgggtaaatggtcctg ggcgaacagagatgagatttgac
rab21 gcgtatcaaggtaggacacc atcacaatgggaacggctaa
For rab21, a 3-step PCR was used: 98oC for 2 minutes, then 40 cycles of 98oC for 10s,
60oC for 15s and 68oC for 1 minute. For fuss, a 2-step PCR was used: 98oC for 2 minutes,
then 40 cycles of 98oC for 10s and 68oC for 4 minutes. PCR products were run on a 1%
agarose gel.
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2.7 Genotyping of Drosophila by sequencing
Samples were amplified for sequencing using a single primer (see table in section 2.6.2)
and Big Dye Terminator v3.1 Cycle (Thermo Fischer) according to the manufacturer’s
instructions. Reaction mixtures were cleaned using AgenCourt CleanSEQ magnetic beads
according to the manufacturer’s instructions, and then sequenced using a ABI 3730 DNA
Sequencer (48 Cap). Sequences were analysed using ApE software.
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2.8 Measurement of gene expression by qPCR
2.8.1 RNA extraction
Per sample, 10 flies were placed in a FastPrep tube containing Lysis Beads and Matrix D
(MP Biomedicals), frozen using dry ice, and stored at -80oC. RNA was isolated using phenol-
chloroform extraction based on published methods (Bogart and Andrews, 2006). Briefly,
flies were homogenised in 1ml Qiazol (Qiagen) using a Fast Prep 24 machine (6m/s, 40s).
Homogenates were incubated at room temperature for 5 minutes and centrifuged (12000rcf,
10 minutes, 4oC). The supernatant was transferred to a fresh RNase-free microcentrifuge
tube and 200µl of chloroform (Sigma) added. Solutions were shaken vigorously by hand,
incubated at room temperature for 3 minutes, then centrifuged (10000rcf, 15 minutes, 4oC).
The upper aqueous phase was transferred to a fresh RNase-free microcentrifuge tube and
0.5ml of isopropanol (Sigma) added. After 10 minutes incubation at room temperature and
centrifugation (12000rcf, 10 minutes, 4oC), the supernatant was removed and the pellet
washed by inversion with 1ml 75% ethanol. Pellets were left to air-dry for 10 minutes, and
then resuspended in 100µl of RNase-free water. Samples were purified using an RNeasy
clean-up kit (Qiagen) according to the manufacturer’s instructions, including DNase 1
digestion. Final RNA concentrations were measured on a nanodrop.
2.8.2 cDNA preparation
cDNA was created from each RNA sample. Each reaction contained 10µl of 100ng RNA
in RNase-free PCR tubes. 2µl of each sample was taken to form the pool from which the
-RT control (1µl pool + 9µl water) and +RT control (5µl pool + 5µl water) were made. To
each reaction, 1µl of random primer (Promega) at 1/4 dilution, and 1µl of 100mM dNTPs
(Bioline) at 1/10 dilution was added. The solutions were heated to 65oC for 5 minutes. After
a brief chill on ice, 4µl of 5x first strand buffer (Invitrogen), 2µl of 0.1M DTT (Invitrogen),
and 1µl of Superase RNase inhibitor (Ambion) was added to each tube and mixed gently.
After 2 minutes incubation at 25oC, 1µ l of Superscript II RT was added to all samples except
the -RT control (RNase-free water added instead). Reactions were incubated at 25oC for 10
minutes, 42oC for 50 minutes, and 70oC for 15 minutes.
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2.8.3 qPCR
For each cDNA sample, 5µl was placed into a well of a 96-well plate. All samples were
measured in triplicate and controls in duplicate. 0.2µl of forward primer, 0.2µl of reverse
primer, 0.6µl of nuclease-free water, and 6µl of SYBR Green PCR Master Mix (Thermo
Fisher) was added to each cDNA well. Plates were sealed with MicroAmp Optical Adhesive
Film (Thermo Fisher) and RNA was quantified using an ABI 7900HT Fast Real-Time PCR
System (Thermo Fisher). The -RT samples were used as negative controls. RNA amounts
were quantified by comparing to serial dilutions of the +RT sample.
2.8.4 Primer design
qPCR primers for genes of interest were designed based on publicly available gene sequences
(Attrill et al., 2016). Primers for housekeeping normalisation genes were found in the
literature (Ponton et al., 2011). Primers were synthesised by Sigma. All primers used are
listed in the following table:








Development of a Drosophila-based
screen to detect energy homeostasis
phenotypes
As discussed in chapter 1, there is an unmet need for a high-throughput method to investigate
human genetic data related to the regulation of energy homeostasis. Drosophila are a
genetically tractable model, allowing large numbers of candidate genes to be functionally
analysed quickly, economically, and in a spatiotemporal-specific manner.
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3.1 Chapter aims
The overall aim of this chapter was to create a high-throughput, in vivo screen for energy
homeostasis phenotypes using Drosophila as a model to study human genes of interest. More
specifically the aims were to: identify suitable assays and develop new assays; validate these
individual assays using metabolic perturbation; validate the screen as a whole using positive
and negative control genes; and explore which of the available Drosophila genetic models is
the most suitable for use in this screen.
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Strategy
3.2 Genetic models available in Drosophila
As discussed in chapter 1, one of the advantages of using Drosophila as a model organism is
the availability of several large collections of lines that can be used for manipulation of the
genes of interest. Two different models available from public stock centres were used in this
thesis, and are described in more detail in this section: knock-out and knock-down.
3.2.1 The loss-of-function model
Loss-of-function (LoF) flies were obtained from the Bloomington, Kyoto, and Harvard
Excelis stock centres. In theory, all of these lines have loss-of-function of the gene of
interest (Wangler et al., 2017). Loss-of-function stocks include several types of genetic
perturbation, for example: deletion of a large genomic region which includes the gene of
interest; mutant alleles induced by chemical mutagens such as EMS; and gene disruptions
caused by translocation.
Most of the LoF lines used in this thesis contain a single transposable element (P-,
PiggyBac-, or MiET1- element) inserted into or near to the gene of interest to disrupt gene
function. Such stocks are available for approximately 70% of Drosophila genes (Hummel
and Klämbt, 2008).
Male flies were phenotyped. They are smaller and eat less than females (Wong et al.,
2009), but males are significantly easier to work with because they do not lay eggs, and so
were more suitable for use in a high-throughput screen.
3.2.2 The knock-down model
Two genetic techniques — RNA interference and the UASG-GAL4 system — can be used
together to produce in vivo knock-down of gene expression in precise spatial and temporal
patterns. The combination will be referred to in this thesis as RNAi, and it has been shown
that this technique generally reduces expression levels of the target gene to 25% of wild-type
levels (Perkins et al., 2015; Heigwer et al., 2018).
UASG-GAL4 is a binary genetic system adapted from yeast (Brand and Perrimon, 1993).
GAL4 protein is a transcriptional activator which recognises and binds to Upstream Activating
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Sequences (UASGs) in DNA, resulting in transcription of the gene downstream of the UASG
sequences. UASG-GAL4 does not exist endogenously in Drosophila and so can be used
to specifically perturb the gene of interest (Duffy, 2002). Transcription of GAL4, and thus
expression of the UASG-controlled sequence, can be directed by a plethora of different
enhancers. Many lines are available to express GAL4 specifically in different tissues, cells,
developmental stages, or environmental conditions. The VDRC stock centre alone has 1,000
different GAL4 lines available for purchase. The GAL4 and the UASG parts of the system are
usually maintained in separate lines, allowing numerous combinatorial possibilities. In this
thesis, two GAL4 lines were used: elav-GAL4 which is expressed in the CNS (Robinow and
White, 1991) because the brain has a key role in controlling feeding behaviour and energy
homeostasis (see section 1.4), and act-GAL4 which is constitutively expressed throughout
the body.
RNA interference is a physiological method of targeting mRNAs for degradation. In
cells, small double-stranded RNAs with a specific hairpin structure are processed by Dicer
to form small interfering (si)RNAs. If the siRNAs are complementary to a gene of interest,
they can base pair with the corresponding mRNA and direct specific degradation of this
mRNA by the RISC complex. This reduces, but does not eliminate, expression of the gene.
By transgenically introducing siRNAs into Drosophila, expression of a target gene can be
decreased.
The VDRC stock centre has a collection of transgenic fly lines with siRNAs (that are
designed to each target a single gene of interest) downstream of inducible UASGs. These
lines have been molecularly validated, and shown to provide potent and gene silencing when
crossed to GAL4 (Dietzl et al., 2007). There are siRNA lines available to target 91% of
Drosophila protein-coding genes.
To generate flies for phenotyping, virgin female UASG-siRNA flies were crossed to male
GAL4 flies and then the male offspring were collected (see figure 3.1).
















Fig. 3.1 The UASG-GAL4 and RNA interference genetic systems can be combined to reduce
expression of a specific gene in a spatiotemporal specific manner dependent on the GAL4
promoter.
elav = embryonic lethal abnormal vision, siRNA = small interfering RNA, UASG = upstream
activating sequence.
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3.3 Selection of high-throughput assays to detect energy
homeostasis phenotypes
The first step in development of the screen was to identify assays that have been used in
published literature to detect energy homeostasis and feeding phenotypes in Drosophila,
adapted if necessary, and then combined to use as a high-throughput screen. Assays of
interest were split into two categories: physiology and behaviour. These assays are described
briefly here, and full protocols are detailed in chapter 2.
3.3.1 Assays of physiology
The simplest way to assess flies for existence of an energy homeostasis phenotype is to
measure their mass: a chronic excess of energy intake will result in increased storage of
energy in the body and thus heavier flies, and vice versa (Jumbo-Lucioni et al., 2010). In this
thesis, this assay is referred to as the wet mass assay.
A similar analysis is the dry mass assay: changes in nutrient metabolism can affect the
amount of water in a fly, which can be assessed by measuring the desiccated mass of flies
compared to the wet mass (Waterson et al., 2014).
A more direct assessment of the amount of energy stored in a fly is to measure the levels
of metabolites present. In particular, the amount of TAG stored in the fat body and the
amount of glucose circulating in the haemolymph can both be detected by enzymatic assay
of Drosophila homogenate (Tennessen et al., 2014; Ugrankar et al., 2015). These two assays
are referred to as the TAG assay and the glucose assay, respectively, in this thesis.
Finally, a fly’s resistance to starvation is an indirect measure of their levels of energy
storage - larger energy stores and the ability to use them efficiently allow a fly to survive for
longer when exposed to starvation conditions (Tennessen et al., 2014). This assay is called
the starvation resistance assay.
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3.3.2 Behavioural assays
The CAFE assay
The Capillary Feeder (CAFE) assay is a method of measuring food intake (Ja et al., 2007). In
this assay, the only food available to the flies is liquid food in a capillary tube. The amount of
food ingested by flies over a 24 hour period is measured by movement of the food meniscus
in the capillary. The CAFE assay provides a measurement of total food intake, which is a
combination of both the frequency of feeding and the amount eaten per meal. The set-up of













Dye food absorption assay
Another method of measuring food intake is to mix standard solid Drosophila food with food
dye (Fast Green FCF dye). Flies are exposed to this food for 24 hours and then homogenised.
The amount of dye present in the homogenate (as measured by the absorption of 625nm
light) indicates the amount of food eaten (Edgecomb et al., 1994). In this thesis, this assay is
called the dye food absorption assay.
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Over-feeding dye assay
Using the same dye-containing food, it is also possible to assess acute changes in feeding
in response to starvation. In this assay, as shown in figure 3.2, flies are first fasted for 24
hours, and then given normal diet for 20 minutes to feed which is enough time to satiate
most wild-type flies (Williams et al., 2014). The flies are then transferred to the dye food
which, when ingested, can be easily seen through the cuticle in the abdominal gut using a
bench microscope (figure 3.3). Any flies which eat the dye food were not satiated by the 20
minutes of normal food (Edgecomb et al., 1994). This assay — the over-feeding dye assay —




















Fig. 3.2 The over-feeding dye assay used to measure food intake by in Drosophila
Flies fed dye foodFlies fed normal food
Fig. 3.3 Food dye can be seen through the abdomen after ingestion by Drosophila
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Negative geotaxis (climbing) assay
In Drosophila it has been shown that fasted animals become hyperactive (Yang et al., 2015)
whereas flies given high calorie diets decrease their movement (Birse et al., 2010). Therefore
movement was included in the screen, as measured using a negative geotaxis climbing assay
(Nichols et al., 2012). Flies are put in a column (with no food), tapped to the bottom, and
their speed at climbing up the tube is measured (in this thesis, the number above the mid-line
within 3s was counted), as shown in figure 3.4.
Mid-line
t=0 t=3s (75 frames)
3 flies  
above line
12 flies  
below line
Fig. 3.4 Geotaxic climbing assay used to measure movement of flies
Larval feeding motivation assay
25% of Drosophila genes do not produce viable adults when mutant (Wangler et al., 2017)
and so cannot be phenotyped using the previously described assays. For many of these genes,
homozygous mutants are viable as larvae. Unlike adult flies, young Drosophila larvae feed
continuously (Zinke et al., 1999). However, upon entering the third instar wandering stage of
development, larvae cease constant feeding and so it is at this stage that feeding behaviour is
commonly studied (Shen, 2012). The larval assay used here measured feeding motivation
(Wu et al., 2003; Melcher and Pankratz, 2005). Briefly, third instar larvae were placed on the
edge of an agar plate and the number that moved into the fresh yeast paste in the centre of the
plate (hungry larvae) and those that stayed near the edge (non-hungry larvae) was counted
after 20 minutes.
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Results
3.4 Validation of assays using metabolic perturbation
To validate the protocols for their use as part of a high-throughput screen for energy home-
ostasis phenotypes, all ten of the physiology and behavioural assays described in section 3.3
were tested for their ability to detect metabolic perturbation in wild-type flies. For the assays
using adults, male wild-type (w1118) flies were assayed at five days old having been exposed
to either five days of normal diet (ND), five days of high fat diet (HFD), or four days of
ND plus one day of fasting. For the larval feeding assay, w1118 larvae were either placed in
liquid yeast (fed) or water (fasted) for two hours prior to the assay. The results of each assay
using these flies/larvae are shown in figure 3.5. Note that the over-feeding dye assay and the
starvation assay were not done on fasted flies because the assays themselves involve fasting.
The assays were all able to detect a significant difference in the expected direction
between ND and fasted flies/larvae. As would be expected, fasted flies had decreased wet
mass, dry mass, TAG and glucose levels, ate more in the CAFE assay and dye absorption
assay, and moved faster than ND-fed flies. Fasted larvae also showed increased feeding
motivation compared to fed larvae.
Most of the assays were also able to detect a significant difference between ND- and
HFD-fed flies. Importantly, for the two assays which could not be tested with fasted flies, the
HFD-fed flies show a phenotype in the expected direction: an increase in starvation resistance
and a decrease in the over-feeding dye assay. HFD-fed flies also showed a significant increase
in TAG levels, decrease in CAFE feeding, and increase in dye food absorption compared to
ND-fed flies.
Since all ten of the assays were able to detect at least one of the metabolic perturbations, all
were considered suitable for further validation using genetic controls (section 3.7). However,
it was expected that fasted and HFD-fed flies would show an opposite phenotype to each
other in the assays, but both showed a significant increase in the dye food absorption assay
and a decrease in dry mass compared to ND-fed flies, casting some doubt on the accuracy of
these two assays.
Starvation resistance data analysis
Data from all of the assays was analysed using Student t-test. Initially the starvation resistance
assay data was analysed using a log-rank statistical test as is common in published papers.




























































































































































































Fig. 3.5 All assays were able to distinguish flies fed on ND from flies subject to 24 hours
fasting or 5 days HFD. The physiology assays were a) wet mass, b) dry mass, c) TAG storage,
d) glucose storage, and e) resistance to starvation. The behavioural assays were f) geotaxic
climbing ability, g) over-feeding dye, h) dye food absorption, i) CAFE feeding j) larval
feeding. Mean±SEM is plotted of 7 repeats, each containing (a-h) 15 flies, (i) 8 flies, (j)
20 larvae. Fasted/HFD results were compared to ND results by Student’s t-test. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001.
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With this method, the difference in starvation survival between ND- and HFD-fed flies was
highly significant (p<0.0001). However, this statistical test also assigned 40% (out of 174)
of lines in this thesis the same highly significant p value. Thus the test was not useful for
discriminating between experimental lines. Instead a Student t-test was used on just one data
point: the proportion of flies alive after 78 hours of starvation. This time point was chosen
because this is when the survival of w1118 flies on ND was closest value to 50% and there
was also a significant difference between ND- and HFD-fed w1118 flies (p=0.0222, figure
3.5e).
The TAG and larval assays
The TAG assay could not be done using RNAi flies because the levels of TAG in the samples
were always found to be below the detection limit of the enzymatic assay used. In contrast,
most of the LoF lines registered values at least 5 times greater than the detection limit.
The larval feeding assay was difficult to do with the RNAi flies because setting up a cage
would require collection of 120 virgin females per line, which is impractical and therefore
low-throughput.
All other assays could be used in both the LoF and the RNAi models.
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3.5 Development of an assay to detect feeding motivation
in adult Drosophila
In addition to the high-throughput assays identified in section 3.3, an assay to look for
changes in feeding motivation in adult Drosophila was developed. As before, w1118 flies (5
days old) which had been fasted or fed for 24 hours before the assay were used to develop
the protocol.
The set-up of the assay is shown in figure 3.6. Individual flies were put into each lane of
a 14-lane chamber, each lane was approximately 0.5cm wide x 0.5cm tall x 10cm long. To
move flies into the lanes, they were anaesthetised using ice rather than carbon dioxide (the
standard method of immobilising flies) because the latter is a "stress odour" that Drosophila
avoid and may thus interfere with chemosensory perception of food during the experiment
(Siju et al., 2014). Food was placed at one end of each lane. Flies were filmed for one
hour and the location of the flies within each lane was detected and tracked using hardware
and software developed by Zantiks (www.zantiks.com/). For data analysis, each lane was
split into three zones and the total time that each fly spent in each zone during the one hour
experiment was calculated.
Fig. 3.6 Set-up of the assay for detecting feeding motivation in adult Drosophila. The location
of each individual fly is marked with a cross.
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The first food source placed at the end of each lane was apple juice agar. This food was
chosen because its solid nature means that it is easy to place the same amount into each lane.
The results are shown in figure 3.7. No significant difference was seen in the behaviour of


















Fig. 3.7 Fasted flies do not spend more time close to the apple juice agar food source than do
fed flies. Mean ± SEM is plotted of 7 repeats, each containing 1 fly. Fed and fasted flies
were compared by two-way ANOVA. F is the location of the food.
The flies spent approximately equal times in each food zone. Therefore it was hypoth-
esised that the agar did not have a strong enough odour to attract the flies. Thus, the agar
was replaced with fresh yeast paste, which is a known attractant for Drosophila (Beshel and
Zhong, 2013). As a result, the time spent in the food zone did increase, but still no statistical


















Fig. 3.8 Fasted flies do not spend more time close to the yeast food source than fed flies.
Mean ± SEM is plotted of 7 repeats, each containing 1 fly. Fed and fasted flies were
compared by two-way ANOVA. F is the location of the food.
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One possible explanation for this lack of difference is that the fasted flies feed immediately
on the yeast and then behave like fed flies. Alternatively, perhaps the yeast odour is so
attractive that the fed flies also approach. To counteract both of these suggestions and ensure
that only motivated (hungry) flies approached the food, conditions around the food were made
unfavourable using benzaldehyde, which has been shown to be a repellent for Drosophila
(Vang et al., 2012). The benzaldehyde was placed on cotton wool behind the food.
As can be seen in figure 3.9, this change gave the anticipated results — the fasted flies
were more motivated to approach the food than the fed flies, despite the presence of the
repellent. However, using the repellent at a dilution of 10-4 meant that the flies were strongly
repelled and even the fasted flies spent most of their time far from the food source. Therefore,
although there was a statistically significant difference, it was not large (p=0.0347, two-way
ANOVA, figure 3.9).
Most genetic perturbations are likely to have a smaller effect on feeding motivation than
than a severe metabolic perturbation like 24 hours of fasting. Therefore, the sensitivity of
the assay was improved by increasing the dilution of benzaldehyde to 10-6. As expected, the
fasted flies now spent more time near the food and this greatly increased the significance of
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Fig. 3.9 Fasted flies spend more time close to the food source in the presence of repellent
than do fed flies. Mean ± SEM is plotted of 7 repeats, each containing 1 fly. Fed and fasted
flies were compared by two-way ANOVA. F is the location of the food and R of the repellent.
The requirement for complex equipment and the small number of flies which could be
assayed simultaneously made this assay low-throughput. Therefore it was intended for use
only with genes already identified as top hits by the high-throughput assays identified in
section 3.3.
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3.6 Identity of background lines for data analysis
For data analysis, all experimental Drosophila lines were statistically compared to lines
with closely-matched genetic backgrounds but no perturbation in the genes of interest. As
explained in section 3.2, two Drosophila models were used — LoF and RNAi — which
require different lines to be used as backgrounds.
3.6.1 Background of LoF lines
For the LoF lines used in this thesis, no information about the background was provided by
the stock centre for 53% of the lines. The other lines were created from a large number of
different wild-type backgrounds including w1118, y1w67c23, y1v1, and ry506, but these lines
have been kept separate for many generations, allowing accumulation of modifiers in the
genetic background (Busson and Pret, 2007).
Since there is a lot of variety in the background, no single background line is appropriate
to use for all of the experimental lines. One solution to this problem is to select a wild-type
line to use as background, and then change each LoF line onto this genetic background. To
achieve this, lines of interest must be backcrossed to the chosen background strain at least
five times to replace the background of the experimental line with that of the control line by
recombination. To investigate the practicalities of backcrossing stocks for the screen, and to
observe the importance of the background for the phenotypes of interest, three lines (which
were obtained for use in chapter 4) were backcrossed to w1118.
The K2 and K3 lines both had a P-element insertion into their target genes (fur2 and Ama)
and the background was unknown. The third line (B21) had a known background (y1v1),
but this was not immediately available to phenotype. B21 contained an siRNA against twz
inducible by GAL4 (but in the results shown here, the homozygous B21 line was tested i.e.
the RNAi was not induced, because the phenotyping was done blinded to genotype).
Backcrossing of these three lines to w1118 took approximately four months. All three of
the original lines were homozygous viable. During the backcrossing, the K2 line became
non-viable as a homozygote. The original K2 line was able to complement this lethality
(crossing K2/K2 virgin females to K2*/TM6b males gave viable offspring) suggesting that
the Ama gene or a nearby gene was mutated during recombination.
For K3 and B21, the effect of changing the background was immediately apparent: the
backcrossed flies eclosed three days earlier than the inbred line and produced more than
twice as many offspring each generation. In more than half of the assays, at least one of the
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inbred lines showed a phenotype (figure 3.10) whereas only one significant phenotype is seen
across all the assays in the backcrossed flies.
Therefore it is possible that phenotypes observed in LoF lines could be due to genetic
differences in the background of the line, rather than due to perturbation of the gene of
interest. However, back-crossing was not high-throughput, and resulted in one of the lines
becoming lethal, and so was not deemed an appropriate solution. Further, many of the LoF
lines did not have a visible marker (such as eye colour) to track the mutant gene through the
backcrossing procedure. Therefore, a different approach to counteract the uncertainty due to
background was used: all experimental LoF lines were compared to two backgrounds and
the higher (least significant) of the two p values noted. The background lines were w1118 and


































































































































































































































































































Fig. 3.10 Backcrossed flies (grey) do not have the same phenotypes as inbred flies (white).
Mean ± SEM is plotted of 5 repeats. All lines were compared by Student’s t-test to w1118.
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001
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3.6.2 Background of RNAi lines
The VDRC stock centre has two UASG-siRNA stock collections which were created in
different backgrounds: KK and GD. The GD library has P-element based siRNA transgenes
inserted at random sites across chromosomes 1, 2, and 3. The KK background contains
siRNA transgenes inserted into a chromosome 2 attP site using phiC31 integrase.
The KK and GD backgrounds have slightly different phenotypes to each other and to the
elav-GAL4 and act-GAL4/CyO lines (data in appendix A). Since the experimental flies are a
cross between the siRNA and GAL4 lines, their background is a mix and so no single one of
these parental lines is suitable for use as a background control. Background-matched control
flies were created by crossing KK and GD to each GAL4 line to create: KK-elavGAL4,
KK-actGAL4, GD-elavGAL4, or GD-actGAL4.
To control for leaky expression of some UASG-siRNA transgenes, some papers (for
example Beshel et al. (2017)) cross the UASG-siRNA flies to wild-type flies. However, this
doubles the amount of work required for each line and so is not suitable for a large-scale and
high-throughput screen. A preliminary trial phenotyping the homozygous UASG-siRNA flies
for this purpose was performed (data in appendix A) but did not produce useful information
for the heterozygous experimental flies and so was discontinued.
Over-expression of tiptop in KK lines
The KK siRNA lines offer three advantages over the GD siRNA lines. Firstly, the siRNA
inserts are all at the same site which makes expression more consistent between lines
compared to the GD lines where the genomic insertion is random. Secondly, VDRC improved
their siRNA design for the KK lines, so increasing the efficiency and specificity of gene
disruption compared to the GD lines (Dietzl et al., 2007). Thirdly, the KK lines are easier to
work with: the virgins have a more obvious appearance facilitating virgin collection and the
larvae do not churn the food to the extent that it drowns many of the virgins.
However, the KK line contained two potential genomic sites for insertion of the UASG-
siRNA constructs. 25% of the KK lines contain an siRNA insert at the extra site which is
located in the 5’ untranslated region (UTR) of the gene tiptop. These inserts cause ectopic
UASG-driven expression of tiptop and thus non-specific phenotypes with some GAL4 drivers
(Green et al., 2014; Vissers et al., 2016).
To test whether our assays were affected by this problem, a line (KKtiptop) with GAL4-
responsive UASG repeats but no functional siRNA sequence at the tiptop site was obtained
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(Vissers et al., 2016). This line was lethal when crossed to act-GAL4, likely at the pupal
stage because vials contained black pupae. When crossed to elav-GAL4, the offspring flies
showed significant increases in the glucose and over-feeding dye assays, and significantly
decreased climbing as shown in figure 3.11. They were also heavier and ate more in the
CAFE assay, although these results did not reach significance.










































































































































Fig. 3.11 Ectopic UASG-driven expression of tiptop significantly affects results in the glucose,
starvation, over-feeding dye, and climbing assays, whilst also increasing mass and CAFE
feeding in a non-significant manner. Mean ± SEM is plotted of 5 repeats. Results were
compared by Student’s t-test. * p<0.05, ** p<0.01
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Since this is a strong overall phenotype, GD lines were always used in preference to
KK. If no GD line was available or the GD line(s) had multiple off-target effects, then
a KK line was purchased instead. Any KK lines which were lethal before or during the
pupal stage when crossed to act-GAL4 were considered as possibly being affected by tiptop.
The data from such lines were compared to both KK-elavGAL4 and KKtiptop-elavGAL4 as
backgrounds.
Compound X GD lines
For the GD lines, if the UASG-siRNA insert was on the X chromosome then the stock was
delivered from VDRC balanced as a compound X stock, meaning that only male flies carry
the UASG-siRNA insert. Some published papers have overcome this problem by doing the
cross in reverse (using male UASG-siRNA and female GAL4 flies) and then phenotyping
female offspring (for example, Baranski et al. (2018)). However, since the parental gender
of a gene can influence the offsprings’ phenotype (Wittkopp et al., 2006), in this thesis the
compound Xs were replaced with an FM7 balancer using a series of crosses, allowing the
experimental flies to be created in the same manner for all lines. However, this crossing may
also have replaced some of the 2nd, 3rd and 4th chromosomes with those of the balancer
stock, moving the background of the line away from GD, so any significant phenotypes for
these lines should be viewed with caution. Luckily, only 3 lines in this whole thesis were
compound X stocks.
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3.6.3 Summary of background lines
The different Drosophila models used in this thesis (LoF, whole body RNAi and neuronal
RNAi) each require different lines to be used as background for statistical comparison. These
are summarised in the following table:
Model Background Background line used
LoF variable yw and w1118
Whole body RNAi GD GD-actGAL4
KK KK-actGAL4
Neuronal RNAi GD GD-elavGAL4
KK (viable whole body) KK-elavGAL4
KK (lethal whole body) KK-elavGAL4 and KKtiptop-elavGAL4
where GD is w1118, and KK is y-w1118;P{attP,y+w3}VIE-260B.
Development and metabolism are influenced by environmental conditions such as humidity,
temperature, and food (Strassburger and Teleman, 2016) which could potentially lead to
false positive results. Therefore, all experimental flies were kept in atmosphere-controlled
incubators, and every line was phenotyped over several different batches. Development
and metabolism are also affected by environmental crowding and so flies were raised at
approximately constant density. In addition, experimental flies were allowed to mate before
being phenotyped because mating alters gene expression, metabolic parameters and food
intake (Ellis and Carney, 2010; Kubli, 2010; Papanastasiou et al., 2013). Finally, the assays
were always performed on the same day relative to eclosion, and at a certain time of day,
because Drosophila feeding behaviour and activity levels are affected by age and circadian
rhythms (Xu et al., 2008; Iliadi and Boulianne, 2010).
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3.7 Validation of the high-throughput screen using positive
and negative control genes
As shown in section 3.4, all of the high-throughput physiological and behavioural assays
identified in section 3.3 were able to detect differences in flies with diet-induced metabolic
perturbations. To further validate the screen for large-scale use to detect energy homeostasis
phenotypes, a series of positive and negative control genes was tested. Phenotyping of these
control genes served several purposes.
1. It allowed each assay to be tested as to whether it is high-throughput enough to use in
a large-scale screen — all assays were found to meet this criterion.
2. It allowed the precision and accuracy of each assay to be assessed (see sections 3.7.6
and 3.7.7) which in turn enabled a system to be developed to aid data inspection by
assigning a single score value to each gene (see section 3.8).
3. Comparison of the negative control genes to the positive control genes allowed the
threshold for a result to be considered positive to be established (see section 3.8).
4. The LoF and RNAi Drosophila models could be compared and contrasted for their
suitability for use in the screen (see section 3.10.6).
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3.7.1 Identification of positive control genes
Nine Drosophila genes were selected from published literature to use as positive controls
for the screen (table 3.1). These genes have all been shown to have a phenotype in at least
one of the screen assays, and many are involved in the neuronal control of feeding and were
discussed in section 1.11. In humans, some of these genes are associated with Mendelian
metabolic disorders, for example leptin and monogenic obesity (see chapter 1). Others have
been implicated in polygenic diseases by GWAS, for example TFAP2B and obesity (Speliotes
et al., 2010).
In addition, a mammalian gene from internal lab group data was included: PTPN2. A
literature search returned no published studies of energy homeostasis phenotypes for the fly
orthologue of this gene, Ptp61f. The purpose of including this gene was proof-of-principle
(i.e. is the screen able to detect this gene?) since the intention of the screen was to use
Drosophila to identify novel genes important in mammals. PTPN2 was first identified by
GWAS in dogs, and sequencing of this locus found a 4bp insertion in the 5’UTR of PTPN2
that is significantly associated with adiposity (Eleanor Raffan, personal communication).
LoF and/or RNAi lines of these positive control genes were ordered from publicly
available stock centres.
Table 3.1 Genes used as positive controls
Drosophila gene Human gene Reference
upd1 leptin Beshel et al. (2017)
upd2 leptin Rajan and Perrimon (2012)
DSK CCK Söderberg et al. (2012)
bmm ATGL Gronke et al. (2005)
chico IRS1 Bohni et al. (1999)
leucokinin tachykinin Al-Anzi (2010)
hugin neuromedin U Melcher and Pankratz (2005)
twz KCTD15 Williams et al. (2014)
TfAP-2 TFAP2B Williams et al. (2014)
Ptp61F PTPN2 Eleanor Raffan, personal communication
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3.7.2 Negative control genes
Identification of neuronal disease negative control genes
For negative controls, 11 genes were chosen that have been associated with human diseases
that have a neuronal etymology (because of the key role that the CNS has in controlling
energy homeostasis) but whose primary symptoms are non-metabolic. Some of the genes
have Mendelian links with their respective disease, and the others have been associated by
GWAS. In this thesis, these 11 genes are referred to as the neuronal disease negative control
genes, and they are listed in table 3.2. However, a literature search showed that all of these
neuronal diseases have been associated with weight loss or gain in patients.
Identification of peripheral disease negative control genes
Therefore, another set of negative control genes were selected from diseases which do not
have a strong neuronal effect — the peripheral disease negative control genes (see table
3.3). No published data was found showing that these diseases lead to weight gain/loss,
but it should be noted that the risk of many of these diseases is increased by being over- or
under-weight.
3.7.3 Orthologues of control genes
Drosophila orthologues of the negative control genes and of PTPN2 were identified using
the ENSEMBL orthologue tool (Zerbino et al., 2018). All genes had sequence homology
>20%, and most were >40%.
According to published microarray data (Graveley et al., 2011; Gramates et al., 2017), all of
these Drosophila genes are expressed in the larval and/or adult CNS.
Genes were randomly assigned to be assayed by either RNAi or LoF, or both. Phenotyping
was done in a manner blinded to genotype. It was expected that the neuronal disease negative
control genes would have a stronger phenotype than the peripheral disease negative controls,
but these would both have a distinguishably weaker phenotype than the positive control
genes.
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3.7.4 Genetic control lines affected by over-expression of tiptop
As discussed in section 3.6.2, some KK lines are affected by over-expression of tiptop and
this causes a strong phenotype in the assays used here. Of the genetic control lines assayed by
RNAi, eight had a KK background and four of these were lethal when crossed to actGAL4.
These four lines were therefore compared to both KK-elavGAL4 and KKtiptop-elavGAL4
backgrounds, as shown in figure 3.12.









KK 0.5951 0.0425 0.1009 0.7935 0.0534 0.2174
tiptop 0.3059 0.8621 0.0667 0.1237 0.672 0.1024
KK 0.3154 0.0095 0.0124 0.9258 0.8996 0.0623
tiptop 0.0113 0.3962 0.0877 0.0192 0.0324 0.4468
KK 0.5698 0.0061 0.2605 0.105 0.0473 0.2174
tiptop 0.1288 0.702 0.5968 0.5066 0.7914 0.1024
KK 0.4272 0.2527 0.4445 0.1705 0.3336 0.9324











Fig. 3.12 p values of potential tiptop-affected lines compared to both KK-elavGAL4 and
KKtiptop-elavGAL4 backgrounds. The background with the smaller phenotype was chosen,
indicated in orange. Red is an increase and blue is a decrease compared to background, and
significant results (p<0.05) are highlighted
For the hth and psn siRNA lines, there were significant phenotypes when compared to
KK-elavGAL4, but not when compared to KKtiptop-elavGAL4 , and thus these lines were
assigned to a KKtiptop background.
Conversely, twz showed a strong phenotype when compared to KKtiptop-elavGAL4, but
not when compared to KK-elavGAL4 and so this line was assigned to a KK background.
Although twz is a positive control, choosing the stronger phenotype would be wrong because
(i) the data should be treated consistently across the positive and negative control genes
to avoid bias in the results, and (ii) the strong phenotype is the opposite direction to that
reported in the literature (Williams et al., 2014).
Finally, for mRpS21 the choice of background was less clear as both gave similar numbers
of significant phenotypes. KK was chosen because the average p value across all six assays
was greater (less significant).
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3.7.5 Phenotypes of control genes
The results of the screen for the positive and negative control genes is shown in figures 3.13
to 3.21. In all figures, results from LoF lines were normalised to w1118, and statistically
compared to both w1118 and yw. Results from whole body RNAi were normalised and
statistically compared to either KK-actGAL4 or GD-actGAL4 as appropriate. Results from
neuronal RNAi were normalised and statistically compared to either KK-elavGAL4, GD-
























































































































































































































































































































































































Fig. 3.13 Wet mass of flies with control genes disrupted. Genes were perturbed by
(a) neuronal RNAi, (b) RNAi in the whole body, and (c) LoF. Mean ± SEM is plotted of
(a, b) 5 repeats or (c) 7 repeats, each containing 15 flies. Results were compared to appropriate
background line by Student’s t-test. * p<0.05, ** p<0.01
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Dry mass























































































































































































































































































































Fig. 3.14 Dry mass of flies with control genes disrupted. Genes were perturbed by (a)
neuronal RNAi, (b) RNAi in the whole body, and (c) LoF. Mean ± SEM is plotted of (a, b)
5 repeats or (c) 7 repeats, each containing 15 flies. Results were compared to appropriate
background line by Student’s t-test.
3.7 Validation of the high-throughput screen using positive and negative control genes 79
TAG


































































































































Fig. 3.15 TAG levels in lines with LoF of control genes. Mean ± SEM is plotted of 7 repeats,
each containing 15 flies. Results were compared to appropriate background line by Student’s
t-test. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001






































































































































































































































































































































































































Fig. 3.16 Glucose levels in flies with control genes disrupted by (a) neuronal RNAi, (b) RNAi
in the whole body, and (c) LoF. Mean ± SEM is plotted of (a, b) 5 repeats or (c) 7 repeats,
each containing 15 flies. Results were compared to appropriate background line by Student’s
t-test. * p<0.05, ** p<0.01, *** p<0.001



























































































































































































































































































































































































Fig. 3.17 Resistance to starvation of flies with control genes disrupted. Genes were perturbed
by (a) neuronal RNAi, (b) RNAi in the whole body, and (c) LoF. Mean ± SEM is plotted
of (a, b) 5 repeats or (c) 7 repeats, each containing 15 flies. Results were compared to
appropriate background line by Student’s t-test. * p<0.05, ** p<0.01











































































































































































































































































































































































































Fig. 3.18 Food intake, as measured by the CAFE assay, by flies with control genes disrupted
by (a) neuronal RNAi, (b) RNAi in the whole body, and (c) LoF. Mean ± SEM is plotted of
(a, b) 5 repeats or (c) 7 repeats, each containing 8 flies. Results were compared to appropriate
background line by Student’s t-test. * p<0.05, ** p<0.01, *** p<0.001




















































































































































































































































































































































































































Fig. 3.19 Ingestion of food after starvation, as assessed by the appearance of dye in the
abdomen of flies, by flies with control genes disrupted. Genes were perturbed by (a) neuronal
RNAi, (b) RNAi in the whole body, and (c) LoF. Mean ± SEM is plotted of (a, b) 5 repeats
or (c) 7 repeats, each containing 15 flies. Results were compared to appropriate background
line by Student’s t-test. * p<0.05, ** p<0.01, *** p<0.001
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Dye food absorption assay
Not all control genes were phenotyped with the dye food absorption assay assay, for reasons



























































































































































































































































































































Fig. 3.20 Ingestion of food, as measured by the absorbance of food dye, by flies with control
genes disrupted. Genes were perturbed by (a) neuronal RNAi, (b) RNAi in the whole body,
and (c) LoF. Mean ± SEM is plotted of (a, b) 5 repeats or (c) 7 repeats, each containing 8
flies. Results were compared to appropriate background line by Student’s t-test. * p<0.05,
** p<0.01, *** p<0.001
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Fig. 3.21 Climbing ability of flies with control genes disrupted. Genes were perturbed by (a)
neuronal RNAi, (b) RNAi in the whole body, and (c) LoF. Mean ± SEM is plotted of (a, b)
5 repeats or (c) 7 repeats, each containing 15 flies. Results were compared to appropriate
background line by Student’s t-test. * p<0.05, ** p<0.01
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Larval feeding assay
The larval feeding assay was only performed on the LoF lines, as explained in section 3.4.
Figure 3.22 shows the results of the assay done on larvae in a fed or fasted state. Figure 3.23
shows the change in behaviour between the two states - genes which show no difference are





















































































































































































































































Fig. 3.22 Feeding motivation of Drosophila larvae with LoF of control genes in the (a) fed
and (b) fasted state. Mean ± SEM is plotted of 7 repeats, each containing 20 larvae. Results























































































































Fig. 3.23 Feeding motivation of Drosophila larvae with LoF of control genes in the fed (blue)
and fasted (red) state. Mean ± SEM is plotted of 7 repeats, each containing 20 larvae. All
genes show a statistically significant difference between fed and fasted, unless marked by φ .
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3.7.6 Precision of the assays
The results of each assay will be discussed now, rather than in the discussion section of
this chapter, because it is important to understand the reasoning for the scoring system
developed in section 3.8. This subsection will consider the precision of each assay. Two
factors contribute to precision: the sensitivity of the assay (more sensitive assays can detect
smaller changes in the measured phenotype) and the reproducibility of the data (how much
variation there is between independent repeats).
Among the assays of physiology, the wet mass (figure 3.13), TAG (figure 3.15) and
glucose assays (figure 3.16) are precise, as evidenced by their detection of multiple small
significant phenotypes. Of these three assays, the results of the control genes suggest that the
TAG assay is the most sensitive and the wet mass the least. The starvation resistance assay
(figure 3.17) is less precise, but is still able to detect some significant phenotypes. For the
dry mass assay (figure 3.14), no significant differences were observed in any control genes
which suggests that the assay is insensitive.
As would be expected, the results of the behavioural assays (food intake and movement)
show greater variation than the more definitive measurements of physiology. Despite this,
the CAFE assay, over-feeding dye assay and dye food absorption assay (figures 3.18, 3.19
and 3.20) were all sensitive enough to detect significant changes in food intake amongst the
control genes. The climbing assay (figure 3.21) was not very precise, but was still able to
detect a few significant phenotypes.
For the LoF lines, the w1118 and yw background flies show a very different phenotype
from each other in the over-feeding dye assay (figure 3.19) and the larval feeding assay
(figure 3.22). Since experimental lines were compared to both of these backgrounds (section
3.6.1), few significant changes are seen.
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3.7.7 Accuracy of the assays
Data from the control genes was also used to assess the accuracy of each assay. This was
done by comparing the positive control genes to both the negative control genes, and to
published data.
In the screen, lean phenotypes may truly result from the manipulation of a gene important
in energy homeostasis. However, any genetic manipulations which cause toxicity and/or non-
specific sickness in flies will result in these same phenotypes (Yazdi et al., 2015). Therefore,
in all of the assays, phenotypes that were increases compared to background (referred to here
as "increase phenotypes") were considered more noteworthy than those that were decreases.
For the wet mass, CAFE and over-feeding dye assays (figures 3.13, 3.18 and 3.19), the
positive control genes are enriched for significant increase phenotypes compared to the
negative control genes, implying that the results are accurate. This is particularly true of the
flies with neuronal RNAi, which is unsurprising given the importance of the brain for feeding
behaviour (see chapter 1).
As can be seen in figure 3.22, few lines show a significant phenotype in the larval feeding
assay. However, a highly significant difference was detected between fed and fasted larvae
for each individual line (figure 3.23) which suggests that the results are accurate. The only
line which does not show this behaviour is a mutant in the positive control gene bmm, which
is consistent with mutations in this gene causing increases in TAG storage (see chapter 1).
For the dry mass assay (figure 3.14), whilst variation was small within each experimental
batch, results were very different between batches. This is likely due to environmental factors
which influence the drying of the Drosophila carcasses such as humidity and temperature.
This makes the results inaccurate and so the dry mass assay was not completed for all control
lines and was not taken further as part of the screen (preliminary data for chapter 4 genes is
in appendix A).
For the dye food absorption assay (figure 3.20), many of the genes that showed an
increase in dye absorbance were those which had been noted to have dye on their bodies
during collection, meaning that the assay is not an accurate measure of food intake. Therefore,
this assay was not completed for all control lines and was not taken further as part of the
screen (preliminary data for chapter 4 genes is in appendix A).
The TAG, glucose, starvation resistance and climbing assays (figures 3.15, 3.16, 3.17, and
3.21) do show significant phenotypes in the positive controls, but these genes are not enriched
for phenotypes compared to the negative control genes. As explained in section 3.7.2, the
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negative control genes are all associated with diseases that either cause or are caused by
changes in weight, and so it is possible that they are not true negative controls. Therefore, this
lack of discrimination between control genes does not mean that the assays are inaccurate. In
particular, the climbing assay is not only a measure of activity, but also of cognitive function
and muscle physiology (Chakraborty et al., 2011; Bartholomew et al., 2015), and so the
presence of phenotypes in the negative control genes is unsurprising. Therefore, the accuracy
of each assay was also assessed by comparing the results obtained here for the positive
control genes to published data.
bmm
bmm is a lipase responsible for basal lipolysis in the fat body, the homologue of human ATGL
(see chapter 1). According to published data, flies with P-element induced KO of bmm show
almost complete embryonic lethality, but flies lacking only zygotic bmm show 100% more
TAG as adults than controls and survive 56% longer during starvation (Gronke et al., 2005).
These findings were replicated here using three LoF lines with transposon insertions into
bmm. Firstly, two of the LoF lines were lethal (BB24 and BB27). The viable line (BB10)
showed large increases in both TAG and survival during starvation.
chico
chico is a homologue of human IRS1 and is part of the insulin signalling pathway which
controls growth and glucose homeostasis in Drosophila (see chapter 1). According to
published data, adult flies with P-element induced mutation of chico have decreased wet
mass and dry mass, but increased TAG when normalised to mass, and no change in glucose
levels (Bohni et al., 1999; Murillo-Maldonado et al., 2011). Here, two lines were obtained
with transposon insertions into chico. One of these lines (BB7) was lethal. The other, viable,
line (BB8) showed a significant decrease in wet mass and an increase in TAG compared to a
w1118 background. Although a trend in this direction could be seen when compared to yw,
the results did not reach significance. There is also a trend for a decrease in dry mass, but this
did not reach significance with either background. Finally, there is a significant decrease in
glucose levels which is a different phenotype to that published. Flies with actGAL4-mediated
RNAi of chico (VV72) were able to replicate both the significantly decreased wet mass and
the no change in glucose.
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upd2
Published data has shown that flies with deletion of upd2 have smaller bodies and decreased
levels of TAG (Rajan and Perrimon, 2012). Here, a line with a 4.7kb deletion including the
upd2 coding sequence (BB23) was obtained. In contrast to the published results, this line
showed significantly increased TAG and no change in mass.
upd1
The Drosophila gene upd1 has been suggested to be a functional homologue of the human
gene leptin, a hormone with a key role in signalling body TAG stores (see chapter 1). Flies
with neuron-specific RNAi of upd1 have been shown to have increased mass, and increased
feeding in a CAFE assay (Beshel et al., 2017). Both of these results were replicated here
using flies with neuron-specific RNAi of upd1 (VV3).
hugin
NmU and its Drosophila homologue hugin both have important roles in feeding behaviour
(see chapter 1). Using tetanus toxin light chain to block synaptic transmission of hugin-
expressing neurons causes Drosophila adults to initiate feeding more quickly upon changing
from ND to dye food, although there is no overall change in total food intake (Melcher et al.,
2007; Melcher and Pankratz, 2005). Further, RNAi of hugin has no effect on larval feeding
behaviour (Schoofs et al., 2014). The line used here (BB17) contains an Mi[ET1] element in
the hugin gene. Like the published data, no change in the dye food absorption assay or larval
feeding was seen here. However, no significant difference was found in the over-feeding dye
assay.
Leucokinin
The mammalian tachykinins and the fly homologue Lk have a role in feeding (see chapter 1).
According to published data, flies with disruption of the Lk gene or of Lk-expressing neurons
show increased intake of radioactive/dyed food after starvation, but no changes in the absence
of starvation, an increase in starvation resistance, and decreased locomotor activity (Al-Anzi,
2010; Zandawala et al., 2018). Here, flies with a P-element insertion into Lk (BB11) also
show no change in the dye food absorption assay. For the the over-feeding dye and climbing
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assays, there is a significant phenotype in the expected direction when compared to one
background control but not the other. No change was seen in starvation resistance.
DSK
CCK is a gastrointestinal hormone involved in the regulation of food intake (see chapter
1). RNAi of the Drosophila homologue DSK in IPCs or DSK-producing neurons leads to
increased ingestion of dyed food following starvation, and increased resistance to starvation
(Söderberg et al., 2012). Here, neuronal RNAi of DSK (VV36) resulted in an increase in
post-starvation food intake, but no change in starvation resistance.
TfAP-2 and twz
TfAP-2 and twz function upstream of DSK, and RNAi of each gene in octopaminergic neurons
has been shown to increase ingestion of dye food post-starvation and increase food intake
via the CAFE assay (Williams et al., 2014). Here, neuronal RNAi was used to knock-down
expression of TfAP2 (VV53) and twz (VV54). An increase in both post-starvation food intake
and CAFE assay food intake was seen for TfAP-2, as expected. No phenotype was seen for
twz.
Summary
In summary, for all of the assays, the results for at least one of the positive control genes
were found to match the previously published phenotypes, as summarised in table 3.4. Since
the assay protocols used here were all able to distinguish dietary perturbations (see section
3.4), their ability to replicate the published observations was unsurprising.
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3.8 Development of a scoring system
The screen produces data for eight phenotypes for each gene: wet mass, TAG levels, glucose
levels, starvation resistance, CAFE food intake, dye over-feeding, climbing ability, and larval
feeding motivation. To facilitate data analysis, a method of scoring each gene was developed
in order to give a measure of the overall phenotype. The algorithm takes a weighted average
of the p values for each assay, and subtracts from 1 so that more significant results give
higher scores.
The weighting of the assays in the scoring formula was assigned by ranking them in
terms of the relevance of the phenotype being measured: the food intake assays were given
the highest weighting since this is the phenotype of most interest for this work (human and
mouse genetic studies to date have shown that genes which influence energy homeostasis
have a strong influence on food intake, see chapter 1), and then the physiology assays came
next.
The assays were also ranked according to their precision and accuracy (highest first)
based on the results of the positive and negative control genes, as discussed previously.
The results of the dry mass and dye food absorption assays are not included, as discussed
previously.
Since the summation of 7 phenotypes is 28 (i.e. 7+6+5+4+3+2+1), and of 6 pheno-
types is 21, the p value totals are divided by these totals to produce a range of scores with a
minimum of 0 and a maximum of 1. Therefore, the final equations for the scoring systems are:
ScoreLoFadult = 1−( 128)(7pCAFE +6pdye+5pTAG+4pmass+3pglucose+2pclimbing+ pstarvation)
ScoreLoFlarvae = 1− (12)(plarvae f ed + plarvae f asted)
ScoreRNAi = 1− ( 121)(6pCAFE +5pdye +4pmass +3pglucose +2pclimbing + pstarvation)
where px is the p value in assay x for the gene of interest.
The results of the screen will now be presented according to the Drosophila model used
(LoF or RNAi) and how well the models were able to distinguish between the negative and
positive control genes.
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LoF of positive and negative control genes
The phenotypes of flies with LoF of control genes are summarised in figure 3.24. Many
of the LoF lines show significant phenotypes in multiple assays and these genes are evenly
distributed across the negative and positive control genes. There are more phenotypes which
are decreases compared to background than there are increase phenotypes.
The scores are shown in figure 3.25 - for the adult flies there is no significant difference
between the positive control genes and the negative control genes. For the larvae, the scores
of the positive control genes are significantly increased compared to the neuronal disease
negative control genes.
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CAFE Dye Food TAG Mass Glucose Climbing Starvation
BTBD9 / btbd9 / BB9
FZD3 / fz / BB2
PICALM / lap / BB20
SHANK3 / prosap / BB18
SCL25A37 / mfrn / BB16
GAK / aux / BB21
MAPT / tau / BB29
MAPT / tau / BB28
UNC13 / unc13 / KK1
CHRNA7 / nAChRα5 / BB25
leptin / upd2 / BB23
IRS1 / chico / BB8
ATGL / bmm / BB10
NmU / hugin / BB17
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Fig. 3.24 Summary of phenotypes of (top) adult flies and (bottom) larvae with LoF of control
genes. Red is an increase in comparison to background and blue is a decrease. * p<0.05,
** p<0.01, ***p<0.001, ****p<0.0001






















Fig. 3.25 The phenotype score of control genes in LoF Drosophila. -P are peripheral disease
negative control genes, -N are neuronal disease negative control genes, and + are positive
control genes.
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Whole body RNAi of positive and negative control genes
The phenotypes of flies with whole body RNAi knock-down of control genes are summarised
in figure 3.28. Again, many of the phenotypes are decreases, but the results for most genes are
milder (less significant) than when using LoF flies. The positive control genes are enriched
for the presence of increase phenotypes compared to the negative control genes. As with
the LoF lines, there is a trend towards the positive control genes scoring more highly than
the peripheral disease negative control genes, although this is not significant, and there is no
difference for the neuronal disease negative control genes (figure 3.27).
After whole body RNAi of en (the Drosophila orthologue of EN1), the flies were very
unhealthy — they were unable to move off of the bottom of the vial, hence their strong
decrease phenotype in the climbing assay and the CAFE assay (for which flies have to
climb to reach the food capillaries), but a strong increase phenotype in the over-feeding dye
assay (they could not move off of the dye food). In agreement with this being an unhealthy
phenotype, en is known to play a key role in segmentation of the Drosophila embryo, and null
mutations cause lethality (Kassis, 1990; Gramates et al., 2017). Therefore, since this gene
seems to have a non-specific unhealthy phenotype (rather than a specific energy homeostasis
phenotype), it should perhaps be removed from the data analysis. In this case, the difference
in scores between the positive control genes and the peripheral disease negative control genes
approaches significance (p<0.1).
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CAFE Dye Food Mass Glucose Climbing Starvation
EN1 / en / VV2
GLB1 / Ect3 / VV78
KDM4C / KDM4A / VV79
FZD3 / fz / VV5
UNC13 / unc13-4a / VV35
MCCC1 / MCC / VV37
SHANK3 / prosap / VV70
leptin / upd1 / VV3
CCK / DSK / VV36
IRS1 / Chico / VV72





























Fig. 3.26 Phenotypes of flies with whole body RNAi of control genes. Red is an increase in
comparison to background and blue is a decrease. * p<0.05, ** p<0.01, ***p<0.001




















with en without en
Fig. 3.27 The phenotype score of control genes with whole body RNAi Drosophila. -P are
peripheral disease negative control genes, -N are neuronal disease negative control genes,
and + are positive control genes.
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Neuronal RNAi lines of positive and negative control genes
Finally, a summary of the phenotypes of flies with neuronal RNAi of control genes is given
in figure 3.28. In this case, few decrease phenotypes are observed, suggesting that neuronal
RNAi is generally less detrimental than the whole body genetic perturbations. Further, the
positive control genes show many more significant phenotypes than the negative control
genes.
Of the neuronal disease negative control genes, only MCC (the Drosophila orthologue
of MCCC1) shows a strong phenotype. MCCC1 was originally included as a neuronal
disease negative control because it has been associated by GWAS with Parkinson’s disease
(Lill, 2016). However, transcriptomics data published in July 2018 showed that this gene
is strongly associated with insulin sensitivity and metabolic disease (Timmons et al., 2018).
Given this new data, perhaps MCCC1 is not an appropriate gene to use as a negative control.
Thus, MCCC1 is not included in any further analysis of the negative control genes.
For the neuronal RNAi, there is a significant distinction between the scores of the positive
control genes and both sets of the negative control genes.
There are two low-scoring positive control genes: chico and twz. It is unsurprising that
neuronal RNAi of chico does not produce a strong effect, because the reported phenotypes
(for example decreased mass, see section 3.7.7) depend on peripheral actions of the gene,
not neuronal actions. Therefore, it is perhaps inappropriate to include this gene as a positive
control, and removal of this gene increases the significance of the difference between the
gene control groups. The reasons that twz did not score highly are unclear, and possible
reasons will be discussed in section 3.10.
Therefore, neuronal RNAi was able to significantly distinguish between the positive and
negative control genes. The threshold for doing so was a score of 0.7.
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CAFE Dye Food Mass Glucose Climbing Starvation
EN1 / engrailed / VV2
MEIS1 / hth / VV32
MRPS21 / mRpS21 / VV75
GLB1 / Ect3 / VV78
KDM4C / KDM4A / VV79
UBR4 / poe / VV80
FZD3 / fz / VV5
UNC13 / unc13 / VV35
UNC13 / unc13-4A / VV35
PSEN1 / psn / VV1
MCCC1 / MCC / VV37
SHANK3 / prosap / VV70
leptin / upd1 / VV3
CCK / DSK / VV36
TFAP2B / TfAP2 / VV53
KCTD15 / twz / VV54
IRS1 / Chico / VV72




































Fig. 3.28 Summary of phenotypes of flies with neuronal RNAi of control genes. Red is an
increase in comparison to background control and blue is a decrease. * p<0.05, ** p<0.01
























Fig. 3.29 The phenotype score of control genes with whole body RNAi Drosophila. -P are
peripheral disease negative control genes, -N are neuronal disease negative control genes,
and + are positive control genes. MCC is not included. * p<0.05.
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3.9 Diets
Since high-calorie diets are a major contributory factor to the current obesity epidemic
(French et al., 2001), the inclusion of different diets as part of the screen was explored. These
diets expose flies to metabolic stress, and thus may reveal additional phenotypes that are not
apparent in flies given normal diet (ND) (Smith et al., 2014).
A high-fat diet (HFD) was made by supplementing the ND food with 20% coconut oil,
as this has been reported to cause metabolic phenotypes in flies including increased mass,
increased TAG storage and decreased lifespan (Birse et al., 2010; Heinrichsen and Haddad,
2012; Ormerod et al., 2017). This same HFD was used to validate the individual screen
assays in section 3.4.
The response of the control gene LoF lines to this HFD was tested. Many of the significant
results that were found on ND earlier (section 3.7.5) were replicated with the flies exposed to
HFD (figure 3.30), which provides evidence that these results are true phenotypes of the lines.
Unsurprisingly, the scores (figure 3.31) look similar to those of the ND flies shown earlier
(figure 3.25). However, few novel significant increase phenotypes were revealed using HFD.
For some assays (TAG, starvation resistance, and dye over-feeding assays), there is a
significant difference between ND- and HFD-fed w1118 flies, as shown in figure 3.32. In this
case, it is the genes for which no significant change is found between the two diets which are
notable, as such flies are insensitive to the dietary change. For example bmm does not have
increased TAG levels on HFD compared to ND, suggesting that the TAG stores are already
maximised on ND, which is consistent with the known role of bmm in the break-down of
stored TAG.
By comparison, for some assays there is no difference between ND- and HFD-fed w1118
flies (figure 3.33, wet mass, glucose, CAFE and climbing assays), in which case it is the flies
which do show a significant change which are notable, as they have increased sensitivity to
the metabolic stress.
However, neither insensitivity nor increased sensitivity to HFD are enriched in the positive
control genes compared to the negative control genes.
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ND HFD ND HFD ND HFD ND HFD ND HFD ND HFD ND HFD
RLS BTBD9 btbd9 *** ** * *** ****
Schizophrenia FZD3 frizzled * **
Alzheimers PICALM lap * * *
Autism SHANK3 prosap ** *
Depression SLC25A37 mitoferrin ** * *
Parkinsons GAK auxilin ** * * *
Parkinsons MAPT tau (BB29) ** **** *** *** **** *
Parkinsons MAPT tau (BB28) ** * *
ALS UNC13A unc13 * * * *
Multiple CHRNA7 nAChRα5 **
Leptin upd2 * ***
IRS1 chico * * *** ** **** * **
ATGL bmm * **** ** ** * *
Neuromedin U hugin * * * *












TAG Glucose Starvation CAFE Dye food Climbing
Fig. 3.30 Control genes in LoF lines exposed to ND and HFD show similar phenotypes. Red
is an increase in comparison to background control and blue is a decrease.
* p<0.05, ** p<0.01, *** p<0.001, ****p<0.0001










Fig. 3.31 Scores of control genes in LoF lines exposed to HFD


































































































































































































































































































































































































































































































































104 Development of a Drosophila-based screen to detect energy homeostasis phenotypes
The HFD had to be kept below 20oC to prevent the coconut oil melting, but GAL4 is
less active at this temperature (Busson and Pret, 2007) and so HFD was not suitable for the
RNAi flies. Instead, a high sugar diet (HSD) was tested containing 35% sucrose and glucose
(compared to 15% in ND) which has been reported to cause strong metabolic phenotypes in
flies (Morris et al., 2012b; Musselman et al., 2011; Na et al., 2013; Pasco and Leopold, 2012;
Tennessen et al., 2014; Trindade de Paula et al., 2016; May et al., 2015). The effects of this
diet were tested with w1118 flies. As can be seen in figure 3.34, no difference between ND-
and HSD-fed flies was seen in most assays. Therefore HSD was not continued for further
















































































































Fig. 3.34 Phenotype of w1118 flies exposed to five days of either ND or HSD.
Mean ± SEM is plotted. Results for ND and HSD were compared by Student’s t-test.
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3.10 Discussion
There is an unmet need for a high-throughput method to investigate human genetic data
related to the regulation of energy homeostasis. The aim of this chapter was to create and
validate a high-throughput screen of energy homeostasis phenotypes using Drosophila as a
model to study specific human genes of interest.
3.10.1 Drosophila models and their backgrounds
Several large collections of Drosophila stocks for gene manipulation are readily available
from public stock centres. Two models were used in this chapter — LoF and RNAi — and
the basic principles underlying their genetic perturbations were outlined in section 3.2. The
two models required use of different background lines for statistical comparison.
For many LoF lines, the background is either not known or not available for use. Further,
lines obtained from stock centres are inbred, which is known to cause changes in gene
expression, disproportionately affecting genes involved in metabolism (Kristensen, 2005).
According to the Bloomington stock centre (from which most of the LoF lines were obtained):
"For many collections there likely isn’t a good control". Backcrossing two LoF lines to w1118
showed that background was an important factor for the assays of energy homeostasis, with
strong phenotypes in inbred flies disappearing after backcrossing (section 3.6.1). Therefore,
the use of matching backgrounds for comparison for each line is important. However,
backcrossing stocks reduces the speed of the screen, can only be applied to lines where the
mutation has a visible marker, and can introduce novel mutations, so is not practical for use
in a high-throughput screen. Instead, the variability and uncertainty in the background of the
LoF lines was overcome by using multiple backgrounds for statistical comparison (yw and
w1118).
For RNAi, the backgrounds of the lines were known (KK-GAL4 or GD-GAL4) and
easily obtainable for phenotyping (section 3.6.2). There are two exceptions to confident use
of these backgrounds. Firstly, the compound X stocks may have slightly altered backgrounds
due to the crosses required to remove the compound X balancer chromosome. Secondly,
some of the KK siRNA lines cause over-expression of the tiptop gene which produces a
strong phenotype, and thus requires use of an additional background line.
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3.10.2 Assay selection
Ten assays were found in the literature that, when combined together to form a screen, allow
measurement of a number of characteristics related to energy homeostasis in Drosophila: five
assays that measure physiology, four assays that measure food intake, and one that measures
movement (section 3.3). These assays were all found to be high-throughput enough for use
in a large scale screen.
In addition, an assay was created that is able to detect feeding motivation in adult flies
(section 3.5). This assay was quite low-throughput and thus was intended for use on just a
few genes which the high-throughput assays indicate are top hits.
Several high-throughput genetic screens of metabolic phenotypes have been published,
but these generally use just one assay, for example TAG (Baranski et al., 2018) or glucose
(Ugrankar et al., 2015). To my knowledge, there are no published results in which a suite
of assays was used to screen a large number of genes for energy homeostasis phenotypes.
Using multiple assays in a screen has two advantages. Firstly, the screen is less likely to give
false positive results because anomalous results would have to be obtained for several assays.
Secondly, genes which do not show a large phenotype in any single assay, but which have
subtle changes in multiple assays will also be highlighted, making the screen more sensitive.
This sensitivity is particularly important given that behavioural traits (such as feeding) are
difficult to measure precisely. The disadvantage of using a multi-assay screen is that results
generation is slower.
3.10.3 Assay validation via metabolic perturbation
The high-throughput assays were all validated for use by their ability to differentiate w1118
flies given ND from flies with metabolic perturbation, either given HFD or fasted (section
3.4). Significant differences were detected in the expected direction for all assays between
ND and fasted flies. The phenotype of the HFD-fed flies is less strong, likely because
these flies were kept in different conditions in order to stop the HFD food melting. These
conditions (lower temperature, lower humidity, and no light) have been shown to affect
metabolic phenotypes in Drosophila (Al-Saffar et al., 1996; Caravaca and Lei, 2016) which
complicates interpretation of the results.
Based solely on the metabolic perturbation validation, the TAG and CAFE assays seemed
the most sensitive, able to detect both dietary perturbations, whereas the dye food absorption
and dry mass assays were potentially inaccurate.
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The TAG assay could not be done using the RNAi lines as the levels of TAG in the
sample were always below the detection limit. This is unlikely to be due to user error or
contamination of reagents because the samples were extracted and analysed at the same time
as samples from LoF lines which did show detectable levels of TAG. It is also unlikely to be
an anomalous result, since >300 RNAi samples were tested in this manner. This suggests
that perhaps the background of the RNAi lines contain low levels of TAG. This is unfortunate
because, based on the results from the metabolic validation, control genes validation and
HFD trial experiments, the TAG assay seemed to be one of the most accurate and sensitive
assays.
It is possible to do the larval feeding assay on RNAi lines, but the requirement to
collect such a large number of UASG-siRNA virgins means that this assay would not be
high-throughput.
All other assays could be used in both models.
3.10.4 Validation using control genes
Identification of control genes
Previous Drosophila screens of GWAS loci, for example by Baranski et al. (2018) and Pendse
et al. (2013), have used just one assay to probe their genes of interest, and so were able to
compare their results to published genome-wide screens of the same assay. Both papers
found that their phenotype of interest was enriched in their GWAS genes compared to the
genome average. However, such an approach was not possible for the suite of assays used
here, since there is not, to my knowledge, any published work for a genome-wide screen
using most of the assays.
Instead, the Drosophila-based screen for energy homeostasis phenotypes was tested
using a series of negative and positive control genes (section 3.7). This allowed the screen
to be validated by its ability to differentiate between these two types of controls, and the
difference to be quantified to provide a threshold for interpretation of experimental genes in
later chapters. The positive and negative control genes were phenotyped in a blinded manner
to avoid biasing of the results.
There were some differences in the way in which the positive and negative control genes
were selected. Firstly, most of the positive control genes were identified from published
Drosophila literature, whereas the negative control genes did not have any similar data
published. Further, the positive control genes have proven functional homology between
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humans and flies, but the orthologues of the negative control genes were identified using
only sequence homology, which does not guarantee conservation of function. Therefore,
whilst the results from the control genes can be compared, there is a limit on the confidence
associated with the comparison.
18 genes were chosen as negative controls. Whether these genes are truly suitable for this
purpose is not certain, given that they are all associated with diseases that are, in some way,
related to body weight/fat (the neuronal control diseases have a weight-related symptom,
and the risk of developing the peripheral control diseases is affected by weight). This is
exemplified by the recent data showing that MCCC1, which was chosen as a negative control
gene due to its association with Parkinson’s disease (Lill, 2016), is also associated with
metabolic disease (Timmons et al., 2018). However, since the purpose of the screen is
candidate gene selection, it is important to avoid false positive results, and so setting the
threshold at a high level by using these negative controls is perhaps advantageous.
The negative control genes were chosen due to their association with human disease.
In order to prevent bias in gene selection, published Drosophila phenotypes of these genes
were not researched. However, after the phenotyping data was complete, a literature search
revealed that en plays a key role in segmentation of the Drosophila embryo (Kassis, 1990;
Gramates et al., 2017). Therefore, the unhealthy phenotype observed is unsurprising, and
this gene was (retrospectively) considered unsuitable for use as a negative control.
According to published microarray data, all of the chosen control genes are expressed
in the larval and/or adult CNS in Drosophila, which is an important consideration for the
neuronal RNAi data.
Comparison of positive control genes to published data
The accuracy of the assays was partially assessed by comparing the results of the positive
control genes to published data. For some genes, the protocols used here were able to replicate
all of the published phenotypes (e.g. upd1, bmm and TfAP-2). Most of the other genes were
able to replicate at least some of the data. For those cases in which no phenotype or the
opposite phenotype was seen in an assay, this is likely due to differences in experimental
paradigms:
• The assay protocols used are not identical. For example, Söderberg et al. saw an
increase in starvation resistance for DSK after single-housing their flies (Söderberg
et al., 2012), but here no change was seen here where the flies were kept in groups of
15.
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• The genetic perturbation was different. For example, Melcher et al. saw an effect on
feeding after blocking transmission of hugin-expressing neurons using tetanus toxin
light chain (Melcher and Pankratz, 2005; Melcher et al., 2006, 2007), whereas no effect
was seen here using RNAi against hugin itself.
• There is variation in the effectiveness of different genetic perturbations of the same
gene: the precise location of a P-element integration in LoF lines affects how much the
target gene is perturbed (Groth et al., 2004), and siRNAs are differentially expressed
depending on their genomic location (Heigwer et al., 2018). For example, two of the
bmm LoF lines were lethal, but one was not, despite all three lines having a transposable
element inserted into the gene. This difference in viability between lines which affect
the same gene suggests that there is also variability in energy homeostasis phenotypes.
Generally, the Drosophila lines used in the literature were not identical to those used
here.
• The GAL4 lines used with the RNAi flies had a different expression pattern. For
example, Söderberg et al. performed RNAi in DSK-producing neurons only, whereas
here, elav-GAL4 was used to perform pan-neuronal RNAi, and the starvation resistance
phenotype was not seen.
• One or both of the lines used as background for the LoF lines was not appropriate. For
example, flies with chico LoF showed decreased glucose, but might not have had they
been compared to their actual background of y1w67c23.
• The assay is inaccurate and/or insensitive, for example the dry mass assay (section
3.7.7).
There is only one gene for which none of these factors can explain the lack of phenotypes
observed: twz. The same twz siRNA line was used as in the literature (Williams et al.,
2014), discounting siRNA variability as the cause of the absent phenotype. There were
multiple differences in the methods used (different food, temperature, GAL4 driver), but
these same arguments also apply to TfAP-2 (from the same paper) for which a phenotype
was observed here, so these cannot explain the lack of phenotype. Thus, the reason for this
lack of phenotype seen with twz remain unclear.
Precision and accuracy of the assays
Phenotyping of the positive and negative control lines allowed the assays to be tested for
their use in a large-scale screen. The precision and accuracy of each assay were discussed
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in detail earlier (sections 3.7.6 and 3.7.7), and so will not be discussed again, just briefly
summarised in the following table. The precision refers to both the sensitivity of the assay
and the variability of the phenotype, as evidenced by how small a change was detected as
significant. The accuracy refers to whether the positive control genes were enriched for
significant phenotypes compared to the negative control genes, and whether published data
could be replicated with the positive controls.
Assay Precision Accuracy Included in screen
CAFE assay High High Yes
Over-feeding dye Medium High Yes
TAG High High Yes
Wet mass High High Yes
Glucose High High Yes
Climbing Low Medium Yes
Starvation resistance Low High Yes
Larvae Low High Yes
Dye food absorption High Low No
Dry mass Low Uncertain No
The assays were all considered suitable for further use, except the dry mass and dye absorption
assays which were found to be inaccurate and/or imprecise.
Scoring system
Based on the results of the positive and negative control genes, a scoring system was
developed using the results for each assay (section 3.8). An advantage of this scoring system
is that genes which show subtle phenotypes in multiple assays will score more highly than
genes which show strong phenotypes in just one assay, which both highlights genes that
would not be detected by a screen consisting of only one assay, and also makes false positive
results less likely. There are two limitations of the scoring system. Firstly, results which are
increases compared to background are not distinguished from those that are decreases, and
thus flies which are unhealthy (rather than having a specific energy homeostasis phenotype)
may also score highly, as was seen with en-actGAL4. Thus, the scores should not be viewed
in isolation from the assay data. Secondly, as discussed earlier, the negative control genes
may not be totally free of energy homeostasis phenotypes, and so choosing a cut-off score of
0.7 based on these genes limits the sensitivity of the screen.
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Control genes in different Drosophila models
In both the negative and positive control genes, many of the LoF lines show significant
phenotypes in multiple assays. Since many of these phenotypes are maintained across ND
and HFD, this implies that the results do accurately represent the phenotype of the lines.
However, the lines may not truly represent the phenotype of the genes for two reasons.
Firstly, the background lines used for statistical comparison (w1118 and yw) may not be
appropriate for every line, generating false positive/negative results. Secondly, most of
the significant results are decreases (compared to background) rather than increases, and
although this leanness may be a true phenotype, it may just be non-specific unhealthiness.
The scoring system found a trend towards the positive control genes scoring more highly
than the peripheral disease negative control genes, but it was not significant.
Similar to the LoF flies, flies with whole body RNAi showed many decrease phenotypes.
However, the results are milder than LoF, likely because RNAi does not completely stop
gene expression. Some increase phenotypes can also be seen, and these are enriched in the
positive control genes. Again, a trend is seen in the scores, but it does not reach significance.
Finally, for neuronal RNAi, few decrease phenotypes are observed, suggesting that the
neuronal RNAi is not commonly detrimental. Further, the positive control genes show many
more increase phenotypes than the negative control genes. There was a significant difference
between the positive control genes and the negative control genes.
3.10.5 Use of diets
Since the aim of studying obesity genetics is to understand common obesity, and modern
high-calorie diets are thought to be a major factor in the current obesity epidemic, the use of
a HFD and a HSD as part of the Drosophila screen was explored (section 3.9). Both diets
have been reported to cause metabolic phenotypes in flies. However, when tested here, the
HFD did not reveal any genes which showed a different response to HFD across multiple
assays, and the HSD did not cause any detectable phenotype. This is likely because most of
the published papers exposed flies to the diet for several weeks (as opposed to the five days
used here), and many used female flies (as opposed to males, which feed less than females
and so will be less affected by the change in diet). Further, the published literature has
conflicting evidence for the effect of these diets on the phenotypes of interest. For example,
HSD has been shown to increase (Morris et al., 2012b), decrease (Musselman et al., 2011)
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and not change (May et al., 2015) the wet mass of Drosophila. Therefore, neither diet were
considered further for inclusion as part of the screen.
3.10.6 Comparison of the LoF and RNAi models
The two Drosophila models used to assay the positive and negative control genes - LoF and
RNAi - will now be compared for their suitability for the high-throughput screen.
Background: All of the RNAi lines came from a known background (KK or GD) which
are available to use for comparison. For >50% of the LoF lines, the background was
not known, and the rest came from a range of backgrounds, which has a strong effect on
phenotype (section 3.6.1).
Assays: All of the assays can be applied to LoF lines (but only if adults are viable).
However, the TAG assay, larval assay and use of HFD could not be performed on RNAi flies
(sections 3.4 and 3.9).
Viability: 25% of Drosophila genes are lethal when mutant (Wangler et al., 2017). This
figure is slightly lower for whole body RNAi because some residual gene expression remains,
and even lower for neuronal RNAi (for example, see chapter 4).
Results: RNAi was able to significantly distinguish between positive and negative control
genes, whereas LoF was not (section 3.8).
Speed: It was found that the LoF and RNAi models produced results at approximately
the same rate. However, the LoF lines can be assayed as soon as the first generation are
born, whereas phenotyping of RNAi flies is delayed by two weeks because the siRNA lines
must be crossed to GAL4 and then the offspring assayed. Further, some siRNA lines require
removal of a compound X balancer chromosome, which takes three generations.
Tissue-specificity: LoF lines have universal disruption of the gene of interest, which
makes many of the lines unhealthy, thus potentially masking energy homeostasis phenotypes.
By contrast, RNAi is tissue-specific, which reduces the lethality and sickness associated with
universal mutation, whilst also providing some mechanistic information (location of gene
action) about the gene being studied.
Efficiency: The efficiency of both LoF and RNAi is known to be variable. For LoF, the
exact position of the P-element integration influences gene expression (Groth et al., 2004).
For RNAi, the design of the siRNA and the location of genomic integration both affect the
efficiency of knock-down (Dietzl et al., 2007). With LoF it is possible to completely stop
expression of the gene of interest, whereas with RNAi the knock-down can only be partial
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(generally to a level of 25%, Heigwer et al. (2018)) which may not be enough to affect some
genes.
Genetic specificity: Both LoF and RNAi can have off-target effects. For RNAi, this
happens when an siRNA has sequence similarity to non-target RNAs (Seinen et al., 2011).
For LoF stocks this can happen if the line contains a deletion of a genomic locus encompassing
several genes, or if the location of the P-element influences multiple genes (Groth et al.,
2004).
Availability: For both models, mutant flies can be sourced from publicly available stock
centres. Approximately 70% of Drosophila genes have lines available with P-element
insertions (Hummel and Klämbt, 2008), whereas 91% of genes have siRNA lines available.
LoF lines are generally cheaper than RNAi lines.
On the basis of all of these factors, it was decided that RNAi was the more suitable model
for use in a high-throughput screen of genes for effects on energy homeostasis and food
intake.
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3.11 Summary
In this chapter, a collection of assays were identified for investigation of physiology, energy
intake and movement. They were validated by their ability to detect dietary perturbation
of wild type flies. Two genetic models (LoF and RNAi) were explored in Drosophila for
their use in the screen. Next, a series of positive and negative control genes were identified
and assayed in order to validate the screen by showing that it is able to differentiate between
the controls, and RNAi was found to be a better model than LoF for doing so. Thus, the
framework of a Drosophila-based genetic screen for energy homeostasis phenotypes was
established.
Chapter 4
A Drosophila-based screen of genes
identified by GWAS to influence BMI
4.1 GWAS and polygenic obesity
As discussed in chapter 1, genetics is a powerful tool with which to identify and study
the pathways involved in energy homeostasis in humans. In the past, rare monogenic and
syndromic obesity disorders have provided invaluable insights into the control of body weight
and food intake. Now, advances in technology and the accessibility of genomic resources
covering large general populations is beginning to allow the relationship between genes and
common obesity to be investigated. It is hoped that these studies of complex polygenic
obesity will bring new discoveries that advance our understanding of energy homeostasis,
and eventually facilitate development of new therapies for obesity. To date, multiple GWASs
(see chapter 1) have been performed on general populations for various obesity-related traits
such as BMI, and these have uncovered many novel genetic loci which are the subject of this
chapter.
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4.2 Moving from GWAS to biological understanding
BMI is an approximate measure of body fat and obesity. Between 2007 and 2013, GWASs of
hundreds of thousands of people had identified 36 genetic loci which are robustly associated
with BMI (Speliotes et al., 2010; Lu and Loos, 2013). Some of these loci are near genes that
were already known to have a role in energy homeostasis, for example MC4R and POMC.
But for many of the genetic loci discovered by GWAS, very little is known about the biology
of the nearby genes.
To move from the genetic findings of GWAS to development of therapies, the genes
responsible for the GWAS signals must be studied. However, the speed of converting these
GWAS statistical associations into an understanding of the underlying biological mechanisms
has been slow. Since 2013, 168 novel genetic loci associated with BMI have been identified
by GWAS (Locke et al., 2015; Akiyama et al., 2017). But in the same time period, only a
handful of GWAS BMI genes have had functional studies published in mouse models: FTO
(Speakman, 2015; Tung et al., 2015), TMEM18 (Larder et al., 2017), NEGR1 (Lee et al.,
2012) and CADM2 (Rathjen et al., 2017). There are three reasons underlying this slow speed
of progress.
Firstly, GWASs generate large lists of data - to date 204 genetic loci have been associated
with BMI. This problem is compounded by the fact that GWASs lack the resolution to
specifically identify the causal gene. As was explained in chapter 1, GWASs genotype
millions of SNPs across the entire genome. These SNPs represent the common variation in
their region of the genome and exist in linkage disequilibrium with several hundred kilobases
containing multiple genes and regulatory elements of remote genes (Nicolae et al., 2010;
Wall and Pritchard, 2003; Wangler et al., 2017). This means that it is not clear from the
GWAS data alone which gene is causing the effect on energy homeostasis, thereby increasing
the number of genes which must be functionally investigated.
Secondly, rodent models have been invaluable in studying monogenic obesity and to date
they have been the model organism of choice for studying the GWAS genes. But as discussed
in chapter 1, experiments with mice are low-throughput and expensive. Unfortunately the
scientific community lacks the resources to study all of the GWAS genes in detail in mice.
Finally, use of gene expression microarrays has shown that gene expression is enriched
in the CNS for the GWAS BMI loci genes (Locke et al., 2015). However, the difficulty of
obtaining tissue samples from the brain makes it a complicated system to study.
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Currently the genetic variation that has been identified by GWAS only accounts for
less than 10% of the heritability of body weight (Bogardus, 2009; Speakman et al., 2018).
Therefore it is likely that more genetic loci will be found, and improvements in technology
mean that they will be found at an increasing rate.
This discrepancy in speed between the identification and the validation of genes calls for
use of a high-throughput model organism to screen the GWAS candidate genes, so allowing
resources to be focussed on studying only the most promising genes in mammalian models.
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4.3 Drosophila as a tool to investigate GWAS loci
High-throughput in vivo screens using Drosophila have the potential to assess candidate
genes from GWAS in an unbiased manner, and so accelerate functional studies of GWAS
data. As exemplars, two recent papers have used Drosophila to functionally evaluate genes
from GWASs of diseases of energy homeostasis.
Pendse et al. (2013) studied 38 human genetic loci that GWAS had found to be associated
with type 2 diabetes. They took the 130 human genes which lie within an 100kb window of
each of the GWAS SNPs, and identified fly orthologues for 71 of these genes. Using RNAi to
knockdown each gene in the whole body, Pendse et al. tested the flies for sucrose-dependent
toxicity. Most (33/38) of the GWAS SNPs were able to be studied in this manner. 42% of
the Drosophila genes showed a sucrose-toxicity phenotype, which is much higher than the
genome average of 9% which affect glucose levels (Ugrankar et al., 2015). At 13 loci, only 1
gene showed a phenotype in flies, and at 9 loci multiple human genes had a fly phenotype.
Some of these genes have proven effects on phenotypes of relevance to diabetes in mouse
studies. Based on their results Pendse et al. suggested which novel genes should be the focus
of further studies in humans/mice.
Very recently, Baranski et al. (2018) used Drosophila to examine 78 genetic loci which
GWASs have associated with BMI. They looked at all genes within a 250kb radius of each
SNP, and found at least one gene had a fly orthologue at 62 of these loci. After RNAi
knockdown of each gene in the brain and fat body, they measured the amount of TAG in the
flies. Of the 62 testable loci, 26 (42%) contained at least one gene with a significant TAG
phenotype, which is higher than the genome-wide average of 5% (Pospisilik et al., 2010).
Further, at 10 of these 26 loci, the gene producing a phenotype was not the gene closest to
the SNP, which led the authors to suggest that further studies in rodents or humans should
focus on these more distant genes, which would perhaps not be obvious just from looking at
the GWAS statistical data.
In both of these studies, the measured phenotypes are considerably enriched within the
genes from the diabetes/BMI GWAS loci compared to the genome average. This suggests that
there are high levels of conservation of energy homeostasis pathways during evolution, and
provides evidence for the utility of a Drosophila-based high-throughput functional genetic
screening strategy.
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4.4 Chapter aims
GWASs have provided a glut of potential insights into the genetics underlying obesity, but
there remains the need to study the biological mechanisms of these statistical associations.
This chapter focusses on genetic loci which GWASs have found to be associated with
human BMI. This statistical data was functionally investigated using the high-throughput
Drosophila-based screen for energy homeostasis phenotypes which was developed in chapter
3. This data set was chosen because some of the genes have already been functionally
explored, so allowing verification of the screen results. But most of the genes have not yet
been studied, thus also allowing for the potential discovery of novel results. Further, mouse
studies of a few of the GWAS-identified genes within the lab, for example TMEM18 (Larder
et al., 2017), have shown that their effects on energy homeostasis phenotypes are relatively
small, and so if the Drosophila-based screen is able to detect such genes (proof-of-concept),
then it is likely to also be sensitive enough to use on other types of genetic data.
Although similar to the work of Baranski et al. (2018), this work used a suite of assays to
evaluate multiple phenotypes including feeding behaviour, rather than only examining TAG
levels.
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4.5 Identification of human and Drosophila genes for study
4.5.1 Selection of human genes for study
The work in section 4.5.1 was done by Dr Loraine Tung. Briefly, by 2014, published GWASs
had identified 36 loci robustly associated with BMI (Speliotes et al., 2010; Lu and Loos,
2013), as shown in figure 4.1.
Fig. 4.1 Figure from Lu and Loos (2013) showing the GWAS loci that are associated with
BMI and were investigated in this thesis. SNPs are annotated by the nearest gene.
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At 28 of these loci, just the gene closest to the SNP was selected for study: FTO, MC4R,
BDNF, TMEM160, FANCL, CADM2, PRKD1, LRP1B, PTBP2, MTIF3, ZNF608, RPL27A,
NUDT3, PCSK1, KLF9, GP2, CDKAL1, LRRN6C, TNNI3K, SLC39A8, ETV5, MTCH2,
KCTD15, SEC16B, TFAP2B, FAIM2, NRXN3, GPRC5B.
At the remaining 8 loci, multiple genes were studied in order to investigate whether the
screen could be used to differentiate between multiple genes at the same locus. At each of
the following 6 loci, genes whose expression level correlates with the SNP variant (Speliotes
et al., 2010) were studied in addition to the nearest (underlined) gene:
• The rs7359397 locus: SH2B1, APOB48R, SULT1A2, AC138894.2, ATXN2L, SBK1
and TUFM.
• The rs713586 locus: RBJ, ADCY3, and POMC
• The rs2241423 locus: MAP2K5 and LBXCOR1
• The rs2287019 locus: QPCTL and GIPR
• The rs2112347 locus: FLJ35779, HMGCR, COL4A3BP
• The rs10938397 locus: GNPDA2 and GABRG1
In addition, 2 SNPs were screened in a more systematic manner. These were chosen because
the lab group are studying mouse models of genes present within these loci:
• The rs2815752 locus: the closest gene is NEGR1. In addition, ZRANB2, PTGER3
and LRRIQ3 lie within 1500kb as well as a binding site for the transcription factor
NKX6.1 (Wheeler et al., 2013).
• The rs2867125 locus, at which all genes within 500kb of the SNP were studied:
TMEM18, FAM150B, SH3YL1, ACP1, and SNTG2.
Therefore in total, 57 human genes were chosen for study.
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4.5.2 Identification of Drosophila orthologues
The work in section 4.5.2 was done with Dr Loraine Tung. The Drosophila orthologues of
each of the 57 human genes were identified using the ENSEMBL orthologue tool (Zerbino
et al., 2018) and FlyBase BLAST searches of protein sequences (Altschul et al., 1990;
Gramates et al., 2017). 45 out of the 57 human genes (79%) had at least 1 Drosophila
orthologue, giving a total of 58 fly genes, as summarised in figure 4.2. Each GWAS SNP, its
position, the nearest gene(s), and their Drosophila orthologues are all shown in table 4.1.
4.5.3 UASG-siRNA lines to target Drosophila genes
A UASG-siRNA line was available for each of the 58 Drosophila genes, whereas LoF lines
were only available for 39 of the genes (table 2.1). This reinforced the decision made in
chapter 3 to use RNAi as the primary tool for screening genes in Drosophila.
Of the siRNA lines ordered, two (boss and sbb which are the orthologues of GPRC5B and
ZNF608 respectively) died in quarantine - these lines were re-ordered but suffered the same
fate. In addition there was a problem with ordering the siRNA line for the SH2B1 orthologue
Lnk, but fortunately there are already several papers which examine energy homeostasis
phenotypes related to perturbation of this fly gene (for example Slack et al. (2010) and Song
et al. (2010)).
Three of the GD lines used in this chapter (V14, VV22, and VV46) contain the UASG-
siRNA insert on the X chromosome. As explained in section 3.6.2, these lines were delivered
from VDRC as a compound X stock, and so were crossed onto an FM7 balancer prior to
phenotyping.
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Fig. 4.2 79% of the human genes from GWAS BMI loci had at least one orthologue in
Drosophila, resulting in acquisition of UASG-siRNA lines to study 55 Drosophila genes
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Table 4.1 Genes within loci associated with human BMI and their Drosophila orthologues
SNP name Chr Position (bp) Nearest gene Nearby genes Drosophila orthologue(s) Homology (%)
rs1555543 1 96,717,385 PTBP2 - heph 52
rs543874 1 176,156,103 SEC16B - dSec16 17
rs887912 2 59,156,381 FANCL - Fancl 22
rs2890652 2 142,676,401 LRP1B - Lrp1 36
rs13078807 3 85,966,840 CADM2 - sns 29
rs9816226 3 187,317,193 ETV5 - Ets96B 31
rs13107325 4 103,407,732 SLC39A8 - Zip71B 29
rs261967 5 95,850,250 PCSK1 - fur1, fur2, rab2 50,48, 48
rs4836133 5 124,360,002 ZNF608 - sbb 17
rs9356744 6 20,685,255 CDKAL1 - CG6550 59
rs206936 6 34,410,847 NUDT3 - Aps 53
rs987237 6 50,911,009 TFAP2B - TfAP-2 41
rs10968576 9 28,404,339 LRRN6C - trn, caps, fili, CG14762 21, 23, 24, 29
rs11142387 9 72,998,332 KLF9 - sp1, cabot 64, 31
rs4929949 11 8,561,169 RPL27A - RpL27A 66
rs10767664 11 27,682,562 BDNF - NT1 24
rs3817334 11 47,607,569 MTCH2 - CG10920, Mtch 31, 35
rs7138803 12 48,533,735 FAIM2 - Nmda1 42
rs4771122 13 26,918,180 MTIF3 - mIF3 32
rs11847697 14 29,584,863 PRKD1 - PKD 52
rs10150332 14 79,006,717 NRXN3 - Nrx-1 36
rs12444979 16 19,841,101 GPRC5B - boss 28
rs29941 19 39,001,372 KCTD15 - twz 46
rs1558902 16 52,361,075 FTO - - -
rs571312 18 55,990,749 MC4R - - -
rs1514175 1 74,764,232 TNNI3K - - -
rs3810291 19 52,260,843 TMEM160 - - -
rs12597579 16 20246545 GP2 - - -















SBK1 CG4945, PKN 27, 25
TUFM mEFTu1 60
rs713586 2 25,011,512 RBJ - rab21 32
ADCY3 Ac3 39
POMC - -
rs2241423 15 65,873,892 MAP2K5 - dsor1 42
LBXCOR1 fuss 29
rs2287019 19 50,894,012 QPCTL - QC, isoQC 40, 47
GIPR Dh44-R1, Dh44-R2 30, 30
rs2112347 5 75,050,998 FLJ35779 - - -
HMGCR Hmgcr 47
COL4A3BP cert 44
rs10938397 4 44,877,284 GNPDA2 - Oscillin 74
GABRG1 CG8916, Grd 32, 37
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4.6 Expression of BMI GWAS genes in the Drosophila CNS
The CNS has a key role in the regulation of energy homeostasis and feeding behaviour (see
chapter 1). Published gene expression microarray data has shown that expression of genes at
the GWAS BMI loci is enriched in the CNS (Locke et al., 2015), in contrast to GWASs of
waist-to-hip ratio where the genes show enriched expression in adipose tissue (Shungin et al.,
2015).
Therefore, the expression pattern of the GWAS BMI Drosophila homologues was ex-
amined using published microarray data which shows RNA levels in different Drosophila
tissues and developmental stages (Graveley et al., 2011). According to this data, of the 58
Drosophila genes selected for study 55 are expressed in the larval, pupal and/or adult CNS.
Of the other 3 genes, Grd was not detected anywhere in the body, and CG10920 and Ets96B
were only expressed in the Drosophila testes.
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4.7 Lethality of BMI GWAS genes in Drosophila
All of the Drosophila lines with neuron-specific RNAi of the GWAS BMI genes were
viable as adults. However, the same is not true for the whole-body perturbations, and the
lethality/viability of the each gene is shown in figure 4.3.
For the 35 RNAi lines with a GD background, 18 (51%) did not produce viable male
adults with ubiquitous RNAi. Some of these lethal crosses were bred at 18oC because GAL4
is less active at this temperature (Duffy, 2002), but the crosses were still not viable. For the
siRNA lines with a KK background, 10 out of 19 genes did not produce viable male adults,
although interpretation of the KK results is complicated by the fact that over-expression
of tiptop in some lines also causes lethality (chapter 3.6.2). 4 genes showed male-specific
lethality: fur2 (PCSK1), PKD (PRKD1), Lac and DIP-iota (both NEGR1).
Of the 39 BMI GWAS Drosophila genes available as a LoF line, 23 (59%) were not
viable as homozygous adults (these stocks were maintained on balancer chromosomes).
In total, the viability of 38 genes was tested with both the RNAi and the LoF models. Of
these, 13 were lethal with both models, and 5 were viable with both. In addition, 9 genes
were viable with RNAi but not LoF, and 7 GD lines (plus 4 KK lines) were viable with LoF
but not RNAi.
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4.8 Energy homeostasis phenotypes of BMI GWAS genes
Lines screened
In section 4.5, 58 Drosophila homologues were identified of 44 human genes which are
located in genetic loci suggested by GWAS to influence BMI. The Drosophila-based screen
that was validated in chapter 3 was used to phenotype Drosophila adults with RNAi knock-
down of these BMI GWAS genes. act-GAL4 was used to direct constitutive whole-body
RNAi knockdown of BMI GWAS genes — 27 of these crosses produced viable male adults
which were assayed. elav-GAL4 was used to direct neuron-specific RNAi knockdown of
BMI GWAS genes — all of these crosses were viable. As auxiliary studies, larval feeding
motivation was assessed in the 39 LoF lines, and adult feeding motivation was measured in
the top RNAi hits.
Defining the top hit genes
For each individual assay, a hit was defined as a gene in which knockdown resulted in a
statistically significant phenotype (p<0.05). For the overall score, a hit was defined as >0.7,
and a strong hit as >0.8, based on the results of the positive and negative control genes in
chapter 3.
Leanness and decreased food intake phenotypes may truly result from the manipulation
of genes important in energy balance, but may also be linked to sickness of the animal due to
the genetic manipulation (Yazdi et al., 2015). These phenotypes (referred to in this thesis as
"decrease phenotypes") were therefore deemed less important than "increase phenotypes"
(i.e. fatness, increased food intake), even if they showed a greater overall score.
Lines affected by tiptop over-expression
As was shown in chapter 3.6.2, some KK RNAi lines are affected by over-expression of the
tiptop gene and it is important to control for this in order to avoid false positive results.
Nine of the siRNA lines with a KK background (CG10920, PKN, Oscillin, Hmgcr, atx2,
sns, Dh44-R1, Syn2, twz) were lethal with whole body RNAi, marking them as potentially
affected by tiptop. Therefore, all of these lines were compared to both KK-elavGAL4 and
KKtiptop-elavGAL4 as a background. Since the purpose of this screen is candidate gene
selection, it is better to have false negative results than false positives. Therefore, the smaller
phenotype was chosen as the background for each line, as summarised in figure 4.4.
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Three siRNA lines (CG10920, PKN, Syn2) were assigned to a KKtiptop background
because this gave the smaller phenotype. Two of these were not tested as LoF lines, but a
Syn2 LoF line was viable which agrees with the theory that the lethality observed is caused
by tiptop.
The other six siRNA lines (Oscillin, Hmgcr, atx2, sns, Dh44-R1, twz) were assigned to a
KK background because this gave the smaller phenotype. Hmgcr, atx2, and sns LoF lines
were not viable, which agrees with the idea that the lethality seen with RNAi is caused by
the gene itself, and not by tiptop. twz was not tested as a LoF line. The other two genes
(Oscillin and Dh44-R1) are viable as LoF lines, but their phenotype is very strongly decreased
compared to KKtiptop, so even if this background was chosen, the genes would be considered
unhealthy and not worthy of further study.
Line Background Fly Gene
Human 
Gene
CAFE Dye Food Mass Glucose Climbing Starvation Score LoF line
KK 0.7122 0.8363 0.0534 0.1759 0.3341 0.6564 0.50
tiptop 0.0125 0.1023 0.0007 0.1682 0.0589 0.4421 0.92
KK 0.1591 0.6990 0.5933 0.0913 0.0192 0.1658 0.65
tiptop 0.3037 0.0366 0.0115 0.0112 0.9124 0.0990 0.81
KK 0.7354 0.2351 0.0177 0.3297 0.0360 0.3538 0.66
tiptop 0.1278 0.0077 0.0001 0.0027 0.2589 0.7092 0.90
KK 0.6370 0.1066 0.9199 0.0104 0.6847 0.9653 0.50
tiptop 0.0155 0.0071 0.0163 0.0655 0.0201 0.6663 0.95
KK 0.4087 0.3620 0.5579 0.1771 0.1011 0.3645 0.64
tiptop 0.2226 0.0113 0.0599 0.0054 0.5767 0.2245 0.86
KK 0.1705 0.3336 0.4272 0.2527 0.9324 0.4445 0.64
tiptop 0.1783 0.0202 0.0077 0.0047 0.0376 0.8444 0.90
KK 0.8032 0.0433 0.0094 0.0311 0.1302 0.6505 0.71
tiptop 0.0245 1.0000 0.1605 0.5207 0.0658 0.9329 0.60
KK 0.2889 0.0560 0.0318 0.0058 0.5654 0.2987 0.83
tiptop 0.0034 0.8421 0.4522 0.6849 0.0079 0.6792 0.58
KK 0.1213 0.1770 0.0341 0.3209 0.8005 0.8430 0.75
tiptop 0.3600 0.4219 0.5681 0.0260 0.1470 0.7725 0.63VV52 Syn2 SNTG2

















Fig. 4.4 KK lines which were lethal with whole body RNAi were compared to both KK-
elavGAL4 and KKtiptop-elavGAL4 as potential backgrounds, and the smaller phenotype
chosen (orange). Red is an increase compared to control, blue is a decrease and significant
values are highlighted.
Results
A summary of the phenotypes of the GWAS BMI lines in each assay, as well as the overall
scores, are shown in figure 4.5 for neuronal RNAi, and figure 4.6 for whole body RNAi.
The full phenotypes are shown in figures 4.7 to 4.12. In each graph, the genes which show
the strongest overall phenotype compared to background (a score >0.8) are highlighted in
purple. Conversely, the genes which are the most similar to background (a score <0.45) are
highlighted in yellow. The auxiliary feeding motivation studies are in figures 4.14 and 4.15.
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CAFE Dye Food Mass Glucose Climbing Starvation
TFAP2B / TfAP2 / VV53
NEGR1 / DIP-iota / VV45
PCSK1 / Fur2 / VV49
RPL27A / RpL27A / VV23
NRXN3 / Nrx-1 / VV47
MTIF3 / mIF3 / VV60
GABRG1 / CG8916 / V7
LRRN6C / caps / VV10
PCSK1 / rab2 / VV16
KLF9 / Sp1 / V9
LRRN6C / CG14762 / VV56
COL4A3BP / cert / VV11
SEC16B / Sec16 / V15
NEGR1 / Ama / VV46
MTCH2 / Mtch / VV43
NUDT3 / Aps / VV48
APC1 / shtd/ VV12
QPCTL / isoQC / VV25
NEGR1 / Lac / VV44
RBJ / Rab21 / V11
FAIM2 / Nmda1 / VV28
KLF9 / Cabot / V10
PRKD1 / PKD / VV58
SBK1 / CG4945 / VV59
LRP1B / Lrp1 / VV17
SH3YL1 / RtGEF / VV31
TUFM / mEFTu1 / VV24
SULT1A2 / St2 / V4
GABRG1 / Grd / VV55
HMGCR / hmgcr / VV29
ADCY3 / Ac3 / VV14
GIPR / Dh44-R1 / VV41
SLC39A8 / Zip71B / VV51
KCTD15 / twz / VV54
PTBP2 / heph / VV15
CADM2 / sns / VV40
QPCTL / QC / VV50
SNTG2 / Syn2 / VV52
ETV5 / Ets96B / V14
LRRN6C / Fili / VV22
MTCH2 / CG10920 / V1
SBK1 / PKN / V5
ZRANB2 / CG3732 / VV26
TMEM18 / CG30051 / VV21
MAP2K5 / dsor1 / VV18
LBXCOR1 / fuss / V3
BDNF / NT1 / V16
ATXN2L / atx2 / VV30
FANCL / Fancl / VV13
GNPDA2 / Oscillin / VV27
GIPR / Dh44-R2 / VV42
PCSK1 / fur1 / VV9
LRRN6C / trn / VV7
CDKAL1 / CG6550 / V8





































































Fig. 4.5 Summary of the phenotype and overall score of flies with neuronal RNAi knockdown
of GWAS BMI gene homologues
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CAFE Dye Food Mass Glucose Climbing Starvation
TUFM / mEFTu1 / VV24
QPCTL / isoQC / VV25
SLC39A8 / Zip71B / VV51
RBJ / Rab21 / V11
GABRG1 / CG8916 / V7
CDKAL1 / CG6550 / V8
LBXCOR1 / fuss / V3
BDNF / NT1 / V16
NUDT3 / Aps / VV48
SEC16B / Sec16 / V15
MTCH2 / Mtch / VV43
KLF9 / Cabot / V10
SBK1 / CG4945 / VV59
MTIF3 / mIF3 / VV60
COL4A3BP / cert / VV11
GIPR / Dh44-R2 / VV42
NKX6.1 / HGTX / VV8
LRRN6C / trn / VV7
FAIM2 / Nmda1 / VV28
ETV5 / Ets96B / V14
ZRANB2 / CG3732 / VV26
GABRG1 / Grd / VV55
LRRN6C / Fili / VV22
ADCY3 / Ac3 / VV14
TMEM18 / CG30051 / VV21
FANCL / Fancl / VV13
LRP1B / Lrp1 / VV17










































Fig. 4.6 Summary of the phenotype and overall score of flies with whole body RNAi
knockdown of GWAS BMI gene homologues










































































































































































































































































































































































































































































































































































































Fig. 4.7 CAFE food intake by flies with (top) neuron-specific and (bottom) whole-body
RNAi knockdown of GWAS BMI gene homologues. Background lines are black, the overall
top-scoring genes are purple, and bottom-scoring genes are yellow. Mean ± is plotted of
5 repeats each containing 8 flies. Results were compared to appropriate background by
Student’s t-test. * p<0.05, ** p<0.01























































































































































































































































































































































































































































































































































































































Fig. 4.8 Dye food over-feeding by flies with (top) neuron-specific and (bottom) whole-body
RNAi knockdown of GWAS BMI gene homologues. Background lines are black, the overall
top-scoring genes are purple, and bottom-scoring genes are yellow. Mean ± is plotted of
5 repeats each containing 15 flies. Results were compared to appropriate background by
Student’s t-test. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001
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Fig. 4.9 Wet mass of flies with (top) neuron-specific and (bottom) whole-body RNAi knock-
down of GWAS BMI gene homologues. Background lines are black, the overall top-scoring
genes are purple, and bottom-scoring genes are yellow. Mean ± is plotted of 5 repeats each
containing 15 flies. Results were compared to appropriate background by Student’s t-test.
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001















































































































































































































































































































































































































































































































































































































Fig. 4.10 Glucose levels in flies with (top) neuron-specific and (bottom) whole-body RNAi
knockdown of GWAS BMI gene homologues. Background lines are black, the overall
top-scoring genes are purple, and bottom-scoring genes are yellow. Mean ± is plotted of
5 repeats each containing 15 flies. Results were compared to appropriate background by
Student’s t-test. * p<0.05, ** p<0.01







































































































































































































































































































































































































































































































































































































Fig. 4.11 Climbing ability of flies with (top) neuron-specific and (bottom) whole-body RNAi
knockdown of GWAS BMI gene homologues. Background lines are black, the overall
top-scoring genes are purple, and bottom-scoring genes are yellow. Mean ± is plotted of
5 repeats each containing 15 flies. Results were compared to appropriate background by
Student’s t-test. * p<0.05, ** p<0.01, *** p<0.001







































































































































































































































































































































































































































































































































































































Fig. 4.12 Survival during starvation of flies with (top) neuron-specific and (bottom) whole-
body RNAi knockdown of GWAS BMI gene homologues. Background lines are black, the
overall top-scoring genes are purple, and bottom-scoring genes are yellow. Mean ± is plotted
of 5 repeats each containing 15 flies. Results were compared to appropriate background by
Student’s t-test. * p<0.05, ** p<0.01, *** p<0.001, **** p>0.0001
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Auxiliary study: larval feeding motivation
The LoF lines which were viable as homozygous adults were assayed by Dr Loraine Tung.
The LoF lines which were lethal as adults may be viable as larvae, but studying these
larvae required a slightly different approach. These stocks were maintained on balancer
chromosomes which have easily visible markers in adult flies, but not in larvae. Therefore,
the balancers were replaced (by crossing) with YFP-tagged FM7, GFP-tagged CyO, or GFP-
tagged TM3 as appropriate. The GFP was expressed throughout the larval body whereas
the YFP was expressed in the larval mouth hook. This allowed the homozygous larvae to
be separated from the balanced heterozygous larvae by their absence of fluorescence (see
figure 4.13). Of the 23 lethal LoF lines, this YFP/GFP-based sorting showed that only 8 were
viable as third instar larvae. Homozygotes from these 8 lines were selected and used to study
larval feeding motivation.
The results are shown in figure 4.14. Nrx-1 and Grd show significant increases in larval
feeding motivation. Also, most genes show a significant difference in behaviour between the
fed and the fasted state, but a few (Nrx-1, DIPiota, Dh44-R2, fur2 RtGEF, Ac3) do not.
26 Homozygous lethal adult 
12 lethal at 3rd instar 




  Tmem18 
  Tmem18 




  Tmem18 
 CyO-GFP 
Heterozygotes (fluorescent) 
Heterozygotes (fluorescent) Embryonic lethal 
Homozygous mutant larvae 
Fig. 4.13 Homozygous mutant larvae were selected for assay by their absence of fluorescence.



























































































































































































































































































































































































































































































































































































































Fig. 4.14 Feeding motivation of Drosophila larvae with LoF of BMI GWAS genes in the fed
and fasted states. Mean ± SEM is plotted. All statistical comparisons were Student’s t-test.
Homozygous viable lines were assayed by Dr Loraine Tung. For fed (top) and fasted (middle)
larvae, * p<0.05, ** p<0.01, *** p<0.001 compared to background. For the difference graphs
(bottom), φ indicates that there is no significant difference between fed and fasted larvae for
the gene.
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Auxiliary study: adult feeding motivation
In chapter 3, an assay was developed to test a fly’s motivation to approach food despite the
presence of a repellent. The Drosophila genes with the top 5 scores from the screen (TfAP-2,
DIPiota, fur2, Nrx1 mEFTu1) were tested with this assay. The gene with the lowest score
from the screen (HGTX) was also included as a negative control. The results are shown in
figure 4.15. A significant change was only detected for TfAP-2 but this was not driven by
differences in the food/repellent zone and so the relevance of this result is unclear.
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Fig. 4.15 Time spent by Drosophila close to yeast despite the presence of benzaldehyde
repellent . Mean ± SEM is plotted of 7 repeats. Data was analysed by two-way ANOVA.
FR = food + repellent.
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4.9 Comparison of Drosophila screen results to published
literature
As has been mentioned previously, Baranski et al. (2018) carried out a screen of BMI
GWAS genes looking for changes in levels of TAG. Despite using a different initial list of
human genes, and a different computational tool to select their Drosophila orthologues, 17
Drosophila genes were screened in common.
Their preference for use of KK lines and ours for use of GD lines means that for 12 of
these genes, a different siRNA line was used. Therefore their results provide a method to
independently verify the results obtained here for these 17 genes (although Baranski et al.
used RNAi in both the neurons and the fat body (cg-GAL4) compared to just the neurons
(elav-GAL4) here).
As can be seen in table 4.2, Baranski et al. observed increased TAG for 5 of the 17 genes
(CG4945, Nrx-1, Sec16, Aps and cert). Here, a score >0.7 was seen for 4 out of these genes
(all except CG4945). Further, for three of the genes (lac, isoQC and mtch), Baranski et al.
did not see any TAG phenotype, but because multiple assays were used here, the screen was
able to detect more subtle phenotypes, suggesting increased sensitivity. Finally, they found
that 2 of the genes (RpL27A and EfTuM) gave a lethal phenotype (and overall 13% of their
genes were lethal) whereas all of our crosses were viable.
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Table 4.2 Results obtained in this thesis generally agree with those published by Baranski
et al. (2018). Scores >0.7 are highlighted in red. *The same siRNA line was used
Human Fly Adult TAG Neuronal
gene gene (Baranski et al., 2018) RNAi score
SBK1 CG4945 * fatter 0.69
NRXN3 Nrx-1 * fatter 0.82
SEC16B Sec16 fatter 0.77
NUDT3 Aps * fatter 0.74
COL4A3BP cert fatter 0.78
SLC39A8 CG10006 wt 0.65
SKOR1 fuss * wt 0.54
NEGR1 Lac wt 0.73
TMEM18 Tmem18 wt 0.58
LRP1B LRP1 wt 0.69
ATXN2L Atx2 * wt 0.50
QPCTL isoQC wt 0.73
MTCH2 Mtch wt 0.76
GPRC5B boss wt parental line died
KTCD15 twz wt 0.64
RPL27A RpL27A lethal 0.84
TUFM EfTuM lethal 0.67
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4.10 Phenotype of genes not expressed in the CNS
As discussed in section 4.6, Grd, CG10920 and Ets96B are not expressed in the Drosophila
CNS according to published microarray data. Therefore these genes can be used as negative
controls for the neuronal RNAi. As would be expected, none of these three genes were a
hit with neuronal RNAi: their scores were <0.7 and none of the individual assays were
significant.
4.11 Phenotype of genes with altered backgrounds
For another three of the genes (Ets96b, Fili Ama), the siRNA transgene was on the X
chromosome and so the stock was balanced (by VDRC) using a compound X. As explained
in chapter 3, such lines cannot be used in the screen until the compound X is replaced with an
FM7 balancer. However this process of changing the balancer may alter the background away
from GD, making GD-GAL4 an inappropriate background to use for statistical analysis.
Of these three genes, Ets96b and Fili show no phenotype in the screen. The other gene,
Ama, does have a strong phenotype, and so this result must be viewed with caution. Ama is
an orthologue of NEGR1, and luckily this gene had several other orthologues which were
also studied.
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4.12 Interpretation of results according to human gene
The aim of this screen was to select genes which are top candidates for further study from
an original list of human genes that have been associated with BMI by GWASs. The results
of the Drosophila-based screen will now be presented in terms of the human genes tested.
Where available, Baranski et al.’s results are included too (Baranski et al., 2018), because
a TAG measurement was not included in the screen used here, although note that in some
cases they used a different Drosophila orthologue of the same human gene.
4.12.1 Loci at which just one gene was tested
At 28 of the 36 SNP loci studied, only the closest gene was studied. Out of these single gene
loci, 23 were testable in Drosophila. 14 genes showed a phenotype and 10 of these were
considered worthy of further study.
Single gene loci that were not testable
Five loci could not be studied because no Drosophila orthologues were found: FTO, MC4R,
TNN13K, TMEM160 and GP2. An additional two genes (ZNF608 and GPRC5B) could not
be studied because the siRNA lines to target the Drosophila homologues sbb and boss died —
they were re-ordered from VDRC but suffered the same fate.
Single gene loci that were not hits
At seven of the GWAS loci, the genes were not classed as hits in the Drosophila-based
screen based on their score (<0.7). Further, none of these genes showed a significant result
in more than one assay. These genes (and their Drosophila orthologues) were: ETV5
(Ets96b), FANCL (Fancl), CADM2 (sns), PRKD1 (PKD), PTBP2 (heph), LRP1B (Lrp1),
and KCTD15 (twz). Baranski et al. did not find a TAG phenotype for their orthologues of
ETV5, LRP1B or KCTD15, and did not test the other genes.
Four genes — RPL27A (RpL27A), FAIM2 (Nmda1), SLC39A8 (Zip71B) and MTCH2
(Mtch) — had scores which were indicative of a hit (<0.7). However, these scores were
composed solely/mostly of decrease phenotypes which could be a specific energy homeostasis
phenotype, but is indistinguishable from a general unhealthiness. Thus these four genes were
not deemed worthy of further study.
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Single gene loci that were potential hits
Four genes had scores between 0.7 and 0.8 composed of increase phenotypes, marking
them as potentially worth investigation. BDNF (NT1) and CDKAL1 (CG6550) showed a
phenotype only with ubiquitous RNAi, whereas NUDT3 (Aps) did so only with neuronal
RNAi. In contrast, SEC16B (dSec16) is a hit with both RNAi paradigms. Baranski et al.
found that their orthologues of both SEC16B and NUDT3 have increased TAG, and did not
test the other two genes. Another study has shown that neuronal RNAi of Aps in Drosophila
increased food intake but decreased starvation resistance and circulating glucose (Williams
et al., 2015).
Single gene loci that were strong hits
KLF9 had scores between 0.7 and 0.8 for neuronal RNAi, and these were related to increase
phenotypes, marking it as potentially worth investigation. However, because KLF9 has two
Drosophila orthologues (sp1 and cabot) which both show the same phenotype, this gene was
considered a strong hit.
Four additional genes were highlighted as top hits based on their neuronal RNAi score
being >0.8 and composed of increase phenotypes: TFAP2B (TfAP-2), NRXN3 (Nrx-1),
PCSK1 (fur2, rab2) and LRRN6C (caps, CG14672). These were lethal with ubiquitous
RNAi. PCSK1 and LRRN6C both have multiple homologs which are top scores, increasing
confidence in these genes. In addition, Nrx-1 showed a significant increase in larval feeding
in both the fed and fasted states, and no difference in behaviour between these two states (i.e.
fed larvae behaved as if they were fasted). Similarly, fur2 larvae showed no difference in
behaviour between the fed and fasted states. Baranski et al. found increased TAG for their
NRXN3 orthologue, and increased food intake has been reported in flies with neuronal RNAi
of TfAP-2 (Williams et al., 2014).
MTIF3 (mIF3) was also considered to be a top hit, although it has a discordant phenotype
with neuronal RNA: Drosophila show increased feeding but decreased measurements in the
physiology assays.
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4.12.2 Loci at which multiple genes were tested
As explained in section 4.5, multiple genes were studied at eight of the GWAS loci. Of these,
three loci had no noteworthy results, three loci contained a gene which is a potential hit, and
two loci showed a clear top hit. In three cases, the gene highlighted is not the one closest
gene to the SNP.
Multi-gene loci with no noteworthy results
At the rs2287019 SNP, two genes were analysed: QPCTL (QC, isoQC) and GIPR (Dh44-
R1, Dh44-R2). Only isoQC shows a score >0.7, but this is associated with mostly decrease
phenotypes and so is not worth pursuing. Baranski et al. also found that neither of these genes
affected TAG. Dh44-R2 larvae do not show any difference in feeding behaviour between the
fed and the fasted states.
Similarly, at the rs2241423 SNP locus, neither MAP2K5 (dsor1) nor LBXCOR1 (fuss)
show a strong phenotype with neuronal RNAi. LBXCOR1 does show a noteworthy score
with ubiquitous RNAi but this score is biased by a strong phenotype in just one assay so may
a false positive result. Baranski et al. found no hits in this region.
TMEM18 (Tmem18), SH3YL1(RtGEF), and SNTG2 (Syn2) were phenotyped at the
rs2867125 SNP locus, but none of these genes were hits based on either the score or the
individual assay results. Baranski et al. also saw no TAG phenotypes in this region.
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Multi-gene loci with potential hits
At the rs7359397 locus, the expression of genes correlates with the BMI SNP variant
(Speliotes et al., 2010). In the screen here, only TUFM shows a phenotype worthy of further
investigation, with increases in all assays for whole body RNAi. As explained earlier, the
SH2B1 homologue Lnk was not tested here, but this gene is already known to affect the
storage of carbohydrates and lipids (Slack et al., 2010; Song et al., 2010).
Gene Drosophila orthologue Homology (%) Neuronal score Whole body score
SH2B1 Lnk - not tested not tested
APOB48R - - - -
SULT1A2 St2 29 0.67 lethal
AC138894.2 - - - -
ATXN2L Atx2 8 0.5 lethal
SBK1 CG4945 27 0.69 tiptop
PKN 25 0.58 0.62
TUFM EfTuM 60 0.67 0.87
At the rs713586 SNP. Only two of the genes had a Drosophila orthologue. One of these, RBJ
(rab21), is a hit with both neuronal and ubiquitous RNAi.
Gene Drosophila orthologue Homology (%) Neuronal score Whole body score
RBJ rab21 32 0.72 0.76
ADCY3 ac3 39 0.66 0.46
POMC - - - -
NCOA1 - - - -
Three genes were studied at the rs2112347 locus. Of these, COL4A3BP (cert) may be worth
further investigation as it has a score >0.7, but its individual assay results are complicated,
with increases in feeding, but decreases in measures of physiology. Baranski et al. found no
genes which affected TAG in this region.
Gene Drosophila orthologue Homology (%) Neuronal score Whole body score
FLJ35779 - - - -
HMGCR hmgcr 47 0.66 lethal
COL4A3BP cert 44 0.78 0.59
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Multi-gene loci with strong hits
The region near the rs2815752 SNP contains the gene NEGR1 as well as three other genes and
a binding site for the transcription factor NKX6.1. There were no Drosophila homologues of
LRRIQ3 and PTGER3, but ZRANB2 and NKX6.1 both have an orthologue and NEGR1 has
three. All of the NEGR1 homologues have scores >0.7 which makes it a strong hit, whereas
ZRANB2 and NKX6.1 do not. Further, DIP-iota mutant larvae behave in the same way
regarding food irrespective of whether they are in the fed or the fasted state.
Gene Drosophila orthologue Homology (%) Neuronal score Whole body score
NEGR1 lac 24 0.73 male-lethal
DIP-iota 26 0.86 male-lethal
ama 24 0.77 semi-lethal
ZRANB2 CG3732 45 0.58 0.53
NKX6.1 HGTX 39 0.37 0.58
LRRIQ3 - - - -
PTGER3 - - - -
Two genes were investigated in relation to the rs10938397 SNP: GNPDA2 and GABRG1.
Based on the Drosophila screen, GABRG1 is a more promising candidate for this locus,
despite not being the nearest gene to the SNP: the orthologue CG8916 shows a score >0.8 in
the screen, and the orthologue Grd shows a strong increase in larval feeding behaviour.
Gene Drosophila orthologue Homology (%) Neuronal score Whole body score
GNPDA2 Oscillin 74 0.50 lethal
GABRG1 CG8916 32 0.81 0.75
Grd 37 0.67 0.51
150 A Drosophila-based screen of genes identified by GWAS to influence BMI
4.13 Published mammalian phenotypes of top hit genes
If a particular gene has already been studied in humans and/or mice, such data can be used to
validate or discredit the results of the Drosophila-based screen used here. Conversely, if very
little is known, then the gene is a prime candidate for further study to obtain novel results.
Therefore, a PudMed search was performed for published data from mice and/or humans
about the top genes from the screen.
4.13.1 Strong hits
The strong hits were genes which scored >0.8 in the Drosophila-based screen, or >0.7 with
multiple orthologues, based on increase phenotypes. These genes were: PCSK1, NEGR1,
MTIF3, TFAP2B, NRXN3, GABRG1, KLF9 and LRRN6C.
For three of these genes, mouse/human studies have shown an involvement in energy
homeostasis. Firstly, PCSK1 has been identified to be the cause of some monogenic obesity
disorders (see chapter 1) — mice/humans with KO mutations in PCSK1 show dramatically
increased food intake, increased mass and hypoglycaemia (Dickinson et al., 2016; Zhu et al.,
2002; Stijnen et al., 2016). Secondly, NEGR1 mutant mice have decreased body mass, food
intake and physical activity (Lee et al., 2012; Dickinson et al., 2016; Speakman, 2013).
Finally, mice with KO of MTIF3 show hypoactivity and increased body fat (Dickinson et al.,
2016).
Although mice with KO of TFAP2B have been studied, they show a range of detrimental
phenotypes across multiple organs and systems, which makes it difficult to identify any
specific energy homeostasis phenotypes (Jackson Laboratory, 2018).
There were four genes for which no published studies were found related to energy
homeostasis: NRXN3, GABRG1, KLF9 and LRRN6C.
An important point to note is that several of these genes have also been genetically linked
to diseases that were used as negative controls in chapter 3, for example NRXN3 with autism
and schizophrenia (Wang et al., 2018; Hu et al., 2013), LRRN6C with Parkinson’s (Wu et al.,
2011), and MTIF3 with Parkinson’s (Behrouz et al., 2010).
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4.13.2 Potential hits
The potential hits were genes which scored between 0.7 and 0.8 in the Drosophila-based
screen with increase phenotypes. These genes were: CDKAL1, RBJ, COL4A3BP, BDNF,
SEC16B, TUFM and NUDT3.
Again, there is published mammalian data which shows a role in energy homeostasis for
some of these genes. CDKAL1 KO mice show significantly reduced fat storage, impaired
insulin signalling and an increased respiratory exchange ratio, and this is amplified by HFD
(Okamura et al., 2012; Dickinson et al., 2016). Mice with KO of RBJ also have an altered
respiratory exchange ratio and glucose response (Dickinson et al., 2016). In humans, levels
of RBJ in the plasma and adipose tissue are elevated in obese individuals and positively
associated with leptin (Cherian et al., 2018).
For some of the genes, KO mutations have many detrimental phenotypes which makes the
results difficult to interpret. For example, COL4A3BP mutations have been linked to severe
intellectual disability in humans (Hamdan et al., 2014) and KO mice are very unhealthy
(Wang et al., 2009; Dickinson et al., 2016). Similarly, mice with KO of BDNF have many
developmental abnormalities, particularly in the brain (Jackson Laboratory, 2018), although
there are many published papers exploring the function of BDNF in the nervous system.
Few phenotypes are published for SEC16B KO mice, but they have been shown to have
altered cholesterol levels (Dickinson et al., 2016). There was no data specifically related to
energy homeostasis for TUFM or NUDT3.
Again, some of these genes have been linked to the negative control diseases used in
chapter 3 such as BDNF with schizophrenia (Jönsson et al., 2006).
4.13.3 Unhealthy genes
The unhealthy genes were those which scored >0.7 in the Drosophila-based screen, but had
solely/mostly decrease phenotypes and thus were suspected of being unhealthy rather than
having a specific lean phenotype. There were four such genes in the Drosophila screen, and
published data for three of these suggests that mammals are similarly affected. Mice with
KO of SLC39A8 are embryonic lethal (Dickinson et al., 2016) and two human patients with
mutations in this gene showed developmental abnormalities, severe spasms and dwarfism
(Park et al., 2015). Mice with KO of MTCH2 are embryonic lethal (Dickinson et al., 2016;
Zaltsman et al., 2010). Similarly, mice with KO of RPL27A are homozygous lethal, and
heterozygotes show retarded growth and ataxia (Terzian et al., 2011).
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4.14 Discussion
In this chapter, the Drosophila-based screen which was validated in chapter 3 was used to
explore genes which were identified by published GWASs to be related to human BMI.
4.14.1 Conservation of BMI GWAS genes
Human genes were selected for study which published GWASs have associated with variation
in BMI. 79% of these human genes had at least one orthologue in Drosophila (section 4.5),
which is higher than the genome-wide average of 53% (Wangler et al., 2017). Since human
genes linked to monogenic disorders show increased levels of conservation in Drosophila
(Fortini et al., 2000), this result in the GWAS genes is unsurprising.
UASG-siRNA lines were available to target all of the selected genes. Despite the fact that
two of the lines died, the number of researchable genes was still 77%, which is high enough
for a Drosophila-based screen to be a useful tool for exploration of the data.
Gene expression microarrays have shown that expression of genes at the GWAS BMI loci
is enriched in the CNS (Locke et al., 2015). Published microarray data showed that 55 (out
of 58) of the Drosophila genes are expressed in the larval, pupal and/or adult CNS (section
4.6). This conservation of expression patterns increases the likelihood of conservation of
function of the genes (Wangler et al., 2017). Further, it shows that use of neuron-specific
RNAi is a valid approach to study these genes. The three genes which are not expressed in
the CNS showed no significant phenotype with neuronal RNAi, which increases confidence
that the screen is not detecting false positive results. One caveat is that the microarray data
is not 100% accurate, for example it shows no expression of upd1 in the adult brain which
contrasts to immunostaining data published by Beshel et al. (2017).
4.14.2 Lethality of BMI GWAS genes
59% of the LoF lines were lethal as adults (section 4.7), which is much higher than the
genome-wide figure of 25% (Wangler et al., 2017). The true figure may be even higher
because some transposable element insertions (the most common perturbation in the LoF
lines used here) do not disrupt their target gene very strongly, dependent on the location of
the insertion (Groth et al., 2004).
For the RNAi lines, 51% of the GD lines were lethal when crossed to actGAL4 (section
4.7). It is unsurprising that this figure is lower than the LoF lines, since RNAi only causes a
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partial reduction in gene expression, but is still much higher than the genome average. The
fifteen lethal Drosophila GD lines represent ten human genes, and viability data is available
for eight of these in mice: six are lethal (Jackson Laboratory, 2018). This suggests that
perhaps viability in Drosophila could be used as an indicator of whether a mouse LoF model
will be viable, although the numbers here are too low to confidently draw such a conclusion.
Four genes showed male-specific lethality in Drosophila, which tentatively suggests that if
these genes are studied further in mice/humans it may be important to study both genders.
The high levels of lethality observed in the GWAS BMI genes suggests that they have a
very important role within the body. Indeed, humans with loss-of-function mutations have
not been identified for many of the GWAS BMI genes, and one possible explanation for
this is that such mutations are so detrimental that humans are not viable (lab group internal
discussion).
Half of the genes show the same viability/lethality in both the RNAi and LoF models,
increasing confidence in these results. For the genes which were viable with RNAi but lethal
with LoF, there are three possible explanations for the discrepancy:
1. RNAi reduces (rather than prevents) gene expression to levels of approximately 25%
(Heigwer et al., 2018), and so there may be enough residual gene function to allow
viability — this is likely the explanation for genes such as isoQC which showed a very
unhealthy phenotype with whole body RNAi.
2. The siRNA was ineffective — this may explain why genes such as Lrp1 and Fancl had
the very lowest scores in the screen (i.e. they showed no phenotype).
3. The LoF perturbation also affected non-target genes, and it is these which are the cause
of the lethal phenotype — for example the DNA sequence of mEFTu1 overlaps with
the mip120 gene and so both genes could be affected by a genomic insertion, but the
RNA exons do not overlap so could be differentially targeted by RNAi.
In contrast, for the RNAi lines which are viable with LoF but lethal with RNAi, there are also
three possible explanations: (1) the siRNAs may have off-target effects; (2) the lethality of
KK-background lines may be caused by over-expression of tiptop (see chapter 3.6.2), and/or
(3) the location of the transposable element may mean that it does not significantly disrupt
gene expression in the LoF line.
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4.14.3 Phenotyping of GWAS BMI genes in Drosophila
Neuronal and whole-body RNAi were used to perturb expression of the 55 Drosophila genes
selected for study (section 4.8). The resulting adult flies were subject to a suite of assays
(validated in chapter 3) to assess energy homeostasis phenotypes of each gene: CAFE food
intake, over-feeding dye, wet mass, glucose levels, climbing activity, and starvation resistance.
In addition, LoF lines were used to measure larval feeding motivation, and adult feeding
motivation was measured in the top RNAi hits.
Difficulties associated with tiptop over-expression
As was found in chapter 3.6.2, KK lines in which the UASG-siRNA transgene is inserted into
the tiptop gene have a strong phenotype when crossed to elav-GAL4 in the screen. Therefore,
it is important to compare such lines to the correct background in order to avoid false positive
results.
For the KK lines which were lethal when crossed to act-GAL4, the background for
neuronal RNAi was assigned to whichever gave the smaller phenotype, since it is better to
have false negative results than false positives in this screen for candidate gene selection. If
the larger background was chosen, then all 9 of the genes had a score that would be classed
as a hit.
This method means that valuable true positive results are potentially falsely attributed
to tiptop and therefore missed. Further, a phenotype may be present, but smaller than the
effect of tiptop and therefore hidden. For both of these reasons, GD lines should be chosen
in preference to KK lines whenever possible.
Comparison of GWAS BMI results to published literature
The results of the neuronal RNAi screen were compared to the recently published results
from Baranski et al. (2018), who studied 17 fly genes in common (section 4.9). They found
that 5 of these genes were associated with increased TAG storage in flies, and the matching
results seen here for 4 of these genes provides independent validation of the accuracy of the
screen. For the other gene, it is possible that their observed phenotype is due to an effect of
the gene in the fat body — Baranski et al. used cgGAL4 to drive their RNAi in both the CNS
and fat body, whereas elav-GAL4 was used here which only targets neurons.
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Further, they found that 13% of their genes gave a lethal phenotype, whereas all of our
crosses were viable with neuronal RNAi. This may be because of the wider expression of
their RNAi (using cg-GAL4), and/or because they chose KK lines wherever possible but did
not mention a control for tiptop over-expression. Therefore, the screen used here is likely to
be able to generate results for a higher proportion of genes.
Finally, for 3 of the genes, Baranski et al. did not see any TAG phenotype, but because
multiple assays were used here, the screen was able to detect some more subtle phenotypes
of energy homeostasis.
4.14.4 Interpretation of results according to human gene
The aim of this screen was to select genes for further study from a list of human SNPs that
were identified by GWASs of human BMI. In summary, 36 genetic loci were studied. 7 of
the BMI loci could not be interrogated with the Drosophila screen because the constituent
genes did not have a fly orthologue, or the siRNA lines died.
Single gene loci
At 19 loci, only the gene closest to the SNP was studied. Of these, 11 genes were not a
hit in the Drosophila-based screen. In some cases, this was due to potential sickness, for
example RPL27A. In other cases, no phenotype was detected in the screen assays, and there
are several possible explanations for this:
1. The siRNAs were not effective, either because of their sequence or because their
genomic location means that they are only expressed at low levels (Heigwer et al.,
2018).
2. The Drosophila gene may not be a functional orthologue of the human gene due to
differences in mammalian and insect physiology. (Wangler et al., 2017)
3. Some genes may only cause a phenotype when up-regulated, and so would not be
detected by the RNAi approach used here.
4. The screen was designed to avoid false positive results rather than false negatives. For
example, genes were considered hits if their score was >0.7, but this cut-off was based
on the results of the negative control genes in chapter 3. As discussed previously, these
negative control genes are not necessarily independent of energy homeostasis, and so
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perhaps the stringency of the screen was too high. Indeed, as mentioned in section
4.13, there is data linking many of the GWAS BMI genes to the same negative control
diseases.
5. The screen was designed to focus on energy intake and physiology, rather than on
energy expenditure. Therefore genes which affect the latter may not be detected. For
example, CADM2 was not a hit in the screen, but CADM2 KO mice have been shown
to have altered energy expenditure (Yan et al., 2018), but there is currently no published
data on food intake.
6. For the Drosophila lines which were potentially affected by tiptop, the background
chosen was that which gave the smaller phenotype. If the incorrect background was
chosen, hits would be overlooked.
7. The human gene does not actually function in energy homeostasis. For such genes, it
may be useful to explore other genes within the region. For example, Baranski et al.
(2018) looked at all genes within a 500kb window of each SNP.
Since the purpose of this high-throughput screen was to find top candidate genes involved
in energy homeostasis, and not to provide a definitive list of the function of the individual
genes, false negative results are not problematic. Instead, they increase the confidence in
those genes which were deemed hits.
At the single gene loci, five genes were strong hits with neuronal RNAi: TFAP2B
(TfAP-2), NRXN3 (Nrx-1), PCSK1 (fur1, rab2), KLF9 (sp1, cabot), and LRRN6C (caps,
CG14672). BDNF (NT1) and CDKAL1 (CG6550) were modest hits with ubiquitous RNAi,
NUDT3 (Aps) was a hit with neuronal RNAi, and SEC16B (dSec16) was a hit with both.
Overall, more hits were obtained with neuronal RNAi than with ubiquitous RNAi, which
is unsurprising given the role that the CNS plays in the control of energy homeostasis (see
chapter 1), and the fact that whole-body genetic perturbations are often detrimental to an
organism (Yazdi et al., 2015).
Multi-gene loci
At eight loci, multiple genes were studied. Two genes were identified as top hits worthy of
further study (NEGR1 and GABRG1) and two as potential hits (COL4A3BP, RBJ). Half
of these (GABRG1 and COL4A3BP) are not the gene closest to the SNP, highlighting the
utility of using a high-throughput organism to perform an unbiased screen for phenotypes.
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The other four loci showed no noteworthy results, and this is likely due to the same reasons
discussed above in relation to the single gene loci.
Genes with multiple orthologues
For a few genes (PCSK1, LRRN6C, NEGR1, KLF9), more than one Drosophila orthologue
was studied and found to be a hit, which increases confidence that the corresponding human
gene is worth further study. For other genes (GABRG1, MTCH2), multiple orthologues were
phenotyped but only one was found to be a hit. For both of these reasons, it is perhaps worth
testing multiple homologues (where possible) in future screens. This depends on a balance
between the impact of false negative results versus the size of, and the time available for, the
screen.
Published data for the top hit genes
The Drosophila-based screen performed in this chapter provided data to support more detailed
experiments on the mechanism of action for these genes in influencing human BMI.
Based on a search of published literature (section 4.13), several of the top hit genes do
have an energy homeostasis phenotype in mammalian models (PCSK1, NEGR1, MTIF3,
CDKAL1, BDNF), which provides evidence that the screen is producing accurate and
relevant results. This is also true for the genes which produced lean/unhealthy phenotypes in
the Drosophila screen (SLC39A8, MTCH2, RPL27A).
On the other hand, some genes (LRRN6C, KLF9, NRXN3, GABRG1, SEC16B, TUFM,
NUDT3, COL4A3BP, TFAP2B) are relatively unexplored in relation to energy homeostasis,
marking them as prime candidates for further study.
4.14.5 Reliability and limitations of the results
The use of multiple assays in the screen and a stringent cut-off score together reduced the
chance of results being false positives. Therefore, it is likely that the results observed are a
true representation of the phenotype of the line tested. However, it is possible that some of the
siRNA lines used had off-target effects which were responsible for the phenotype observed.
To confirm that the results were indeed due to the gene of interest, several different models
could be used. Firstly, some genes (although not all) have more than one different siRNA line
available which could be used to repeat the experiment. Secondly, LoF Drosophila lines could
158 A Drosophila-based screen of genes identified by GWAS to influence BMI
be obtained and studied, although again these do not exist for all genes, and these whole-body
mutations may not be able to replicate a neuron-specific perturbation. Alternatively, for
some genes, there is relevant data published which could be compared. However, none of
these methods are applicable to all genes, and all have draw-backs. Therefore, in chapter 5,
methods of generating precise perturbations of the genes of interest de novo was explored.
Since the initial list of genes are already suspected of playing a role in energy homeostasis, it
could perhaps be argued that the risk of a hit in the screen being a false positive is low.
The main limitation of the screen is that not all genes can be studied: not all human
genes have an identifiable homologue in Drosophila; some of the genes do not have a healthy
siRNA line that produces efficient knock-down; and it is difficult to be certain of phenotypes
in the tiptop-affected lines. Further, the Drosophila genes were chosen based on sequence
homology to the human genes, and it is possible that they are not also functional homologues.
4.14.6 Further work
There are several experiments which could be performed based on the results in this chapter.
Firstly, the results for the top candidate genes could be replicated in a different model in
order to check for off-target effects (a method for doing so is explored in chapter 5).
Secondly, for those loci at which the gene(s) studied were not hits in the Drosophila-based
screen, it may be beneficial to screen more of the genes in the region. Perhaps initially just
the top hits from Baranski et al.’s results (who examined all genes within 500kb of each SNP)
could be studied.
Further, at the time that this project began, 32 loci had been identified that are associated
with BMI (Lu and Loos, 2013). Now, more than 100 such loci are known (Locke et al.,
2015; Akiyama et al., 2017), and this number will likely increase as technological and
computational techniques improve even further. Experiments in mice cannot keep pace, and
thus a screen using Drosophila would be beneficial to decide which of the new candidate
genes are worth pursuing.
Finally, the top hits identified here (PCSK1, NEGR1, MTIF3, CDKAL1, BDNF, LRRN6C,
KLF9, NRXN3, GABRG1, SEC16B, TUFM, NUDT3, COL4A3BP, TFAP2B) should be
investigated in complex model organisms such as mice, particularly those genes for which not
much is currently known. This could involve looking at where the genes are expressed, what
conditions alter their expression, and what happens to a mouse if expression is deliberately
perturbed. The detrimental effects seen in many of the LoF and ubiquitous RNAi lines here
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suggests that, even though tissue-specific experiments are not as easy in mice as they are in
Drosophila, it is worth investing in such experiments.
160 A Drosophila-based screen of genes identified by GWAS to influence BMI
4.15 Summary
In conclusion, in this chapter the Drosophila-based screen that was developed in chapter 3
was used to study a series of human genes identified by GWAS to influence BMI. Drosophila
homologues were identified of these genes, and shown to be (mostly) expressed in the
CNS and enriched for lethal phenotypes. These were phenotyped using a suite of energy
homeostasis assays, allowing selection of top candidate genes for further study. Published
results already exist for some of these genes, and many showed the expected phenotypes
based on the Drosophila results. Others have not been studied making them favourable for
investigation. Many of the positive findings from the fly screen implicate the nearest gene to
the SNP, but there are also some loci for which a more distal gene is the top candidate. Thus,
the results in this chapter provide data to support more detailed experiments in mammals on
the mechanism of action for certain genes in relation to human BMI.
Chapter 5
CRISPR gene editing in Drosophila
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5.1 The specificity of RNAi and LoF in Drosophila
As discussed in chapters 1 and 3, one of the main advantages of using Drosophila as a model
organism is the availability of large stocks which can be used to genetically perturb almost
any gene of interest. These stocks are convenient, especially for large-scale screens, but have
drawbacks (as discussed in chapter 3) in particular with regards to specificity. For LoF lines,
the genetic perturbation can delete or disrupt multiple genes and regulatory elements (Groth
et al., 2004).
The screen of GWAS BMI genes carried out in chapter 4 used flies (obtained from VDRC:
www.vdrc.at) which express siRNAs that target the genes of interest. But siRNAs can have
off-target effects if they have enough sequence similarity to hybridise with non-target RNAs
(Seinen et al., 2011). Of the 142 siRNA lines used in this thesis (chapters 3, 4 and 6), 24
lines are predicted by VDRC to have one off-target effect and three lines are predicted to
have at least two.
One way to check that a result obtained is not due to off-target effects is to replicate the
results using a different line. However, only 60% of Drosophila genes have an additional
UASG-siRNA line available at VDRC to use for comparison. Therefore, in this chapter, a
method of generating de novo mutations in a specific target gene was explored for use in
confirming results from an RNAi-based Drosophila screen.
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5.2 Gene editing using CRISPR
CRISPR is a recently developed technique for genetic engineering. The endogenous function
of CRISPR-Cas9 as a bacterial immune system was discovered in the 1990s, and in 2013 two
papers were published showing that this system could be adapted to use in genetic editing of
eukaryotic cells (Cong et al., 2013; Mali et al., 2013). The first use of CRISPR in Drosophila
followed soon after (Gratz et al., 2013).
The basic principle of generating mutations using CRISPR is to introduce two components
into the target cells: Cas9 protein and guide (g)RNAs. Cas9 is an endonuclease which creates
double strand breaks (DSBs) with blunt ends in DNA. gRNAs are approximately 100
nucleotides long and have a specific secondary structure which binds and activates Cas9, as
well as a 20 nucleotide sequence which is homologous to the target DNA. Cas9 is guided to
a target sequence in the cell’s DNA by the gRNA’s sequence homology. The homologous
sequence in the gRNA can be altered to target Cas9 to different genes of interest, where Cas9
can then cleave the DNA. Repair of the DSB by non-homologous end-joining (NHEJ) is
usually imperfect and creates indel mutations, so disrupting the target gene.
One limitation of CRISPR is that Cas9 requires the presence of a protospacer-associated
motif (PAM) sequence (NGG) at the 3’ end of the target sequence, restricting the possible
target sites. Whilst it is possible that a desired sequence can not be targeted, this is not usually
a problem for creating indel mutations because it is rare that the mutation must be in a very
precise location.
Cas9 protein is unlikely to act using endogenous RNAs (which would cause non-specific
effects) because they lack the Cas9-activating secondary structure of the gRNA. However,
gRNAs can have off-target effects because the homology region between gRNAs and genomic
DNA is small (only 20bp) and some base mismatches are tolerated (Hsu et al., 2013; Fu et al.,
2013; Pattanayak et al., 2013). Since it is unlikely that the off-targets of CRISPR would be
the same as that of RNAi, if the same phenotype is seen with both models then it is likely to
be a true phenotype of the gene of interest.
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5.3 Chapter aims
In this chapter, three methods of CRISPR were explored for their potential to use as part of a
Drosophila-based screen of genes involved in the regulation of human energy homeostasis.
Firstly, creation of lines with uniform whole-body mutation of the target genes was
explored in section 5.6. This method is referred to as homogeneous CRISPR.
Secondly, a method to create tissue-specific but non-homogeneous mutations in fly
somatic cells was explored in section 5.7. This method is referred to as tissue-specific
CRISPR.
Finally, a method similar to tissue-specific CRISPR but mediated by the UASG-GAL4
system was investigated in section 5.8 and is referred to as GAL4 CRISPR.
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Results
5.4 Selection of target genes
To test methods of modifying genes by CRISPR, two target genes were chosen: fuss and
rab21 which are homologues of the human genes LBXCOR1 and RBJ respectively. These
two genes were chosen because (i) they are viable as actin knock-downs, increasing the
chance that CRISPR mutants will be viable, and (ii) results from preliminary RNAi data
were promising. Another reason for using fuss is that its genomic location makes it difficult
to target and thus good for testing the system - fuss is located on chromosome 4 which is
largely heterochromatic, relatively unstudied, and difficult to obtain balancer chromosomes
for (Sun et al., 2000).
Once RNAi data collection was complete, rab21 had a score of 0.72 for neuronal RNAi
and 0.76 for ubiquitous RNAi and was considered a hit (see chapter 4). fuss had a score
of 0.54 for neuronal RNAi and 0.74 for ubiquitous RNAi but was not considered a hit (see
chapter 4).
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5.5 Design of gRNAs
In order to increase the likelihood of gene deletion, each gene was targeted with two gRNAs.
Using this method, deletions of 6.1kb of the intervening DNA have been demonstrated in
Drosophila (Gratz et al., 2013) and even larger deletions have been shown in other model
systems including 65kb in mice (Zhang et al., 2015a). Possible gRNA sequences were
identified using the CRISPOR tool (Haeussler et al., 2016) and two chosen for each gene
based on the following criteria:
• 20bp long — this is widely reported in the literature to be a good length to balance the
specificity and efficiency of CRISPR (for example see Zhang et al. (2016))
• Predicted to have a high efficiency of mutation (Fusi-Doench score >50, Doench et al.
(2016))
• No predicted off-targets with three or fewer mismatches, to ensure specificity
• Position of the gRNA target site within the gene of interest:
– One gRNA near the beginning of the coding sequence and one near the end to
increase the likelihood of deletion of key regions(s) of the gene
– Regions of the gene which were present in all isoforms
– The fuss gene overlaps with the sphinx gene and thus the gRNAs were chosen
to avoid sphinx. fuss also overlaps with a non-coding RNA, but this was not
annotated at the time the gRNAs were designed
The location of the gRNAs relative to each gene are shown in figures 5.1 and 5.2 and the
sequences are given in methods section 2.5.
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gRNA 2 gRNA 1
Chromosome X
Fig. 5.1 Map of the rab21 gene with locations of the designed gRNAs. The gene is shown in
blue, introns as thin lines, coding sequence exons in orange, and UTRs in grey.
Chromosome 4
gRNA 1gRNA 2
Fig. 5.2 Map of the fuss gene with locations of the designed gRNAs and overlapping genes.
The gene is shown in blue, introns as thin lines, coding sequence exons in orange, and UTRs
in grey.
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5.6 Mutation of genes by homogeneous CRISPR
5.6.1 Homogeneous CRISPR strategy
The overall strategy to generate homogeneous mutants by CRISPR is summarised in the
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To produce a fly with the same mutation throughout the body (non-mosaic), the germ
cells of the parents need to be targeted. Therefore, the gRNA mixtures were injected into
dechorionated syncytial preblastoderm Drosophila embryos before formation of the germ
cells. In the injected Drosophila line, Cas9 expression is controlled by the nanos promoter
and so is only present in the area of the pole cells. The injected embryos were grown to
adults, crossed to balancer flies, and then future generations examined for mutation of the
target genes.
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Injection plasmid design
Port et al. have previously reported creation of a vector (pCFD5) in which two gRNAs are
separated by tRNAs (Port and Bullock, 2016). When in a cell, the U6:3 promoter present
in the plasmid drives ubiquitous transcription by RNA polymerase II/III of the plasmid, so
producing a single transcript of gRNAs separated by tRNAs (figure 5.3). The endogenous
tRNA processing machinery liberates tRNAs from this transcript with concomitant release of
the gRNAs.
Fig. 5.3 Map of plasmid pCFD5 which was used to introduce gRNAs into Drosophila.
Diagram obtained from www.crisprflydesign.org/plasmids/
Using genetic cloning techniques described in section 2.5, a single plasmid for each
target gene was created containing both of the designed gRNAs. The gRNA-tRNA sequences
designed to target fuss and rab21 were correctly created and inserted into the pCFD5 plasmid,
as confirmed by sequencing.
Screening by co-mutation of white
To facilitate screening for mutants, a plasmid with gRNAs that target the white gene was
co-injected with the gRNA plasmids targeting fuss or rab21. In its wild-type form, the white
gene produces the red colour of Drosophila eyes. KO mutation of the white gene results in
flies with white eyes. Mutation of white can be assessed quickly and simply by looking at
eye colour using a bench microscope.
Using this approach Ge et al. (2016) showed that flies which gain a mutated white gene (as
evidenced by white eyes) have a higher rate of mutation of the gene of interest compared to
flies which retain wild-type white (as evidenced by red eyes). Selecting flies with white eyes
reduces the number of flies that need to be screened molecularly which is a time-consuming
process. gRNA sequences to target white were taken from the literature (Ge et al., 2016). A
tRNA-gRNA plasmid targeting the white gene was created using the same method as above
and confirmed by sequencing.
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5.6.2 Production of mutant flies by homogeneous CRISPR
rab21
202 nanos-Cas9 embryos were injected with gRNA-tRNA plasmids targeting rab21 and
white. 41 (20%) of the injected embryos survived to adulthood and 7 (3%) of these produced
some progeny with white eyes (i.e. a mutated white gene). 4-10 offspring from each of the 7
white-eyed fly lines were screened using PCR to look for deletion of the DNA between the 2
gRNA sites. In wild-type flies the PCR product is 785bp long (for example see figure 5.4),
but in mutants the expected product would be approximately 340bp depending on the exact





Fig. 5.4 PCR spanning the CRISPR target site did not reveal any large deletion mutations in
offspring of the gRNA injected flies.
Therefore the rab21 gene was sequenced in these flies. This revealed mutations in flies
derived from 3 (1%) of the injected embryos. All of these mutations were at the gRNA site
closer to the start of the gene, with none at the second site.
In the first mutant line, 4 out of 10 of the progeny contained a 13bp deletion in rab21, as
shown in figure 5.5. This causes a frameshift which is predicted to result in 22 or 55 amino
acids (depending on isoform) of wild-type sequence, followed by 5 incorrect amino acids
and then a stop codon before the GTPase domain. For comparison, the wild type protein is
189 or 222 amino acids long. This line is referred to as rab21∆13 henceforth.
In the second line, 3 out of 4 of the progeny had a deletion of 6bp in rab21 (figure 5.6).
This results in deletion of only 2 amino acids from the protein. This line is referred to as
rab21∆6.
In the final line, there was a deletion of 9bp and an addition of 3bp in rab21 in 2 out
of 5 of the flies, as shown in figure 5.7. The resulting proteins have 1 incorrect amino acid
and 2 missing amino acids at the target site. Unfortunately, the founder fly died and so this
mutation could not be tested further.









Fig. 5.5 Sequencing showed deletion of 13bp at the gRNA1 target site in rab21 in the









Fig. 5.6 Sequencing showed deletion of 6bp at the gRNA1 target site in rab21 in the rab21∆6









Fig. 5.7 A line of injected Drosophila had a 9bp deletion and 3bp insertion at the gRNA1
target site in rab21. See figure 5.1 for the location of gRNA1 within rab21.
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One of the white-eyed flies which did not have any mutations in rab21 was selected to
use as a background-matched control. This line is referred to as rab21WT henceforth.
fuss
191 nanos-Cas9 embryos were injected with gRNA-tRNA plasmids targeting fuss and white.
Only 17 (9%) of the injected embryos survived to adulthood, and none of these produced
progeny with white eyes. A small number of the red-eyed flies were genotyped by PCR but
none showed deletion of the DNA between the two gRNA target sites.
white
The white gene in some of the mutant rab21 flies was also sequenced. Although the exact
mutations varied between lines, there were many examples of deletion of the DNA in between
the two gRNA sites. For example, figure 5.8 shows a deletion of the 209bp from the middle
of the first gRNA to the middle of the second gRNA in one of the white-eyed flies.
Fig. 5.8 Sequencing showed deletion of 209bp in the white gene in one line of injected
Drosophila (bottom) compared to wild-type (top)
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5.6.3 Efficiency of disruption of rab21 expression in mutant flies
The two mutant lines, rab21∆6 and rab21∆13, were tested to see whether their mutations
affected expression of the rab21 gene. qPCR showed that RNA levels of rab21 were
decreased in the rab21∆13 mutants (figure 5.9). For the rab21∆6 mutants, there was a trend
towards a decrease but it did not reach significance. Even in the rab21∆13 line, the RNA



























































Normalised to: tub Mnf RpS20
Fig. 5.9 Levels of rab21 RNA are decreased in the homogeneous CRISPR mutant flies, as
shown by qPCR. Mean ± SEM is plotted of 5 repeats each containing 10 flies. Results were




































































Fig. 5.10 RNA levels of rab21 are decreased by actGAL4-driven RNAi. Mean ±SEM is
plotted of 5 repeats each containing 10 flies. Results were compared by Student’s t-test.
* p<0.05, *** p<0.001, **** p<0.0001
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5.6.4 Phenotype of rab21 mutant flies
It was immediately apparent that the rab21 mutant flies were less fecund than wildtype, and
the rab21∆13 flies were more affected than the rab21∆6 flies (figure 5.11h). Fecundity was
not measured in the RNAi flies.
In addition, the phenotype (in the same screening assays used in chapter 4) of flies with
ubiquitous RNAi of rab21 was compared to that of flies with CRISPR-induced mutation of
rab21. The results (figure 5.11) are broadly in agreement: there was a significant increase in
dye food over-feeding and no phenotype for mass or CAFE feeding. Two results for which
there was a trend with RNAi (a decrease in climbing and a decrease in starvation resistance)
became significant with CRISPR. The only disagreement in the results is the glucose assay,
where no phenotype is seen for CRISPR but a decrease is seen for RNAi. Finally, it was
possible to measure TAG in the CRISPR flies but levels were undetectably low in the RNAi
flies (see chapter 3.4).


































































































































































































































































































Fig. 5.11 rab21 mutants generated by homogeneous CRISPR show a similar phenotype to
flies with whole body RNAi of rab21. Background control lines are black and mutant/RNAi
lines are white. Mean ± SEM is plotted of 5 repeats. Results were compared to appropriate
background by Student’s t-test. * p<0.05, ** p<0.01, ***p<0.001
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5.7 Tissue-specific CRISPR
The screen of GWAS genes carried out in chapter 4 focussed mainly on neuronal RNAi,
and so results from a line generated by homogeneous CRISPR (in which the gene is KO
throughout the whole body) may not always be relevant for comparison. Further, as discussed
in chapter 3, a whole body KO mutation is detrimental or lethal for many genes which limits
the information available from the homogeneous CRISPR model.
Therefore, to maximise the usefulness of creating de novo CRISPR mutations for the
screen, the feasibility of neuron-specific CRISPR was explored.
5.7.1 Strategy
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Embryo injection
The gRNA-tRNA plasmids created in section 5.6 contained an attB site. Thus, the rab21-
gRNA and fuss-gRNA plasmids were separately injected into Drosophila embryos which
expressed PhiC31 integrase under the control of the nanos promoter. PhiC31 integrase
promotes sequence-specific recombination between the plasmid attB site and a genomic attP
site (in this case on chromosome 2), thus integrating the plasmid into the Drosophila genome.
The PhiC31 integrase was under the control of the nanos promoter so, as before, the genomic
integration should only occur in the germ cells.
Screening for plasmid integration
The injected embryos were grown to adulthood and their offspring screened for plasmid
integration. The gRNA plasmids also contained the vermillion marker gene sequence and so
it was therefore possible to screen the flies for plasmid insertion simply by the presence of
vermillion-coloured eyes. For both target genes, many flies had successful integration of the
plasmid but only one founder fly was used to create a line in order to ensure homogeneity.
These lines are referred to henceforth as rab21-gRNA flies and fuss-gRNA flies.
Introduction of Cas9
As before, the gRNAs are downstream of a U6:3 promoter and so are ubiquitously expressed
throughout the fly. When crossed to a Drosophila line expressing Cas9, CRISPR-induced
mutation of the target gene can occur in the offspring. Several lines are available with Cas9
under the control of different promoters which affect when/where Cas9 is expressed and
thus when/where mutation can occur. Mutations created in this way are somatic (unless a
germ-line Cas9 is used) and are likely to be different in each cell (mosaic).
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5.7.2 Gene expression after tissue-specific CRIPSR
Although the aim was to create neuron-specific mutations, a Cas9 line with an appropriate
promoter was not immediately available for doing so. Further, it is easier to observe the
effectiveness of the method (gene expression levels) using whole-body mutation because no
tissue dissection is required. Therefore, whilst waiting for delivery of an elav-Cas9 line, the
efficiency of the tissue-specific CRISPR method was first tested by crossing the gRNA flies
to a line with ubiquitously expressed Cas9 (actin5C-Cas9)
When the rab21-gRNA line was crossed to actin5C-Cas9, there was no change in the
levels of rab21 RNA compared to either parental line as shown by qPCR (figure 5.12). This is
in comparison to both ubiquitous RNAi and homogeneous CRISPR which caused a decrease


















































































Fig. 5.12 No changes in rab21 expression were detected after tissue-specific CRISPR.
Mean ± SEM is plotted of 6 repeats each containing 10 flies. The results of each genotype
were compared by Student’s t-test.
When the fuss-gRNA line was crossed to actin5C-Cas9, qPCR showed an increase in
the level of fuss RNA (figure 5.13). By comparison, ubiquitous RNAi caused a decrease in
expression of fuss (figure 5.14).
Since it was not possible to show effective perturbation of rab21 or fuss expression, the
lines were not phenotyped.

















































































Normalised to: tub Mnf RpS20
Fig. 5.13 An increase in expression of fuss was detected after tissue-specific CRISPR.
Mean ± SEM is plotted of 6 repeats each containing 10 flies. The results of each genotype



























































Fig. 5.14 A decrease in expression of fuss was detected after ubiquitous RNAi.
Mean ± SEM is plotted of 5 repeats each containing 10 flies. Results were compared by
Student’s t-test. * p<0.05
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5.8 GAL4-mediated CRISPR
One possible explanation for the lack of RNA perturbation seen with tissue-specific CRISPR
is that the Cas9 was not expressed at high enough levels to cause mutation of the target
genes. GAL4 can drive very high levels of expression of Cas9, which may increase the
likelihood of mutation of target genes (Port et al., 2014; Port and Bullock, 2016). In addition,
an elav-GAL4 line was already available (as used in chapters 3 and 4) for expression of
GAL4 in neurons.
Therefore a strategy in which GAL4 was used to drive tissue-specific CRISPR was
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A line was obtained from the University of Cambridge fly facility which expresses Cas9
under the control of a UASG promoter (+/+ ; +/+ ; UASG-Cas9/TM6b).
Lines were also used which express GAL4 neuronally (+/+ ; elav-Gal4/CyO ; +/+) and
throughout the whole body (+/+ ; actin5C-Gal4/CyO ; +/+).
Using a series of crosses, two sets of flies were created which express both GAL4 and
UASG-Cas9, meaning that the expression pattern of Cas9 is controlled by that of the GAL4
promoter:
+ / + ; elav-GAL4 / CyO ; UASG-Cas9 / TM6b
and
+ / + ; actin5C-GAL4 / CyO ; UASG-Cas9 / TM6b
The intention was to establish stable lines of these two genotypes and cross them to the
gRNA flies created in section 5.7 which ubiquitously express the gRNAs. However, the
GAL4;Cas9 flies had very low viability and were infertile, preventing any further use of this
method. By comparison, the parental lines were all viable and fertile.
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5.9 Discussion
One of the main advantages of using Drosophila as a model organism is the ready availability
of many different types of stocks for genetic manipulation of the genes of interest. However,
these mass-produced lines do have some problems with off-target effects. Therefore in
this chapter, the practicality of using CRISPR to generate specific de novo mutations was
explored to use for confirmation of results from the RNAi screen.
5.9.1 Homogeneous CRISPR
In the first method tested (section 5.6) , an approach involving both tRNA-mediated liberation
of gRNAs and co-mutation of white was used to facilitate mutation of the target genes. To this
end, plasmids encoding multiple gRNAs to target rab21, fuss and white were successfully
created. Injection of these plasmids into Cas9-expressing embryos led to creation and
identification of three lines with mutation of rab21 (and white), but none with mutation of
fuss.
These methods were successful in that mutants were successfully created. However, since
the flies which retained red eyes were not genotyped, it is not known what proportion (if any)
had mutations in rab21 and therefore it is impossible to tell whether the co-injection strategy
facilitated the screening process as has been published (Ge et al., 2016). Similarly, whether
encoding multiple gRNAs on the same plasmids by separating them with tRNAs was more
efficient than making separate plasmids for each gRNA is unknown.
The intention was to delete all of the DNA in between the two gRNA sites. However, this
was not detected in any of the flies screened. Instead, for rab21 all of the mutations found
were at just one gRNA site. Luckily, the functional gRNA was the one closer to the start of
the gene, increasing the chance that the mutations would perturb the gene. This shows that
the CRISPR strategy worked but suggests that there was a problem with the gRNAs.
It has been shown that the position of the gRNA on the plasmid does not affect the
mutagenesis efficiency (Port and Bullock, 2016). Instead, the most likely explanation for the
failure to mutate the second site is that the gRNA design was not optimal. In the future, this
may not be a problem as the algorithms to design gRNAs improve. In addition, more than
one gRNA should be used at both target sites. It is possible to use the same tRNA approach
to create a plasmid containing up to four gRNAs, although the cloning requires more stages
and so is less time-efficient.
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Mutation of rab21
Two rab21 mutant lines were created. In the rab21∆13 line, a premature stop codon results in
deletion of most of the protein including the GTPase domain, and so would be predicted to
strongly affect gene function. Indeed, qPCR showed that RNA levels of rab21 are decreased
(possibly due to nonsense-mediated decay of the mRNA transcripts) and a phenotype was
seen in many of the energy homeostasis assays. In the rab21∆6 line, most of the protein
is still present but it is possible that the mutation would influence folding or regulation of
the rab21 mRNA/protein. Therefore, any effects would be expected to be milder for the
rab21∆6 than for the rab21∆13 line, and this is seen in both qPCR and some of the phenotype
assays. There is no premature stop codon in the rab21∆6 line and so reasons for the decrease
in mRNA levels are not obvious, but it could be hypothesised that there is some form of
feedback loop.
The RNA levels are affected less by the CRISPR mutations than they are by RNAi.
This is unsurprising given that RNAi targets the RNA and qPCR measures RNA levels,
whereas CRISPR affects the DNA and protein. However, it does not follow that the effects
on phenotype will be larger for RNAi than for CRISPR. If the gRNAs had been designed to
target the promoter or other regulatory sequences of the rab21 gene, then a larger change in
RNA levels would be expected with CRISPR than was observed.
The phenotype of the homogeneous CRISPR flies matched that of the ubiquitous RNAi
flies for rab21. Since it is unlikely that the two models have the same off-target effects, this
provides validation that both genetic approaches are successfully targeting rab21. Specifically,
the dye ingestion, mass and CAFE results matched precisely. Results for which there was
a trend with RNAi (climbing and starvation resistance) became significant with CRISPR,
either because the genetic perturbation is stronger and/or because the CRISPR flies were all
genotyped within the same batch which decreased variation in the results compared to the
RNAi flies which were phenotyped across multiple batches. The only disagreement in the
results is the glucose assay where no phenotype is seen for CRISPR but a decrease is seen for
RNAi. It is possible that this last result is a false positive in the RNAi flies due to to off-target
effects of the siRNA, or a false-negative result in the CRISPR flies due to a problem with the
assay.
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Failure to mutate fuss
As stated in section 5.4, one of the reasons that fuss was chosen as a target gene is that its
presence on chromosome 4 makes it difficult to target (Sun et al., 2000) and so the failure to
create a mutant line with homogeneous CRISPR is not surprising.
Only a very small proportion (9%) of the injected embryos survived to adulthood which
reduced the chance of finding mutants. Since the Cas9 expression was limited to the pole
cells, no (or very few) mutations should have occurred in the somatic cells and so mutation of
fuss is unlikely to be the cause of the lethality. This suggests that instead there was a problem
with the microinjection, either molecularly (for example the injected plasmid solution was
too concentrated) or physically (for example a blunt needle). For the few injected embryos
which did survive to adulthood, there were no white-eyed offspring.
Further, the chromosome 4 balancer lines were very unhealthy. Therefore, even if a
mutation in fuss had been found it may have been difficult to maintain the line if the mutation
affected viability or fertility. As chromosome 4 contains less than 0.5% of a fly’s genes
(Sun et al., 2000; Van Holde and Zlatanova, 2018), the need for chromosome 4 balancers in
future work is likely to be low, but if required, the maintenance conditions would need to be
optimised.
5.9.2 Failure of tissue-specific CRISPR
Perturbation of neither fuss nor rab21 could be shown using tissue-specific CRISPR (section
5.7). This is in agreement with published results which found that CRISPR using tissue-
specific expression of Cas9 combined with ubiquitously expressed sgRNAs often leads to
poorly penetrant phenotypes (Port et al., 2014; Port and Bullock, 2016).
For rab21, the problem is not the gRNAs because the same gRNAs were able to cause
mutation with the homogeneous CRISPR method. Further, the gRNA plasmid is definitely
being expressed within the genome as evidenced by the presence of vermillion eye colour. In
addition, the qPCR protocol is functional as it was able to detect differences in RNA levels
for both RNAi and homogeneous CRISPR. Therefore, the exact reasons why no perturbation
was seen remain unclear. It could be speculated that CRISPR is less efficient in adults than
in embryos, perhaps because the fast nuclear division occurring in embryos provides more
opportunities for Cas9 to access the target DNA. Alternatively, perhaps the Cas9 used for
tissue-specific CRISPR is less active than that which was used for homogeneous CRISPR. In
addition, the background controls used in the qPCR were the two parental lines — these are
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homozygous throughout their genome unlike their heterozygous offspring so are perhaps not
ideal for use as background controls.
When the fuss-gRNA line was crossed to act-Cas9, qPCR showed an increase in the level
of fuss mRNA. Again, the reasons for this unexpected result are not certain, but in addition
to the theories discussed above for rab21, it could be hypothesised that because fuss is on
heterchromatic chromosome 4, the gRNA-directed Cas9 may cause the chromatin structure
around fuss to relax and thus increase gene transcription.
For both genes, it is possible that mutations were in fact being created, but since this
could not be shown it would be difficult to confidently interpret any phenotype data.
5.9.3 Failure of GAL4-mediated CRISPR
The intention was to cross GAL4;UASG-Cas9 lines to gRNA-expressing flies in order to use
the high expression levels of the UASG-GAL4 system to increase the likelihood of obtaining
CRISPR mutations (section 5.8). However these lines had very low viability and were
infertile. The four starting parental lines were healthy, meaning that it is not the individual
transgenes that are problematic. In theory, their combination should also not cause viability
or fertility issues since no CRISPR-induced mutation should occur in the absence of gRNAs.
This suggests that the expression of this Cas9 is having a detrimental effect even in the
absence of gRNAs. Published results have also found that GAL4-mediated expression of
UASG-Cas9 causes lethality (Port et al., 2014; Port and Bullock, 2016; King-Jones and
Huynh, 2018) and the authors’ suggestion was that the very high levels of Cas9 expression
that result from the UASG-GAL4 system causes substantial cytotoxicity independent of the
endonuclease activity.
5.9.4 Comparison of homogeneous and tissue-specific CRISPR
Tissue-specific CRISPR has a number of advantages in comparison to homogeneous CRISPR,
and many of these are the same as the differences between LoF and RNAi discussed in chapter
4. Firstly, the information is tissue-specific which both provides mechanistic information
about the gene being studied and avoids any detrimental effects of a whole-organism LoF.
Secondly, the gRNA and Cas9 lines are maintained separately which allows mutations in a
range of different tissues or conditions to be studied without needing to create an additional
line. Finally, the post-injection screening is easier for tissue-specific CRISPR as it requires
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only looking at eye colour for plasmid integration rather than the sequencing needed to detect
mutation by homogeneous CRISPR.
There are also four disadvantages of the tissue-specific method compared to homogeneous
CRISPR. Firstly, CRISPR almost always has off-target effects due to sequence similarity
with non-target genes (Zhang et al., 2015b) and unlike with homogeneous CRISPR, these
off-targets cannot be removed by crossing. Secondly, suitable lines to use as background
controls are not easily available for tissue-specific CRISPR but are for homogeneous CRISPR.
Further, tissue-specific CRISPR may create different mutations in every cell which makes
the results more difficult to interpret than homogeneous CRISPR where the exact mutation
is known. For homogeneous CRISPR, different lines can have different mutations which
potentially provides different information. Finally and most importantly, homogeneous
CRISPR was demonstrated to cause perturbation of the gene of interest whereas this could
not be shown for tissue-specific CRISPR.
5.9.5 Comparison of RNAi and CRISPR
The main draw-back of using RNAi is the potential for off-target effects. Like RNAi, CRISPR
can also have off-target effects. However, it is unlikely that the off-targets would be the same
for both CRISPR and RNAi, and so the results can be compared to look for specific and
non-specific phenotypes.
Creation and screening of the CRISPR lines is very low-throughput compared to RNAi.
siRNA lines are already available and can be shipped and passed through quarantine in four
weeks. By comparison, it took one year from selection of the target genes to obtaining
homogeneous CRISPR flies for phenotyping. In this time, a mouse model of the gene of
interest could be obtained, which may provide information that is more directly relevant to
human physiology. The tissue-specific CRISPR gRNA flies were obtained more quickly
(approximately 1 month) after injection so could provide results in a time-frame more
appropriate for a high-throughput screen.
Two genes were chosen for CRISPR targeting: rab21 and fuss. The homogeneous
CRISPR only worked for rab21 and the tissue-specific CRISPR did not appear to work for
either. Although most lines studied in this thesis were not analysed by qPCR to check for
knock-down of gene expression, RNAi is widely accepted within the Drosophila research
community as a reliable tool (for example see St Johnston (2002); Mohr et al. (2014); Wangler
et al. (2017) and Heigwer et al. (2018)). Since the idea of a Drosophila-based screen is
to simultaneously study a very large number of genes to select top candidates, a few non-
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functional siRNA lines (and therefore false negative results) does not matter. In comparison,
the low-throughput nature of CRISPR means that it is only suitable for studying a small
number of genes, and so it is important that the genetic perturbation is strong, accurate,
reliable and precise, which it was not possible to show here.
The aim of this thesis was to generate a model for high-throughput and economical
analysis of large numbers genes relevant to human obesity. Based on the work in this and
previous chapters, tissue-specific RNAi in Drosophila seems to be the best model for such a
purpose.
On the other hand CRISPR has potential for studying a small number of genes in detail
and so could be used to study just the top hits of an RNAi-based screen. In that case, further
optimisation of the methods would be required including: use of more than two gRNAs to
target each gene; creation of lines more suitable to use as background controls for neuron-
specific CRISPR; and acquisition/creation of neuron-specific Cas9 lines. It would perhaps be
helpful to use mutation of a gene such as white which has an easily scored phenotype to carry
out the optimisation, before moving to genes like fuss and rab21 which require molecular
techniques for assessment.
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5.10 Summary
In summary, in this chapter CRISPR was explored as a method of perturbing expression
of genes of interest. Use of tRNAs to separate gRNAs was used to facilitate creation of a
single gRNA-containing plasmid for each target gene. Co-targeting of the white gene was
used to facilitate the process of screening for mutants. Two mutant lines were successfully
created for rab21 and shown to have decreased levels of rab21 mRNA. Phenotypes of these
lines matched those of flies with ubiquitous RNAi against rab21. No mutant lines were
successfully created for fuss. Further, attempts to do tissue-specific CRISPR were thwarted
by the inability to detect whether mutation was occurring or not. Thus for now, neuronal
RNAi remains the most suitable model for the screen to probe genes of interest for a role in
the CNS’s control of food intake and energy homeostasis.
Chapter 6
A Drosophila-based screen of
hypothalamic genes affected by fasting
As discussed in chapter 1, up to 70% of the variation in BMI and fat mass between individuals
is influenced by genetic factors (Maes et al., 1997). However to date, genetic studies such as
GWAS have only been able to account for less than 10% of this variation (Bogardus, 2009;
Speakman et al., 2018).
Many of the genes that have been studied from Mendelian obesity and polygenic common
obesity are linked to the leptin-melanocortin pathway in the CNS which has a key role in the
control of energy homeostasis (see chapter 1). Therefore a different approach to studying
obesity genetics is to look specifically at the POMC and NPY neurons in the arcuate nucleus,
since these are an important site of action of the leptin-melanocortin pathway. Briefly, in
response to energy deficit, NPY neurons cause an increase in food intake brought about by
changes in gene expression and electrical activity, whereas POMC neurons have the opposite
action during energy surplus.
Therefore in this chapter, a data set derived from transcriptomic data of mouse POMC
and NPY neurons subjected to metabolic perturbation (fasting) was interrogated using the
high-throughput Drosophila-based screen for energy homeostasis phenotypes which was
developed and refined in chapters 3-5.
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6.1 Transcriptomic studies of hypothalamic neurons
Gene expression is not uniform but instead has strong temporal and spatial characteristics.
These depend on genetics and also on the present and past environment. For example, food
intake affects the neuronal pathways that control feeding, but this would not be detectable
by purely genomic data. The transcriptome refers to the RNA transcripts produced from the
genome in a specific condition and/or cell. Transcriptomic techniques such as microarrays and
RNAseq measure levels of these RNAs and their temporo-spatial variation. Transcriptomic
studies generally produce large lists of data and so require a high-throughput model to study
the identified genes.
Fasting increases hunger and triggers feeding behaviour, and so studying changes in the
transcriptome bought about by fasting provides a foundation for further investigation into the
regulation of energy homeostasis.
Henry et al. (2015) studied gene expression in both NPY and POMC neurons from fed
and fasted mice. Briefly, they bred NpyhrGFP and PomctopazFP transgenic male mice from
which the NPY and POMC neurons, respectively, could be isolated by their expression of
fluorescent protein. For each genotype 5 young adult male mice (6.5-8 weeks) were fed ad
libitum for 24 hours and 5 were deprived of food for 24 hours. Then the hypothalamus was
dissected from each brain, the neurons dissociated, and Fluorescence Activated Cell Sorting
(FACS) used to separately collect NPY and POMC neurons. From each of the 20 neuron
pools, each containing 44-214 neurons, the RNA was extracted and RNAseq used to measure
the expression levels of every gene. Henry et al. showed their samples were uncontaminated
by checking for marker genes of other cells types, and that their results were accurate by
checking that the data was consistent with previously published data for specific genes.
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6.2 Chapter aims
The aim of this chapter was to use the Drosophila-based screen that was developed and
validated in chapter 3 and tested in chapter 4 to probe the transcriptomics data from Henry
et al. (2015) in order to identify top candidate genes that warrant further exploration in
mammalian models.
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6.3 Chapter-specific methods
In previous chapters, the flies were housed in incubators with 60-70% humidity. For the
work done in this chapter, the humidity regulator was broken and so the flies were instead
kept at 10-40% humidity. This dried the food, making it more difficult for larvae to infiltrate
and feed which, in turn, may affect their development and physiology. To compensate, 10
UASG-siRNA virgin female flies were used for each cross (rather than 5).
Since all of the genes in this data set are known to be expressed in the mammalian brain,
all were phenotyped in Drosophila using neuronal RNAi. Only viability was tested using
ubiquitous RNAi.
The climbing and starvation assays were not used as they were found in chapters 3 and
4 to be less sensitive than the other screen assays. Instead the TAG levels were determined
as an extra measure of physiology, but using the method from Baranski et al. (2018). Their
method involves no centrifugation of the fly homogenate sample, unlike the method detailed
in chapter 2 which involves two centrifugation steps. As can be seen in figure 6.1, Baranski

























lower detection limit of assay
Fig. 6.1 TAG levels in KK/GD-elavGAL4 samples are much higher using the method
described by Baranski et al. (2018) than they are from the method described in chapter 2
of this thesis. Mean ± SEM is plotted of 10 repeats each containing 15 flies. Groups were
compared by two-way ANOVA. **** p<0.0001
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The scoring formula was amended to accommodate these changes in the screen assays:
Score = 1− ( 115)(5pCAFE +4pdye +3pTAG +2pmass + pglucose)
With the initial set of assays that were used in chapters 3 and 4, the positive and negative
control genes could be differentiated by having a score above or below 0.7, respectively. Since
the formula above uses a slightly different suite of assays, it is possible that the threshold
score for a gene to be considered a hit should be amended. However, as an indicator that
0.7 is still appropriate to use, if the scores for the positive and negative control genes are
calculated with the CAFE, dye food over-feeding, wet mass and glucose assay results (i.e.
the same as this new formula but without the TAG), then 0.7 remains the distinction between










Fig. 6.2 The positive control genes are distinguishable from the negative control genes with
the new scoring system. -P are peripheral disease negative control genes, -N are neuronal
disease negative control genes, and + are positive control genes (see chapter 3). Groups were
compared by Student’s t-test. * p<0.01, ** p<0.001.
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Results
6.4 Selection of genes for phenotyping
In total, Henry et al. reported the expression levels of 35266 mouse genes in both POMC and
NPY neurons. The process used to select genes from this list for screening in Drosophila is
detailed below and summarised in figure 6.3.
Of all the mouse genes, the number which showed a significant change (p<0.05) in
expression between the fed and fasted states was 1234 in POMC cells and 3655 in NPY cells.
To further filter the data, only those genes which show at least a 1.5-fold change in
expression were studied because this increases the statistical power of the data (Conesa et al.,
2016). Most of the genes filled this criterion, resulting in removal of only 196 genes from the
POMC cell list and 101 from the NPY cell list.
Since POMC and NPY neurons have opposing roles in the control of energy homeostasis
(see chapter 1), any genes which change in a reciprocal fashion in these neurons are likely to
be the best targets for future therapeutic development. Fasting caused expression of 39 genes
to decrease in POMC cells and increase in NPY cells. Conversely, fasting caused expression
of 153 genes to increase in POMC cells and decrease in NPY neurons.
All of these mouse genes had a strong homologue in humans which is important if the
results are to be used to understand human physiology.
Next, ENSEMBL was used to identify Drosophila orthologues of these mouse genes
(Zerbino et al., 2018). 58% had a Drosophila orthologue, which is approximately the same
as the genome-wide average of 53% (Wangler et al., 2017). Most of the mouse genes had
just one homologue but some had multiple, and in one case two mouse genes had the same
fly homologue. Overall, this gave a list of 157 Drosophila genes.
To increase the likelihood of these Drosophila genes being functional homologues of the
mouse genes, they were only taken further if the sequence homology was greater than 30%.
This brought the total to 91 genes. Further the genes had to be expressed in the adult and/or
larval CNS according to published microarray data (Graveley et al., 2011), bringing the total
to 61 genes. The neuronal expression of the genes also ensured that it was appropriate to
study the genes using neuron-specific RNAi.
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 Start 35266
 Fed vs fast p<0.05 4889
















 Homology >30% 91
 CNS expression 61
 Good siRNA line available 53





= 192 human genes
Fig. 6.3 Criteria used to select genes for study in Drosophila from genetic data by Henry
et al. (2015)
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Finally, UASG-siRNA lines to target the Drosophila genes were ordered from VDRC.
For 2 of the genes, no siRNA line was available. For 6 of the genes, the only lines available
had multiple off-target effects and so these genes were not ordered. As before, GD lines were
ordered in preference to KK lines. In total 53 Drosophila siRNA lines were ordered.
12 siRNA lines were ordered representing 13 mouse genes whose expression goes up in
NPY neurons and down in POMC neurons during fasting. Given the role that NPY neurons
play in triggering feeding, and that for most genes an increase in expression is more important
for their function than a decrease, these 13 genes are referred to in this thesis as orexigenic
genes.
41 siRNA lines were ordered representing 40 mouse genes whose expression increases in
POMC neurons and decreases in NPY neurons during fasting. These 40 genes are referred to
in this thesis as anorexigenic genes.
3 of the siRNA lines ordered died of a mite infection in quarantine before they could be
phenotyped.
Therefore, in total, 50 genes were studied, which are listed in table 6.1.
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Table 6.1 Mouse genes which respond to fasting in a reciprocal manner in POMC and
NPY neurons, and their Drosophila orthologues. m Mouse genes with the same Drosophila
orthologue. f Fly genes with the same mouse orthologue.
RNAseq of mouse hypothalamic neurons (Henry et al., 2015)
Drosophila orthologue
Gene
POMC neurons NPY neurons
Fast - Fed (TPM) t test p value Fold change Fast - Fed (TPM) t test p value fold change Gene Homology (%)
Orexigenic genes
Arpc5l -62.6 0.0210 1.5 54.5 0.0130 1.5 Arpc5 44
Hsd17b12 -35.9 0.0021 2.0 46.3 0.0000 2.1 spidey 44
Tubb4b -97.7 0.0222 1.6 112.7 0.0010 1.6 βTub56D 94
Chml -1.8 0.0407 2.6 3.6 0.0247 1.6 Rep 33
Ddah1 -94.4 0.0069 1.8 79.1 0.0014 2.6 CG1764 38
Fam162a -42.9 0.0159 1.9 65.0 0.0348 2.0 CG9231 32
Gem -19.7 0.0357 2.3 74.9 0.0004 4.9 Rgk1 30
Hcrtr2 -15.3 0.0054 3.1 11.7 0.0046 6.6 SIFaR 30
Prkcsh -30.0 0.0481 1.5 49.6 0.0447 1.7 GCS2β 38
Spred2 m -40.5 0.0327 2.4 69.3 0.0017 1.9 Spred 35
Spred3 m -46.1 0.0029 6.1 70.0 0.0000 2.7 Spred 30
Ssr4 -122.4 0.0158 2.0 101.1 0.0127 1.6 Tapδ 34
Anorexigenic genes
Acvr2a 58.5 0.0099 1.7 -31.9 0.0088 1.5 put 47
Aldh6a1 35 0.0044 2.2 -15.3 0.0373 1.5 CG17896 67
Atp2b2 42.7 0.0001 1.5 -50.5 0.0007 1.7 PMCA 60
Cacnb4 12.2 0.0002 1.5 -36.3 0.0001 2.3 Ca-β 53
Cdk14 30.7 0.0160 1.6 -12.8 0.0025 4.6 Eip63E 52
Dtna 105.9 0.0004 1.9 -133.2 0.0000 2.2 Dyb 43
Elavl2 f 14.0 0.0061 1.5 -32.8 0.0016 2.0 Rbp9 58
Elavl2 f 14.0 0.0061 1.5 -32.8 0.0016 2.0 fne 59
Epb4.1l4b 13.1 0.0050 1.9 -22.1 0.0001 4.2 yrt 47
Gda 38.2 0.0045 1.7 -21.2 0.0352 2.1 DhpD 45
Gpn3 51.6 0.0009 2.9 -24.1 0.0062 1.8 CG2656 51
Nalcn 58.6 0.0016 1.7 -49.5 0.0015 1.6 na 57
Nedd4l 33.6 0.0102 1.7 -35.5 0.0003 1.7 Nedd4 49
Nmt1 20.8 0.0057 1.5 -21.9 0.0445 1.5 Nmt 56
Pofut1 7.6 0.0014 2.4 -6.2 0.0295 3.4 O-fut1 42
Prkaa1 23.4 0.0284 1.5 -21.3 0.0190 1.5 AMPKα 60
Pura 83.5 0.0206 1.5 -111.8 0.0137 1.9 Pur-α 44
Pygl 11.5 0.0285 1.8 -15.1 0.0003 2.8 GlyP 71
Rasgef1a f m 29.8 0.0055 1.5 -15.6 0.0312 1.5 CG7369 41
Rasgef1c f m 5.4 0.0473 1.9 -9.6 0.0082 9.5 CG7369 46
Rasgef1a f m 29.8 0.0055 1.5 -15.6 0.0312 1.5 CG4853 36
Rasgef1c f m 5.4 0.0473 1.9 -9.6 0.0082 9.5 CG4853 37
Rps6ka6 12.7 0.0277 2.1 -40.1 0.0138 2.4 S6kII 49
Rufy2 34.1 0.0172 1.5 -39.3 0.0281 1.7 CG31064 42
Syt7 4.3 0.0361 2.9 -13.9 0.0085 1.9 Syt7 46
Tub 97.9 0.0083 1.6 -125.9 0.0002 2.2 ktub 42
Ccdc132 20.5 0.0471 1.6 -16.8 0.0101 1.5 Vps50 31
Fat3 15.7 0.0163 2.0 -28.3 0.0019 6.7 kug 36
Htr1a f 12.1 0.0346 5.4 -30.9 0.0000 4.9 5-HT1A 36
Htr1a f 12.1 0.0346 5.4 -30.9 0.0000 4.9 5-HT1B 35
Kcnj3 37.5 0.0431 1.5 -18.6 0.0338 2.1 Irk2 35
Kcnq3 90.7 0.0066 3.1 -54.3 0.0261 2.5 KCNQ 31
Lipa 26.0 0.0061 1.6 -19.9 0.0002 2.4 CG18301 34
Lrch2 36.5 0.0009 1.5 -48.6 0.0259 1.8 Lrch 31
Nr1d2 67.2 0.0024 2.8 -66.8 0.0003 2.3 Eip75B 30
Rbfox1 40.1 0.0046 1.6 -23.1 0.0004 2.5 Rbfox1 36
Rps6ka5 22.1 0.0008 2.7 -31.3 0.0003 2.2 JIL-1 38
Slc44a5 15.4 0.0256 3.0 -6.0 0.0328 1.7 Ctl2 34
Smpdl3b 4.4 0.0415 3.9 -5.1 0.0080 5.9 CG32052 32
Sytl4 11.0 0.0330 2.4 -6.9 0.0004 3.0 btsz 35
Vps39 46.6 0.0072 1.6 -56.1 0.0044 1.7 Vps39 36
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6.5 Rapidity of the Drosophila-based screen
The primary aim of this thesis was to develop a high-throughput in vivo screen of feeding
behaviour and energy homeostasis phenotypes in Drosophila. The study of the fasting
transcriptomics genes in this chapter allowed the speed of the screen to be accurately
measured. From a start-point of being able to collect siRNA virgin flies, it took 6 weeks to
phenotype 50 lines (plus 3 background controls) using 5 assays each.
6.6 Viability of the transcriptomic genes in Drosophila
The lethality of each gene with whole body RNAi can be seen in figure 6.10. Of the GD
lines, 31% are lethal with ubiquitous RNAi. This includes one line in which the flies eclose
but die within a few days. This lethality is only marginally higher than the genome-wide
average of 25% (Wangler et al., 2017).
Of the KK lines, 7 are viable, 1 is viable only in females, and 9 are lethal with ubiquitous
RNAi, although some of this lethality may be caused by over-expression of tiptop (see section
6.7).
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6.7 Lines affected by tiptop over-expression
Of the 16 siRNA lines with a KK background, 7 were lethal during / before the pupal
stage when crossed to act-GAL4. Data from these genes was therefore compared to both
KK-elavGAL4 and KKtiptop-elavGAL4 as a background control. In each case the smaller
phenotype was chosen as the result in order to avoid false positive results which are more
detrimental than false negative results for the purpose of candidate gene selection. The results
are shown in figure 6.4.
The siRNA lines which target betaTub56D, Rbfox1, 5-HT1A, 5-HT1B and fne have a
smaller phenotype using a KK background, with both fewer significant assay results and a
lower overall score.
Only one line (Eip75B) has a smaller phenotype with KKtiptop and was thus assigned to
this background.
For DhpD, there are significant results in more assays when compared to KKtiptop, but
the score is lower with KK, and so the appropriate background is unclear. For data presented







Background CAFE Dye	Food TAG Wet	Mass Glucose Score
KK 0.5987 0.0869 0.7759 0.0707 0.0051 0.61
KKtiptop 0.0210 0.3917 0.0000 0.4757 0.0034 0.82
KK 0.8994 0.0502 0.0866 0.7064 0.0360 0.57
KKtiptop 0.0024 0.3917 0.0000 0.6009 0.6527 0.77
KK 0.5936 0.2340 0.0096 0.3103 0.0117 0.70
KKtiptop 0.0016 0.2426 0.0000 0.2931 0.6441 0.86
KK 0.0773 0.5637 0.0917 0.0320 0.8682 0.74
KKtiptop 0.0437 0.0750 0.0001 0.1306 0.0005 0.86
KK 0.3685 0.5271 0.0633 0.0869 0.0001 0.71
KKtiptop 0.0165 0.0609 0.0000 0.9255 0.0160 0.86
KK 0.6468 0.0005 0.0151 0.0316 0.0135 0.78
KKtiptop 0.0019 0.3349 0.0000 0.4041 0.0035 0.86
KK 0.0252 0.0241 0.0025 0.0161 0.3633 0.96




















Fig. 6.4 p values of potential tiptop-affected lines compared to both KK-elavGAL4 and
KKtiptop-elavGAL4. The background with the smaller phenotype was chosen, indicated in
orange. Red is an increase compared to controls, blue is a decrease, and significant results
are highlighted
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6.8 Phenotype of transcriptomic genes
The feeding and physiology phenotypes of flies with neuronal RNAi of each of the mouse
hypothalamic transcriptomics genes are shown in figures 6.5 to 6.9, with the overall scores
shown in figure 6.10. As can be seen, each assay detected multiple significant changes, and
many nearly significant changes. Almost all of the significant increase phenotypes are seen
in the anorexigenic genes (genes whose expression decreases in NPY neurons during fasting),
rather than in the orexigenic genes (whose expression decreases in POMC neurons during
fasting). The scores have a large range (0.34 to 0.98) meaning that the top hit genes can
clearly be distinguished from those at the bottom.
Genes which were not hits
Based on their score (<0.7) and the individual assay results in the Drosophila-based screen,
the following 31 mouse genes were not deemed worthy of further study: Epb4.1l4b, Gpn3,
Rbfox1, Pygl, Ccdc132, Syt7, Lipa, Smpdl3b, Pura, Acvr2a, Vps39, Atp2b2, Kcnq3, Nalcn,
Nmt1, Fat3, Prkaa1, Hcrtr2, Hsd17b12, Fam162a, Tubb4b, Ssr4, Arpc5l, Gem, Prkcsh,
Spred2, Spred3, Ddah1, Chml, Rasgef1a and Rasgef1c.
From the genes with a score >0.7, there was one mouse gene (Nr1d2) which shows
decrease phenotypes in assays of both energy intake and physiology. As has been mentioned
in previous chapters, this can be a sign of unhealthiness rather than an energy homeostasis
phenotype, and so this gene is likely not worthy of further study.
Genes with discordant results
In addition, there were 6 mouse genes with a score >0.7, but with discordant assay results
in the Drosophila-based screen: Cacnb4, Dtna, Pofut1, and Rps6ka6 showed an increase in
food intake but a decrease in measures of physiology, and Slc44a5 and Kcnj3 showed the
opposite phenotype. These genes may be worthy of further study, but are not considered the
top hits.
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Top hit genes
Finally, there are 10 mouse genes for which neuronal RNAi in Drosophila causes an increase
in both food intake and measures of physiology, giving an overall score >0.7. These genes
are the top hits for further study: Lrch2, Tub, Cdk14, Aldh6a1, Rps6ka5, Nedd4l, Sylt4,
Elavl2, Rufy2, and Htr1a.



























































































































































































































































































































































































Fig. 6.5 Food intake with CAFE assay by flies with neuronal RNAi of transcriptomics-
identified genes. Background control lines are black, orexigenic genes are grey, anorexigenic
genes are white, and the 10 top hit genes are highlighted in red. Mean ± SEM is plotted
of 5 repeats each containing 8 flies. Results were compared to appropriate background by
Student’s t-test. * p<0.05, ** p<0.01, *** p<0.001
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Fig. 6.6 Ingestion of dye food by flies with neuronal RNAi of transcriptomics-identified
genes. Background control lines are black, orexigenic genes are grey, anorexigenic genes are
white, and the 10 top hit genes are highlighted in red. Mean ± SEM is plotted of 5 repeats
each containing 15 flies. Results were compared to appropriate background by Student’s
t-test. * p<0.05, ** p<0.01, *** p<0.001





















































































































































































































































































































































































Fig. 6.7 TAG levels in flies with neuronal RNAi of transcriptomics-identified genes. Back-
ground control lines are black, orexigenic genes are grey, anorexigenic genes are white,
and the 10 top hit genes are highlighted in red. Mean ± SEM is plotted of 5 repeats each
containing 15 flies. Results were compared to appropriate background by Student’s t-test.
* p<0.05, ** p<0.01, *** p<0.001






















































































































































































































































































































































































Fig. 6.8 Mass of flies with neuronal RNAi of transcriptomics-identified genes. Background
control lines are black, orexigenic genes are grey, anorexigenic genes are white, and the 10
top hit genes are highlighted in red. Mean ± SEM is plotted of 5 repeats each containing 15
flies. Results were compared to appropriate background by Student’s t-test.
* p<0.05, ** p<0.01






























































































































































































































































































































































































Fig. 6.9 Glucose levels in flies with neuronal RNAi of transcriptomics-identified genes.
Background control lines are black, orexigenic genes are grey, anorexigenic genes are white,
and the 10 top hit genes are highlighted in red. Mean ± SEM is plotted of 5 repeats each
containing 15 flies. Results were compared to appropriate background by Student’s t-test.
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001
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Results summary
CAFE Dye Food TAG Mass Glucose
Cacnb4 / Ca-beta / VT38
Dtna / Dyb / VT46
Pofut1 / O-fut1 / VT20
Lrch2 / Lrch / VT43
Tub / ktub / VT25
Slc44a5 / Ctl2 / VT31
Nr1d2 / Eip75B / VT44
Rps6ka6 / S6kII / VT41
Gda / DhpD / VT39
Cdk14 / Eip63E / VT36
Kcnj3 / Irk2 / VT28
Htr1a / 5-HT1B / VT52
Aldh6a1 / CG17896 / VT35
Rps6ka5 / JIL-1 / VT45
Nedd4l / Nedd4 / VT40
Sytl4 / btsz / VT33
Elavl2 / fne / VT54
Rufy2 / CG31064 / VT37
Htr1a / 5-HT1A / VT51
Rasgef1a & Rasgef1c / CG7369 / VT49
Epb4.1l4b / yrt / VT16
Elavl2 / Rbp9 / VT53
Gpn3 / CG2656 / VT17
Rbfox1 / Rbfox1 / VT48
Pygl / GlyP / VT23
Ccdc132 / Vps50 / VT26
Syt7 / Syt7 / VT24
Lipa / CG18301 / VT30
Smpdl3b / CG32052 / VT32
Pura / Pur-alpha / VT22
Acvr2a / put / VT14
Vps39 / Vps39 / VT34
Atp2b2 / PMCA / VT15
Kcnq3 / KCNQ / VT29
Nalcn / na / VT18
Rasgef1a & Rasgef1c / CG4853 / VT50
Nmt1 / Nmt / VT19
Fat3 / kug / VT27














































CAFE Dye Food TAG Mass Glucose
Hcrtr2 / SIFaR / VT8
Hsd17b12 / spidey / VT3
Fam162a / CG9231 / VT6
Tubb4b / betaTub56D / VT1
Ssr4 / Tapdelta / VT12
Arpc5l / Arpc5 / VT2
Gem / Rgk1 / VT7
Prkcsh / GCS2beta / VT9
Spred2 & Spred3 / Spred / VT11
Ddah1 / CG1764 / VT5


















Fig. 6.10 RNAi screen of (top) anorexigenic genes and (bottom) orexigenic genes. Genes are
ordered according to score. The top hit genes are highlighted with an arrow.
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6.9 Published data regarding top hits
According to data available at Uniprot (Bateman et al., 2017), the top hit genes have a range
of (predicted) biochemical functions, as summarised below:










Aldh6a1 valine and pyrimidine metabolism
Of the 10 top hit genes, there are published studies for 6 of the genes (Tub, Htr1a, Rufy2,
Sytl4, Cdk14, Nedd4l) in which an energy homeostasis phenotype was seen when the gene
is mutated in mouse and/or humans. No such data was found for Aldh6a1, but the gene
has been statistically associated with metabolic disease (Timmons et al., 2018). Finally, for
Lrch2, Elavl2, and Rps6ka5 no relevant studies were found. This data is summarised in table
6.2.
Also, it is worth noting that there are published studies linking several of these genes
to the same human diseases that were used in chapter 3 as negative genetic controls, for
example ELAVL2 and schizophrenia (Yamada et al., 2011), and SYTL4 and autism (Butler
et al., 2015).
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6.10 Discussion
6.10.1 Selection of mouse genes for study
The RNAseq data provided from Henry et al.’s paper reported the expression levels of 4889
genes whose expression was significantly different between the fed and fasted states in
POMC and/or NPY neurons. Many different criteria could have been used to further filter
the data but the aim here was to identify some genes which are promising candidates for
further study, and not to provide a definitive answer as to the role of each gene. Therefore,
there is no single "correct" set of filters. In this study, mouse genes were chosen if they
showed (i) significant changes in expression between the fed and fasted states, (ii) reciprocal
changes in expression between POMC and NPY neurons, and (iii) a strong homologue in
humans, because genes which meet all of these three criteria are the most likely to have
future therapeutic potential for obesity (section 6.4).
6.10.2 Identification of Drosophila gene orthologues
Drosophila orthologues of the selected hypothalamic fasting mouse genes were identified
using the ENSEMBL ortholog tool. Using this method, 58% of the mouse genes were
found to have an orthologue in flies (section 6.4), which is approximately the same as the
genome-wide average of 53% (Wangler et al., 2017). This level of conservation was high
enough for the data set to benefit from a Drosophila-based screen.
Given that energy homeostasis and feeding are important fundamental processes for all
organisms, it is likely that any associated genetic data will show either similar or increased
levels of conservation between species, and thus could be interrogated using the same
Drosophila-based approach. The absence of homologues for 42% of the hypothalamic
RNAseq genes is not a problem in this particular scenario, because the aim was to select
promising candidates from a large list. However, if a data set requires direct comparison of
the genes (for example, discriminating between genes in the same GWAS locus) but there is
not increased levels of conservation of genes, then a Drosophila-based screen may not be
appropriate.
The fact that the percentage of the hypothalamic fasting genes with an orthologue in
Drosophila was close to the genome-wide average highlights the importance of the GWAS
genes which were shown to have greatly increased levels of conservation — 79% of the
human genes had a fly orthologue (see section 4.14.1).
6.10 Discussion 211
The ENSEMBL orthologue tool used here searches for homologous genes based mostly
on sequence similarity. The screening strategy used here relies on the assumption that, as well
as conservation of sequence, genes also have conserved functions in Drosophila and cause
similar phenotypes when perturbed. This is not always the case, and evolution has repurposed
many conserved molecular systems such as signal transduction pathways (Wangler et al.,
2017). This is a major limitation of working with Drosophila which is only distantly related
in evolution to humans. However, as mentioned previously, the aim of this screen was to find
top candidates for further study from the large list of hypothalamic transcriptomic genes, and
not to give a definitive answer as to the role of each gene. Therefore, any genes which are
detected by the Drosophila screen are much more likely to be important in humans because
evolution has conserved their function in energy homeostasis.
The genes studied in this chapter were all chosen because they are expressed in the
mouse hypothalamus. To increase the likelihood of the Drosophila genes being functional
homologues, they too had to be expressed in the fly CNS. According to published microarray
data (Graveley et al., 2011) only 67% of the genes were expressed in the Drosophila CNS.
As discussed in chapter 4.14.1, this microarray data may under-estimate how many genes
display conserved expression. By comparison, 92% of the GWAS BMI genes were expressed
in the Drosophila CNS (chapter 4.6) which again highlights the importance of that set of
genes.
As explored in chapters 3-5, RNAi seemed the most appropriate model for use in the
Drosophila-based screen for a number of reasons. However, for the gene set in this chapter,
some genes did not have any siRNA line available, and others only had siRNA lines with
multiple predicted off-target effects. In total siRNA lines were only ordered for 82% of
the Drosophila genes of interest. Therefore, although the number of mouse genes with fly
homologues was calculated above, this is a slight over-estimate of the number of genes which
can actually be studied. Again, this is not a problem in this particular scenario but is an
important factor to consider for any future applications of this screen.
Therefore, in total, 52 mouse genes were studied in Drosophila.
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6.10.3 A large-scale high-throughput in vivo screen of genes
The primary aim of this thesis was to develop a high-throughput in vivo screen suitable for
use on large data sets for feeding behaviour and energy homeostasis phenotypes. The speed
for which the data in this chapter was collected (6 weeks, 52 genes of interest, 5 phenotypes
each, section 6.5) shows that the developed screen undeniably fulfils these criteria.
In the same time period it would not be possible to breed a mouse to adulthood. Further,
mice with perturbation (especially tissue-specific perturbation) do not yet exist for most
genes and so would have to be created de novo. Therefore, the overall aim of this thesis was
achieved. The only caveat is that not all of the genes could be studied in Drosophila due to
lack of a homologue, but all of the genes are present in mice.
6.10.4 Phenotype of genes
Each gene was phenotyped using neuronal RNAi and the following five assays: CAFE assay
food intake, ingestion of dye food following fasting, TAG levels, wet mass, and glucose
levels (section 6.8). Further, whether the gene was lethal or viable with whole body RNAi
was assessed.
Lethality
The proportion of genes which were lethal with universal RNAi (31%) is close to the genome-
wide average (section 6.6). This tentatively suggests that it would be possible to create viable
mouse KO models. Further, this result highlights the importance of the GWAS genes for
which the lethality was found to be increased (section 4.7).
Over-expression of tiptop
Whenever possible, siRNA lines with a GD background were ordered in preference to KK.
However, there were still 17 genes for which KK lines had to be used. Of these, 7 were
lethal when crossed to act-GAL4 so were considered as possibly being affected by tiptop,
thus hampering the interpretation of the data and reducing confidence in the results for these
7 genes (section 6.7). Therefore, quite a significant proportion of genes were difficult to
study due to tiptop ambiguity. Although it is better to have a false negative result than a false
positive for the purpose of candidate gene selection this factor does decrease the proportion
of genes which can be studied.
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However, just 10% of genes are only available as KK lines (Dietzl et al., 2007), and
only 25% of KK lines are affected by tiptop (Vissers et al., 2016). Therefore, it is only
(approximately) 2.5% of all Drosophila genes for which the only option is a tiptop-affected
siRNA line. This is much lower than the 25% of the genome which has a lethal phenotype
when mutant (Wangler et al., 2017) and so perhaps the impact of this problem will be
negligible in most screens. Indeed, other published papers (for example Pendse et al. (2013)
and Baranski et al. (2018)) did not state any control for tiptop over-expression. Therefore,
this limitation of the RNAi model may not be hugely detrimental, but should always be taken
into consideration.
Anorexigenic vs orexigenic genes
There were multiple noteworthy results of interest in the anorexigenic genes (section 6.8). It
is not surprising that significant increases in feeding behaviour are seen after RNAi of these
genes given that:
1. activation of NPY neurons triggers feeding behaviours (Aponte et al., 2011)
2. fasting activates NPY neurons (Hahn et al., 1998)
3. fasting decreases expression of the anorexigenic genes in NPY neurons (Henry et al.,
2015)
4. and RNAi causes a decrease in expression of these genes in fly neurons.
In contrast, there are no results of note in the orexigenic genes (which decrease in POMC cells
during fasting), based on either the score or the individual assay results. Perhaps increasing
expression of these genes would produce a phenotype.
However it should be noted that more anorexigenic genes were studied than orexigenic
genes, and so the fact that more significant phenotypes were observed in the former may not
be significant.
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Genes which were not hits
No hits were found in the Drosophila-based screen for 31 of the hypothalamic mouse genes.
Possible reasons that these genes did not test positive in the Drosophila screen are the same
as those discussed in chapter 4 in relation to the GWAS genes. Briefly: the siRNA was not
effective; the Drosophila gene is not a functional orthologue of the mouse gene; the gene
only causes a phenotype when up-regulated; the screen was too stringent; and/or it is difficult
to ascertain the true phenotype of potential tiptop-affected lines. Alternatively, it is possible
that these mouse genes do not actually play a role in energy homeostasis, and the changes in
expression observed upon fasting are instead part of a different pathway.
Genes with discordant phenotypes
The homologues of Cacnb4, Dtna, Pofut1 and Rps6ka6 showed an increase in food intake
but a decrease in measures of physiology. The homologues of Slc44a5 and Kcnj3 showed
the opposite phenotype. It is possible that these genes also had an energy expenditure
phenotype which could explain the discordant results, but which was not measured as part
of the screen. Indeed, CACNB4 mutations have been shown to cause ataxia and epileptic
seizures in humans (Escayg et al., 2000) and deletion of Pofut1 in mice affects skeletal
muscle and motor neurons (Zygmunt et al., 2017). These genes are perhaps worthy of further
investigation in mammalian models, but should not be prioritised.
Gene with decrease phenotypes
The homologue of Nr1d2 showed significant decreases in both energy intake and physiology.
As mentioned previously, it is possible that this genetic perturbation made the flies unhealthy,
rather than caused an energy homeostasis phenotype. In agreement, mice with KO of Nr1d2
show many pathological phenotypes across many different organs and systems (Dickinson
et al., 2016).
Genes which were hits
Finally, there are 10 genes for which neuronal RNAi in Drosophila causes an increase in
both food intake and measures of physiology. It is these genes which should be considered
for further study in complex mammalian models such as mice. This high hit rate (21% of the
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genes studied) is unsurprising, given that the starting list of genes was not random but was
instead selected based on a suspected role in energy homeostasis.
For 7 of these genes, there is published data from mouse and/or human studies. For Tub,
Htr1a, and Nedd4l there is strong evidence for a role of the gene in energy homeostasis, and
for Rufy2, Sytl4, Cdk14 and Aldh6a1 there is suggestive evidence. The supportive evidence
demonstrates the utility of using Drosophila as a high-throughput screen of genes for energy
homeostasis phenotypes.
For Lrch2, Elavl2, Rps6ka5, no published data was found regarding energy homeostasis
phenotypes. Although this data will, one day, be available, the speed of results generation
in mice is exponentially slower than that for Drosophila. Therefore, at least for the time
being, screens such as the one used here in Drosophila are the best way to obtain energy
homeostasis information for a large number of genes, so allowing prioritisation of which
mouse models should be made.
The top hit genes are not the most highly expressed genes in the mouse neurons, nor
the ones which show the largest changes in expression, and they have a variety of different
functions. Therefore, it is unlikely that these genes would have been selected for further
study based solely on the transcriptomic data. This highlights an important advantage of
the Drosophila-based screen: its ability to assess multiple candidates in an unbiased manner
(the screen was done blinded to genotype) allowing discoveries that may otherwise go
un-investigated.
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6.10.5 Further work
The Drosophila-based screen in this chapter identified 10 genes which are worthy of further
investigation. These genes have a variety of predicted functions and thus so require a multi-
disciplinary approach to study their underlying biochemistry and how this impacts energy
homeostasis.
On a cellular level, many experiments could be envisioned to answer questions such as
what other genes/gene products/substrates do they act on? By which genes/proteins are they
themselves regulated? Drosophila may prove to be a good model here as individual pathways
are often conserved even in cases where the overall function is not (Wangler et al., 2017).
Further, where in the cell do the gene products act? And what is their molecular function?
These questions are perhaps easiest to answer using cell culture techniques.
On a physiological scale, it is already known that these genes respond to starvation, but
are they affected by other nutritional perturbations such as HFD? Or by metabolic hormones
such as leptin, insulin or ghrelin? Do mice with KO of these genes eat more and/or have
increased stores of energy? Importantly for drug development, are mice with whole-body
perturbations of the gene viable and healthy? Do humans with KO of these genes exist, and if
so, do they have any measurable phenotype? Perhaps the most informative experiments would
to look at mice with hypothalamic-specific perturbation of the genes. Unlike in Drosophila,
there are no readily available lines for doing this in mice and the experiment would require
injection of the mutating reagents (for example Cas9 plus gRNAs) into the developing mouse
hypothalamus which is a difficult, expensive and time-consuming experiment, so would not




In summary, in this chapter, a Drosophila-based screen has proved itself to be a useful tool for
selecting top candidate genes for a role in energy homeostasis from a large genetic data set. A
set of 52 genes were identified which, based on hypothalamic transcriptomic data from Henry
et al. (2015), respond to fasting and thus may play a role in energy homeostasis. Drosophila
homologues of these genes were identified and then phenotyped using the screen developed
in chapters 3 and 4. The results were used to identify top candidates for further investigation
in mice to advance our understanding of how the CNS controls energy homeostasis, and thus




The causes of obesity are complex with biological, social, and psychological factors all
playing a role. It has been shown that genetics has a strong influence on obesity risk, and
understanding the underlying biology may provide a new avenue into developing novel
pharmaceutical reagents which are both specific and effective for the treatment of obesity.
The advent of modern genomics techniques is massively expanding the number of genes
which are potentially involved at a rate with which functional validation studies in mice —
the traditional model organism of choice for the study of energy homeostasis — cannot keep
pace.
Development and use of a high-throughput screen is important if we are to be able to
fully understand the genetic contribution to obesity. In this light, the aim of this thesis was to
develop a high-throughput screen for genes that are involved in the neuronal control of energy
homeostasis and feeding behaviour using Drosophila melanogaster as a model organism,
and to use this screen to explore data sets from GWAS and transcriptomics.
It is important to note that the primary goal here is not to add to knowledge about
Drosophila biology, as a plethora of such data already exists. Instead, the goal is to use the
fly model as an efficient screen to help move mammalian statistical data towards a functional
understanding. As described in chapter 1, studies with similar objectives have been done
before, but this is a novel approach due to the combination of: use of multiple assays to look
at several related characteristics; a focus on feeding behaviour; and starting from a list of
mammalian genes.
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Development of a Drosophila-based screen
A Drosophila-based screen for energy homeostasis phenotypes was developed and refined
through chapters 3, 4, 5 and 6. To begin, this involved finding and adapting assays from
published literature. These assays were tested for their ability to detect metabolic perturbation,
their ability to distinguish negative control genes from positive control genes, and whether
they were high-throughput. Based on these criteria, not all assays were used in the final
screen: the dry mass was found to be too insensitive, and the dye food absorption assay was
shown to produce inaccurate results. However, the CAFE, dye food over-feeding, wet mass,
TAG, glucose, starvation, climbing and larval feeding assays were all found to be suitable to
use together to form the screen. The rate-limiting step was the CAFE assay due to possession
of only a limited amount of equipment (the lids needed to hold the feeding capillary tubes)
but this could easily be remedied by purchase of more. In addition, an assay to measure
feeding motivation in adults was developed, although this was low-throughput and so only
suitable for use on the top hit genes.
As stated above, one way in which the screen was validated involved control genes.
However, as was discussed in chapters 3, 4 and 6, it is possible that the genes chosen to use
as both positive and negative controls were not ideally suited for this purpose. In particular,
the negative controls were genes which have been associated with other diseases, but these
diseases are not independent of weight, and it was later found that many of the BMI GWAS
genes and hypothalamic transcriptomics genes that were studied have been related to these
same diseases. Therefore, it is possible that the screen is overly stringent and will miss
significant phenotypes. However, given that the purpose of the screen was to select top
candidate genes, it is highly preferable for the screen to have false negative results than for it
to to be too lenient and detect false positives.
Development of the screen also involved comparing and contrasting three different
Drosophila genetic models: LoF (mostly P-element mediated), CRISPR, and UASG-GAL4
RNAi. The various pros and cons of each method were discussed in chapters 3 and 5, and
ultimately RNAi was found to be the most appropriate for use in this screen.
As was seen in chapter 6, the final screen is high-throughput, especially when compared
to mice, and thus the primary aim of this thesis was met.
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Limitations of a Drosophila-based screen
The Drosophila-based screen was used to generate novel results in chapters 4 and 6, thus
proving its utility. However, there are a few limitations of both the screen itself and the
reliability of the data obtained.
It is possible that the siRNAs in some of the lines had off-target effects which were
responsible for the phenotype observed, rather than the gene of interest. Thus, results should
be viewed with some degree of caution. However, since the studied genes were selected
because they are already suspected to be involved in energy homeostasis, the chance of an
off-target effect causing the same phenotype is less likely.
Some might argue that the small size of Drosophila is a disadvantage, since it makes
phenotyping more difficult due to the requirement for more sensitive equipment. However,
this can be easily rectified by measurements of groups of flies, and is compensated for by the
fact that their small size is one of the reasons that working with Drosophila is so economical
and high-throughput.
Instead, the major limitation of using Drosophila to screen the human/mouse genes is that
not every gene can be studied. This may explain why some of the genes which are already
known to have a role in energy homeostasis (for example TMEM18) were not detected in the
screen. Genes are lost at five stages:
1. A gene of interest may not have an identifiable sequence homologue in Drosophila.
The number of genes for which an orthologue was found was increased compared to
the genome average for the GWAS BMI genes (chapter 4), but not for the hypothalamic
transcriptomic genes (chapter 6). Since human genes linked to monogenic disorders
also show increased levels of conservation in Drosophila (Fortini et al., 2000), this
suggests that genetic data linked directly to diseases (like GWAS data) could gain the
most benefit from the Drosophila-based screen in the future.
2. Any sequence homologues which are identified may not also be a functional homologue
of the human gene, potentially leading to false negative results. Whether this is a
problem depends on the exact purpose of the specific screen. For example, with the
hypothalamic transcriptomics data in chapter 6, the purpose was to choose genes for
further study, and there is no single "correct" answer and so a false negative result is
allowable. However, when used for discriminating between genes in the same GWAS
locus as in chapter 4, it is only a fair test if all of the genes can be studied.
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3. 9% of Drosophila genes do not have any UASG-siRNA lines available to order, and
for some genes the only siRNA lines available have multiple known off-target effects.
Again this may not be a problem depending on the purpose of the study. If it is
important to study all of the genes, then another model could be used, for example LoF
flies, although there is no guarantee that all of the genes of interest will be available
with any model.
4. Another limiting factor is lethality. No genes in this thesis were found to be lethal with
neuronal RNAi, but this is unlikely to be universally true. Further, a different GAL4
driver may increase the rates of lethality, as was found in the paper by Baranski et al.
(2018).
5. Finally, for 2.5% of genes, the only siRNA line available is affected by over-expression
of tiptop which causes strong energy homeostasis phenotypes. However, there is
currently no definitive list of which lines are affected, meaning that this genotype had
to be ascertained instead by looking at the phenotype of the flies. Therefore, there is a
large degree of uncertainty regarding the "true" phenotype of these lines, meaning that
false negative results may be introduced. Further, it meant that GD lines were always
chosen in preference, which the VDRC stock centre states achieve less efficient RNAi
compared to the KK lines (VDRC, 2016), potentially introducing more false negative
results.
Advantages of a Drosophila-based screen
The major advantage of the Drosophila-based screen developed and used in this thesis is the
speed with which results are generated. In chapter 6, 50 genes were screened in 6 weeks. The
speed could be increased further by purchase of more CAFE assay lids. By comparison, this
figure is completely unrivalled by mice: the IMPC, whose stated aim is to screen mice in a
high-throughput manner, have a large number of people working on an optimised production
pipeline, but only hope to generate 100 KO mouse lines per year at a cost of £28,000 per
gene (Moore, 2010). Even if a mutant mouse line already exists for a gene of interest, it takes
more than six weeks just to breed new mice for experiments. Further, the IMPC mice have
whole-body KO mutations of the genes, which as was seen repeatedly through this thesis,
is often detrimental and the information provided is not as useful as neuron-specific data.
Although neuron-specific experiments are possible in mice, there are no readily available
lines for doing so and so the mouse models must be produced de novo.
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In both of the data sets screened in this thesis (BMI GWAS in chapter 4 and hypothalamic
transcriptomics in chapter 6), there were a large number of positive findings. This suggests
that much of the biological machinery regulating energy homeostasis is conserved in evo-
lution, which is perhaps unsurprising given its fundamental importance for life. Therefore
there is a strong argument for the utility of high-throughput functional genetic screens in
simple model organisms such as Drosophila.
In its current set-up, the screen can be easily adapted to suit different data sets. Our lab
group is interested in the neuronal control of feeding behaviour, but the screen could be
applied to other tissues. For example, GWAS has identified loci which affect waist-to-hip
ratio, and it has been shown that genes in these loci are preferentially expressed in adipose
tissue. Thus it may be pertinent to explore this data set using RNAi in the Drosophila fat
body driven by Lsp2-GAL4 (Lazareva et al., 2007).
Findings from two Drosophila-based screens of mammalian
genetic data
The developed and validated screen was used to investigate two mammalian genetic data sets
related to energy homeostasis. 53 human genes in loci that GWAS studies have associated
with BMI were explored in chapter 4. Then, in chapter 6, 52 mouse genes which have been
shown to be reciprocally regulated in POMC and NPY hypothalamic neurons by fasting were
studied.
For both data sets, the screen found several genes with a positive energy homeostasis
phenotype in Drosophila. For approximately half of these genes, there are published studies
in mouse and/or humans which show that they do indeed play a role in energy homeostasis:
PCSK1, NEGR1, MTIF3, CDKAL1, and BDNF from the human GWAS BMI genes, and
Tub, Htr1a, Rufy2, Sytl4, Cdk14, Nedd4l, and Aldh6a1 from the mouse hypothalamic
transcriptomics genes. This provides validation that the screen is capable of detecting genes
with a relevant phenotype.
The most interesting genes highlighted by the screens were those for which a positive
energy homeostasis phenotype was observed but for which no mouse/human data has yet
been published. It is these genes which have the most potential to be rewarding for a lab to
study further. From the screen of human GWAS data these genes were: LRRN6C, KLF9,
NRXN3, GABRG1, SEC16B, TUFM, NUDT3, and COL4A3BP. From the screen of mouse
hypothalamic transcriptomics data these genes were: Lrch2, Elavl2, and Rps6ka5. Thus, the
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second aim of this thesis was met: to find novel evidence for a role of genes-of-interest in
energy homeostasis.
Further, RNAi of some of the genes in the screen caused the flies to have a negative energy
homeostasis phenotype. It is not possible to distinguish the cause of such results between
(i) a true lean phenotype caused directly by the gene of interest acting on feeding pathways,
or (ii) a side-effect of the gene perturbation which makes the flies unhealthy and therefore
less developed and/or less motivated to eat. However, a very unhealthy phenotype has also
been reported in mouse models and human patients for some of these genes, suggesting that
the latter hypothesis is true: SLC39A8, MTCH2, RPL27A, Nr1d2. Therefore an important
use of a Drosophila-based screen could be to filter out any genes which are detrimental (or
lethal) before resources are used to develop a mouse model which turns out ultimately to just
be unhealthy or non-viable.
There is currently debate as to whether GWAS studies of BMI are useful in relation to the
study of obesity (see Müller et al. (2018) and Speakman et al. (2018)). Two results from this
thesis highlighted how significant the genes which have been identified by GWAS to date
are: a higher proportion of the genes are conserved in Drosophila compared to the genome
average, and a higher proportion are lethal with whole body perturbation, both of which
suggest that the genes play an important role in physiology. In comparison, both of these
figures are close to the genome average for the hypothalamic transcriptomic genes.
Future work
Drosophila studies of top hits
Through this thesis neuron-specific RNAi was found to be the most suitable model for
the purpose of a screen for genes involved in the neuronal control of energy homeostasis.
However, RNAi does have the potential for off-target effects. Given the investment required
to follow up a gene in a mouse model, it is perhaps wise to first confirm the results seen
in another Drosophila line. The easiest method of doing so would be to use a different
siRNA line. However, for many genes this does not exist, and for those which it does this
second line is equally likely to have off-target effects, or may contain a non-functional
siRNA. A more accurate approach may be to develop a functional method of performing
tissue-specific CRISPR, and various approaches for trying to do so were discussed in chapter
5. However, the genes studied all originally came from lists of human/mouse data for which
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there is already statistical data suggesting a role in energy homeostasis, and so perhaps further
validation in Drosophila is unnecessary.
Mouse studies of top hits
The next step would be to study in mice the genes which were top hits in the Drosophila-based
screen. Based on the Drosophila work throughout this thesis, it is perhaps worth investing
in the creation of brain-specific perturbations of the genes in mice. Examples of potential
experiments were put forward in chapter 6 to investigate both the biochemical function of
these genes as well as phenotypes caused by their perturbation. If mouse studies prove
successful, the final goal would be studies in human, ultimately leading to the development
of therapeutics for obesity.
Future screens in Drosophila
The same Drosophila screen developed and used in this thesis could also be used to explore
other large mammalian genetic data sets. As just one example, the lab group has looked
at transcriptional changes in different parts of the mouse hypothalamus (in contrast to
Henry et al. who looked at different cells but spread across the whole hypothalamus) in
all of the fed, fasted and HFD-fed states. There are also many published papers which
present transcriptomic data in various different tissues and/or states, and multiple GWASs
for phenotypes related to energy homeostasis including more recent studies of BMI (Locke
et al., 2015; Akiyama et al., 2017).
As discussed above, the screen can be adapted to look at other tissues. It can also be
adapted to look at different/more phenotypes. In particular, a more sensitive way of measuring
movement and/or energy expenditure would be a useful addition. One solution would be to
use the same climbing assay used in chapters 3 and 4, but to increase the climbing distance,
for example some labs put single flies into a 50cm long tubes. Alternatively, a method
which simultaneously and automatically measures both food intake and movement of a fly is
currently in development in other labs (Ja, 2018). Other work in the lab group is currently
developing a respirometer to measure production of carbon dioxide by flies as a measure of
metabolic rate. However, all three of these methods are low-throughput, and thus not suitable
for studying large data sets. There are also more assays of feeding behaviour which could be
added to the screen, such as larval mouth hook contraction (Bhatt and Neckameyer, 2013),
adult proboscis extension (Shiraiwa and Carlson, 2007) and food preference (Bantel and
Tessier, 2016), but again these are all low-throughput. Although not suitable for large scale
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screens, these slower assays could be used as a secondary screen of just the top hit genes as
further verification of their phenotype.
Conclusions
In conclusion, in this thesis a high-throughput screen was developed in Drosophila for use in
functional validation of statistical genomic data from humans/mice. This screen was used to
investigate two data sets (GWAS BMI genes and fasting hypothalamic transcriptomics genes)
and identified many candidates worthy of further investigation. Some of these were already
known which provides important validation of the screen, but many are uninvestigated and
thus provide novel results. Follow-up studies of these genes in mammalian models may, one
day, progress our understanding of, and thus treatment of, obesity.
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Fig. A.3 Phenotype of flies fed HSD compared to those fed ND.
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Fig. A.5 Phenotypes of parental siRNA lines





































































































































































































































































































































































Fig. A.6 The KK, GD, act-Gal4 and elav-Gal4 lines have different phenotypes, so were bred
together to create lines for use as experimental controls.
Mean ± SEM is plotted. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
